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ABSTRACT
PROTEIN ASSOCIATION IN LIVING CELLS USING FRET
SPECTROMETRY: APPLICATION TO G-PROTEIN COUPLED
RECEPTORS
by
Suparna Patowary

The University of Wisconsin-Milwaukee, 2013
Under the Supervision of Professor Valerică Raicu

Recent advancements in fluorescence microscopy coupled with newly developed
fluorescent tags have transformed Fluorescence (Förster) Resonance Energy Transfer
(FRET) into a powerful tool studying in vivo molecular interactions with improved
spatial (angstrom) resolution. Though widely used to study protein-protein interactions,
generalizing and testing the FRET theory for oligomeric complexes containing multiple
donors and acceptors has only become possible in recent years. Therefore, many aspects
of it are yet unexplored.

In this work, we tested the kinetic theory of FRET using linked fluorescent
proteins located in the cytoplasm or at the plasma membrane. We used a novel method
developed in our lab that combines an optical micro-spectroscope (OptiMiS) with a
simple kinetic theory of FRET that relates the number and relative disposition of
monomers within an oligomer to the measured FRET efficiency in terms of the pair-wise
FRET efficiencies for an individual donor-acceptor pair in the oligomer. Using this
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framework, we showed that the measured FRET efficiencies of obligate trimers and
tetramers in living cells are correctly predicted by the kinetic theory of FRET.

The method was then used to study the oligomerization of G-protein coupled
receptors (GPCRs), which are cell surface signaling proteins that constitute a large family
of drug targets. The literature on GPCR homo-oligomerization encompasses conflicting
views that range from interpretations that GPCRs must be monomeric, through
comparatively newer proposals that they exist as dimers or higher-order oligomers, to
suggestions that such quaternary structures are rather ephemeral or merely accidental and
may serve no functional purpose. We used a novel FRET framework together with
Optical Micro Spectroscopy (OptiMiS) technology and controlled expression of energy
donor-tagged species of muscarinic M3 acetylcholine receptor, a GPCR of interest, to
show that M3R exists as stable dimeric complexes at the plasma membrane, a large
fraction of which interacts dynamically to form tetramers without the presence of trimers,
pentamers, hexamers, etc. This was also supported by co-immunoprecipitation of
receptors synthesized at distinct times. Based on these findings, we proposed a
conceptual model that may reconcile the conflicting literature views on the quaternary
structure of GPCRs.
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Chapter 1 Overview of FRET theory and its practical application
Proteins are known to play a vital role in most biological processes inside a cell such as
cell growth, gene expression, nutrient uptake, and intercellular communication (1). The
specific activity of proteins and their particular cellular responses has long been a subject
of intense discussions among researchers. The key aspects of protein functions include
the understanding of protein sequence and structure, evolutionary history and conserved
sequences, expression profile, post-translational modification, interaction with other
proteins or proteins of their own type, and intracellular localization (1). Several
techniques have been developed so far to study protein-protein interactions including
high-throughput surface-based identification of interacting protein pairs (2) and in vivo
protein interactions like co-immunoprecipitation, protein complementation assays (PCA)
etc. These techniques, however, are limited in their capability of identifying specific
protein interaction from among ~30,000 of proteins in a living cell (3). Techniques such
as fluorescence spectroscopy and fluorescence imaging were found promising to
investigate molecular association and protein-protein interactions in complex cellular
environments due to the capability of tagging protein of interest with fluorescent markers
(4-6). Fluorescence (Förster) resonance energy transfer (FRET) is one of the widely used
methods that proved to be significantly useful in detecting molecular organization and
protein-protein interaction both in vivo and in vitro (7-10). However, most of the FRET
measurement techniques that use conventional fluorescence microscopy require
sequential scans of emission wavelength, excitation wavelength, or both, making the
measurements time consuming limiting their applicability to study protein dynamics (11-
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13). A very promising method based on a spectrally resolved two-photon microscope
(14) and a competent theory of FRET (12, 15) has recently been proposed that is proved
to be successful in determination of protein complex size, configuration, and spatial
distribution in single living cells (16-18). This approach can also open up potential
pathways towards the understanding of dynamic cellular processes in living cells.

This thesis represents an effort of understanding the FRET theory coupled with
the optical micro-spectroscopy (OptiMiS) as applied to multimeric complexes of
fluorescent proteins, and use of the method to study the oligomerization of G-protein
coupled receptors (GPCRs) in living cells. GPCRs are the largest group of membrane
proteins that can be used as targets of many pharmaceutical drugs (19-22). As a first step,
we used the OptiMiS developed in our lab and the theory proposed by V. Raicu (23) to
validate FRET theory for multimeric complexes. Following the validation, we used this
method to determine the quaternary organization of muscarinic acetylcholine receptor
type 3, a GPCR of interest, responsible for various chronic diseases (24, 25). This chapter
provides a brief overview on the historical development of FRET theory and its diverse
application in a broad range of fields.

1.1

Energetic diagram representation of fluorescence and FRET

FRET, as the acronym stands for, is a phenomenon of non-radiative energy transfer
between two molecules in close proximity (< 10 nm distance). The molecules involved in
the energy transfer are usually fluorescent, though sometimes the energy is transferred
from a fluorescent donor to a non-fluorescent acceptor (4, 26, 27). The unique advantage
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of FRET is the capability to reveal the structure down to molecular scale (~ 10 nm) by
overcoming the limit of optical resolution (~ 200 nm).

Most of the recent FRET experiments are designed to excite a donor by
absorption of photons. Although the experimental details are relevant to how the donor is
excited, the energy transfer rate is independent of it. Once the donor is in the excited
state, it can lose its energy in three different ways: first, through emission of photons,
second, via non-radiative decay and third, transferring energy non-radiatively to nearby
fluorophores. The probability and the rate of de-excitation of the donor through any of
the pathways depend on all the possible pathways through which the donor can emit its
excitation energy to come to the ground state.

A schematic representation of light absorption and emission mechanism also
known as Jablonski diagram was first given by A. Jablonski in 1935. Fig. 1.1 shows a
classical Jablonski diagram illustrating FRET activity. SD0, SD1, and SD2 are the ground,
first, and second electronic states of the donor and SA0, SA1 are the ground state and the
first excited states of acceptor respectively. The vibrational energy levels for each
electronic state are represented by 0, 1, 2 etc. The first triplet state of the donor is
represented by TD1. The molecules can be in any of these vibrational energy states in an
electronic energy level.
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Figure 1.1: Jablonski diagram showing electronic transitions between energy levels. Incident light (hν 1) is
shown by curly blue arrow. Black solid lines represent singlet (S D for donor and SA for acceptor) and triplet
(TD for donor) energy levels corresponding to donor molecule (D) and acceptor molecule (A). Absorption
and emission transitions are shown by solid and dotted blue, green, and yellow lines. Curly orange and
purple arrows show vibrational relaxations, internal conversion (IC) and intersystem crossing (ISC)
respectively. The yellow curly arrow (hν2) from acceptor (A) shows acceptor emission. FRET is shown by
purple dotted arrow pointing from donor (D) to acceptor (A) as non-radiative energy transfer between
donor and acceptor.

In most cases, the donor is excited from the lowest vibrational energy level of the
ground state to the higher vibrational energy levels of SD1 or any higher energy states
than SD1 by absorbing a photon. Depending on the energy separation between SD1 and the
higher energy excited states, it can dissipate its energy through internal conversion (IC),
or thermal relaxation to the thermally stable lowest vibrational energy level of SD1 within
the time interval of 10-11 ─ 10-14 s. The donor molecules in lowest vibrational energy
level of SD1 can lose its energy through various pathways, some of which are dependent
on its molecular environment, e.g. proximity of the acceptors or quenchers and solvent
interactions etc. The process of de-excitation of donor to the ground state through
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emission of a photon is called fluorescence. The lifetime of an excited singlet state is 10-7
─ 10-9 s and hence fluorescence can occur typically in 10-8 s. The donor molecule can
also be de-excited to reach the ground state non-radiatively, converting all its energy into
heat. Donors in their lowest excited singlet state (SD1) can also undergo spin conversion
process to the triplet state (TD1) through the process known as intersystem crossing (ISC)
that is less probable than the singlet-singlet process and can occur within the lifetime of
fluorescence. Once the molecule is in the triplet state, it can undergo internal conversion
(10-7-10-9 s) to the lowest vibrational energy levels of triplet state. The reverse process
(TD1 → SD1) is highly improbable since the energy difference between the lowest
vibrational state of SD1 and the highest vibrational state of TD1 is larger than the internal
conversion energy. The process of emission from TD1 to the ground state is called
phosphorescence, which occur in the lifetime of the triplet state (10-4 – 102 s). Donor
molecule in the lowest vibrational energy state of TD1 can also undergo non-radiative deexcitation to the ground state. If another fluorophore (acceptor) molecule having
excitation energy lower than the emission energy of the donor is in close proximity (< 10
nm) of the donor; the donor molecules can transfer its energy to nearby (acceptor)
molecules through dipole-dipole coupling between the donor and the acceptor. In this
process, the acceptor molecules get excited non-radiatively from the ground to the first
excited state. Similar to the donor de-excitation process, the acceptor molecule de-excites
to the lowest vibrational energy state of first excitation level via vibrational relaxation
from where it can de-excite to the ground state by either photon emission or nonradiatively.
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1.2

Elementary theory of FRET

1.2.1 Historical overview
Although the practical application of FRET occurred after Förster’s quantum mechanical
explanation of Resonance Energy Transfer (RET) introduced in 1946, the first
experimental measurement of energy transfer between two molecules or atoms at a
distance much greater than their radii was performed by Cario and Franck in 1922 (28).
They observed emission from thallium atoms by exciting a mixture of mercury and
thallium vapors at the excitation wavelength of mercury (253.6 nm),

which was

attributed to the excitation of the thallium atoms through energy transfer from the excited
mercury atoms and was named as “sensitized fluorescence” (28). In 1928, Kallmann and
London (29) proposed quantum mechanical theory to explain transfer of energy between
interacting atoms at distance greater than their radii using second order perturbation
calculations. They showed that the effective cross-section (q) of two interacting atoms is
inversely proportional to the 2/3rd power of the difference in excitation energies (σ)
between the two interacting atoms i.e., 𝑞 ∝ 𝜎 −2/3 (28). Their theory was based on the
assumption that the energy levels of interacting atoms were in resonance.

A classical model of energy transfer between interacting molecules in solution
was first proposed by J. Perrin and F. Perrin, assuming the transition dipoles of the
interacting molecules as Hertzian electric dipoles. They also assumed that, if the distance
between two interacting molecules were sufficiently small, the energy transfer between
the molecules can occur non-radiatively, which was termed as “transfer d’ activation”
(28). They concluded that the rate of energy transfer is proportional to 1/R 3, R being the

7
distance between two interacting fluorophores, which is an order of magnitude higher
than the experimentally observed distances between the fluorophores. The central
assumption of Perrins’ derivation, i.e. the condition for exact resonance between the two
fluorophores, led to a large value of the distance between the fluorophores at which
energy transfer may occur. Later, Förster in his work (30) showed that the resonance
between the dipoles is not restricted to only one wavelength, because of the broadening
of the energy levels in solution caused by the vibrational and collisional effects between
the molecules. Following the principle of energy conservation between the states of
energy transfer from a donor to an acceptor, the condition of resonance is limited to their
overlapping spectra. Therefore, the probability of energy transfer between donor and
acceptor depends on the overlap between the donor emission spectrum and acceptor
excitation spectrum and thus is calculated by integrating the overlapping spectra of the
donor’s emission and the acceptor’s absorption. Förster’s theory agrees well with the
measured distance between interacting molecules.

1.2.2 Perrins’ classical model of energy transfer between two identical Hertzian
dipoles
J. Perrin (31) gave the derivation of the interaction energy between two Hertzian dipoles
based on the classical mechanics. F. Perrin extended his theory by developing a
corresponding quantum mechanical approach (28, 32, 33).
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Figure 1.2: Parameterizing the orientations of donor and acceptor dipole moments. Dipole planes for
donor and acceptor are shown in green and yellow making an angle Φ with each other. Green and yellow
lines on the planes are dipole moments for donor and acceptor respectively; 𝜃𝐷 , 𝜃𝐴 are the angle between
the separation vector 𝑅̂ and dipole moment of D and A respectively and 𝜃𝑇 is the angle between dipole
moment of D and A.

The classical model of J. Perrin considered two identical oscillating dipoles
“Donor” (D) and “Acceptor” (A) with respective dipole moments 𝜇⃗𝐷 and 𝜇⃗𝐴 , separated
by a distance 𝑅⃗⃗ as shown in Fig. 1.2. These correspond to the transition dipoles of the
excited molecules. The electric field (𝐸⃗⃗𝐷 ) originating from the oscillating dipole ‘D’ in
the near field zone can be written as:

𝐸⃗⃗𝐷 =

1
𝑛2 𝑅 3

[3(𝜇⃗𝐷 . 𝑅̂ )𝑅̂ − 𝜇⃗𝐷 ]

(1.1)

where n is the refractive index of the medium. The interaction energy experienced by the
dipole ‘A’ in the presence of the electric field 𝐸⃗⃗𝐷 can thus be expressed as:
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𝐸𝑖𝑛𝑡 = −𝜇⃗𝐴 . 𝐸⃗⃗𝐷 =

1
𝑛2 𝑅 3

[(𝜇⃗𝐷 . 𝜇⃗𝐴 ) − 3(𝜇⃗𝐷 . 𝑅̂ )(𝜇⃗𝐴 . 𝑅̂ )]

(1.2)

For identical dipoles, |𝜇⃗𝐷 | = |𝜇⃗𝐴 | = 𝜇. Therefore, equation (1.2) can be written as:

𝐸𝑖𝑛𝑡

𝜅𝜇 2
= 2 3
𝑛 𝑅

(1.3)

where
𝜅 = [(𝜇̂ 𝐷 . 𝜇̂ 𝐴 ) − 3(𝜇̂ 𝐷 . 𝑅̂ )(𝜇̂ 𝐴 . 𝑅̂ )]

(1.4)

is the orientation factor. Using Planck’s ‘old’ quantum theory, equation (1.3) can be
written as:
𝐸𝑖𝑛𝑡

𝜅𝜇 2
ℏ
= 2 3 = ℎ𝜔𝑖𝑛𝑡 =
𝑛 𝑅
𝜏𝑖𝑛𝑡

(1.5)

where, h is the Planck’s constant, 𝜔𝑖𝑛𝑡 is the angular frequency corresponding to the
interaction energy 𝐸𝑖𝑛𝑡 , 𝜏𝑖𝑛𝑡 is the time period of the oscillating donor, and ℏ = ℎ/2.
Rearranging equation (1.5), the interaction time period can be expressed as:

𝜏𝑖𝑛𝑡

ℏ𝑛2 𝑅 3
=
𝜅𝜇 2

(1.6)

For Hertzian oscillating dipole, the energy of the radiation and the radiation time constant
can be written as (28, 34):
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𝐸𝑟𝑎𝑑

𝜇 2 𝜔3
=
3𝑐 3

(1.7)

3ℏ𝑐 3
𝜇2𝜔 3

(1.8)

and
𝜏𝑟𝑎𝑑 =

where 𝜔 is the frequency of the Hertzian donor oscillator and c is the speed of light. In
order to calculate the distance R0 between the oscillating dipoles at which the natural
decay time of the oscillator is equal to the time of energy transfer i.e. 𝜏𝑟𝑎𝑑 = 𝜏𝑖𝑛𝑡 (28,
29), equations (1.6) and (1.8) give,

𝑅03 =

𝜆

or, 𝑅0 = 2𝜋, using 𝑐 = 𝜈𝜆 =

3𝜅𝑐 3
3𝜅
= 2
𝜆3 ≈ 0.01𝜆3
2
3
𝑛 𝜔
𝑛 (2𝜋)3

𝜔𝜆
2𝜋

(1.9)

. At this distance between D and A, half of donor’s

energy that would have been emitted radiatively is transferred non-radiatively to the
acceptor. This calculation of R0 shows that the energy transfer from an oscillating donor
to a stationary acceptor can take place at a distance comparable to the wavelength of the
radiation (or light). For 𝜆 = 600 nm, the value of R0 was found to be 120 nm which is an
order of magnitude higher than the experimental value.

1.2.3 Förster’s correction to Perrin’s model
Förster pointed out that the large theoretical value of R0 in Perrin’s derivation was due to
the assumption of exact resonance between the two interacting particles. In reality,

11
Förster stated, there exists an energy distribution for an ensemble of molecules in a
solution, because of intramolecular and solvent interactions, which results in spectral
broadening and should be accounted for carefully (26, 28). Because of this spectral
broadening, the probability of exact resonance is very low since the emission spectra of
the excited molecule and the absorption spectra of the unexcited molecule are different
and have overlapping spectra only for a particular wavelength as shown in Fig 1.3 (a).
Therefore, the condition of exact resonance will occur only for a very short period of time
during the long time required for energy transfer (26).

Figure 1.3: Spectral overlap between donor emission and acceptor absorption spectra. (a) Representative
intensity vs. angular frequency plot for donor emission and acceptor absorption; hatched area in the plot
shows overlapping spectra of donor and acceptor. (b) Areas under the spectral plot for donors and acceptors
are represented by rectangles of angular frequency of width Ω; hatched area with angular frequency width
𝛺′ shows the overlapping area corresponding to the overlapping area of (a).

Förster calculated the time needed for energy transfer from D to A in terms of the
probability of overlapping frequencies and probability of having simultaneously the same
energies for the two fluorophores within the small interaction energy. Assuming same
spectral width for both the fluorophores and considering Ω and Ω′ to be the spectral
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width and overlapping spectral width respectively (Fig 1.3 (b)) then the probability of
spectral overlap of two fluorophores can be given as Ω′ /Ω, while the probability of the
bandwidth Ω falling within the narrow coupling bandwidth of 𝐸𝑖𝑛𝑡 /ℏ, is given as

𝐸𝑖𝑛𝑡
ℏΩ

.

Hence, the simultaneous probability of occurrence of the above two independent events is
Ω′ 𝐸𝑖𝑛𝑡
Ω ℏΩ

(35). Therefore the interaction energy is corrected to

Ω′ 𝐸𝑖𝑛𝑡
′
𝐸𝑖𝑛𝑡
=(
) 𝐸𝑖𝑛𝑡 .
Ω ℏΩ

(1.10)

Using equation (1.5) for 𝐸𝑖𝑛𝑡 , Förster’s correction to the dipole interaction time can be
written as:
′
𝜏𝑖𝑛𝑡
=

ℏ 2 𝑛 4 𝑅 6 Ω2
.
𝜅 2 𝜇 4 Ω′

(1.11)

Hence, the distance at which the radiative energy is same as the non-radiative energy
transfer, also termed as Förster distance, that is calculated using equation (1.8) and (1.11)
as:
𝑅06

giving 𝑅0 <

0.1𝜆
2𝜋

3𝜅 2 𝜇 2 𝑐 3 Ω′
𝜆 6 𝜅 2 Ω′ 1
=
= 9( ) 4 2
ℏ𝑛4 𝜔 3 Ω2
2𝜋 𝑛 Ω 𝜏𝑟𝑎𝑑

(1.12)

. For 𝜆 = 600 nm, 𝑅0 ~ 10 nm. Equation (1.12) shows that Förster’s

interpretation of resonance in FRET along with the condition of spectral broadening
considerably decreased the effective interaction distance between donor and acceptor.
Förster also emphasized that even though the energy transfer via FRET occur by an
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exchange of quanta, it is essentially a classical resonance effect (26). Förster later
published the quantum mechanical derivation of 𝑅0 and energy transfer rate using timedependent probability of energy transfer (35), which is discussed in the next section.

1.2.4 Quantum mechanical treatment of FRET
Let us consider the energies of donor (D) and acceptor (A) in the ground and excited
states are represented by 𝐸𝐷 , 𝐸𝐴 and 𝐸𝐷′ , 𝐸𝐴′ respectively. The donor (D) is excited by
absorption of a photon to the excited state of energy 𝐸𝐷′ while acceptor is in its ground
state, 𝐸𝐴 . Due to FRET, the donor is de-excited to its ground state, 𝐸𝐷 , by transferring its
energy to the acceptor, which is brought to its first excited state, 𝐸𝐴′ . Let the initial (before
FRET) and final (after FRET) wave functions of the system be 𝜓𝐷′ 𝐴 and 𝜓𝐷 𝐴′ ,
respectively. If ℋ𝐷 and ℋ𝐴 are the unperturbed Hamiltonians of D and A, respectively,
and 𝐸𝑖𝑛𝑡 is their interaction energy, then the total Hamiltonian of the system can be
expressed as:
ℋ = ℋ𝐷 + ℋ𝐴 + 𝐸𝑖𝑛𝑡

(1.13)

So far we know that the interaction between donor and acceptor via FRET is a
very weak coupling; consequently, the interaction has negligible effect on their
absorption and emission spectra, therefore, according to the time-dependent perturbation
theory, the transition probability for a very large interaction time can be written as (36):

14
ΔE𝑡 2
)
1
2
2ℏ | 𝑡 2 𝑑𝐸 𝑑𝐸 ′
𝑃(𝐷′ 𝐴 → 𝐷 𝐴′ ) ≃ lim ∬ 2 |𝑉𝐷′ 𝐴;𝐷𝐴′ | |
𝐷
𝐴
ΔE𝑡
𝑡→∞
ℏ
(
)
2ℏ
sin (

ΔE
sin2 ( 𝑡)
𝑡
2
2ℏ 𝑑𝐸 𝑑𝐸 ′
≃ ∬ 2 |𝑉𝐷′ 𝐴;𝐷𝐴′ | lim
𝐷
𝐴
𝑡→∞
ℏ
ΔE 2
( ) 𝑡
2ℏ

(1.14)

where
Δ𝐸 = 𝐸𝐴′ + 𝐸𝐷 − 𝐸𝐷′ − 𝐸𝐴

(1.15)

is the energy difference between the initial and the final state of the system. Using the
definition of Dirac delta function lim

sin2 𝑥𝑡

𝑡→∞

𝑥2𝑡

= 𝜋𝛿(𝑥) and 𝛿(𝑎𝑥) = 𝛿(𝑥)/𝑎, we can re-

write equation (1.14) as:

𝑃(𝐷′ 𝐴 → 𝐷 𝐴′ ) =

2𝜋𝑡
ℏ

2

∬|𝑉𝐷′𝐴;𝐷𝐴′ | 𝛿(ΔE)𝑑𝐸𝐷 𝑑𝐸𝐴′ .

(1.16)

Since the energy lost by the donor due to de-excitation to the ground state is equal to the
energy gained by the acceptor brought to its excited state, we can write

1

𝐸 = 2 [𝐸𝐷′ − 𝐸𝐷 + 𝐸𝐴′ − 𝐸𝐴 )].

Therefore, 𝐸𝐴′ and 𝐸𝐷 can be expressed as functions of 𝐸 and Δ𝐸.

(1.17)
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Hence,
𝜕𝐸
𝜕(𝐸, Δ𝐸 )
|𝜕𝐸𝐷
𝑑𝐸𝐷 𝑑𝐸𝐴′ =
′ ) 𝑑𝐸𝑑(Δ𝐸) = | 𝜕𝐸
𝜕(𝐸𝐷 , 𝐸𝐴
𝜕𝐸𝐴′

𝜕(Δ𝐸 )
𝜕𝐸𝐷 |
𝑑𝐸𝑑(Δ𝐸)
𝜕(Δ𝐸 )|
𝜕𝐸𝐴′

(1.18)

Using equations (1.15) and (1.17); the determinant in equation (1.18) becomes:
1

−
−1
| 12
| = 1.
−1
2

Therefore, equation (1.16) becomes:

𝑃(𝐷′ 𝐴 → 𝐷 𝐴′ ) =

2𝜋𝑡
2
∬|𝑉𝐷′𝐴;𝐷𝐴′ (𝐸, ∆𝐸)| 𝛿(Δ𝐸)𝑑𝐸𝑑(Δ𝐸)
ℏ

2𝜋𝑡
2
=
∫|𝑉𝐷′ 𝐴;𝐷𝐴′ (𝐸, 0)| 𝑑𝐸 ,
ℏ

(1.19)

where 𝑉𝐷′ 𝐴;𝐷𝐴′ (𝐸, 0) = 𝑉𝐷′ 𝐴;𝐷𝐴′ (𝐸𝐷′ , 𝐸𝐴 ; 𝐸𝐷 , 𝐸𝐴′ ) = 𝑉𝐷′ 𝐴;𝐷𝐴′ (𝐸𝐷′ , 𝐸𝐴 ; 𝐸𝐷′ − 𝐸, 𝐸𝐴 + 𝐸)
Let Φ𝑖 and Φ𝑖′ be the electronic wave functions and χ𝑖 and χ′𝑖 to be the vibrational wave
functions of the fluorophores in their ground and excited states, respectively. Using the
Born-Oppenheimer approximation, we can express the initial and final wave functions of
the system in terms of electronic and vibrational components as:

𝜓𝐷′ 𝐴 (𝐸𝐷′ , 𝐸𝐴 ) = Φ𝐷′ Φ𝐴 𝜒𝐷′ (𝐸𝐷′ )𝜒𝐴 (𝐸𝐴 )

(1.20)

𝜓𝐷 𝐴′ (𝐸𝐷 , 𝐸𝐴′ ) = Φ𝐷 Φ𝐴′ 𝜒𝐷 (𝐸𝐷′ − 𝐸)𝜒𝐴′ (𝐸𝐴 + 𝐸)

(1.21)
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Hence,
𝑉𝐷′𝐴;𝐷𝐴′ = ⟨𝜓𝐷 𝐴′ (𝐸𝐷 , 𝐸𝐴′ )|𝐸𝑖𝑛𝑡 |𝜓𝐷′ 𝐴 (𝐸𝐷′ , 𝐸𝐴 )⟩
= ⟨Φ𝐷 Φ𝐴′ |𝐸𝑖𝑛𝑡 |Φ𝐷′ Φ𝐴 )⟩⟨𝜒𝐷 (𝐸𝐷′ − 𝐸)|𝜒𝐷′ (𝐸𝐷′ )⟩⟨𝜒𝐴′ (𝐸𝐴 + 𝐸)|𝜒𝐴 (𝐸𝐴 )⟩

(1.22)

= 𝑊𝑆𝐷 (𝐸𝐷′ , 𝐸𝐷′ − 𝐸)𝑆𝐴 (𝐸𝐴 , 𝐸𝐴 + 𝐸)

where 𝑊 = ⟨Φ𝐷 Φ𝐴′ |𝐸𝑖𝑛𝑡 |Φ𝐷′ Φ𝐴 )⟩ is the interaction energy matrix and 𝑆𝑖 (𝐸1 , 𝐸2 ) =
⟨𝜒𝑖′ (𝐸2 )|𝜒𝑖 (𝐸1 )⟩ are the vibrational overlap integral. Using equation (1.3) for nonidentical dipoles and inserting equation (1.21) in equation (1.19), the transition
probability can be expressed as:

2𝜋𝑡 𝜅 2 𝜇𝐷2 𝜇𝐴2
𝑃(𝐷 𝐴 → 𝐷 𝐴 =
∫ 𝑆𝐷2 (𝐸𝐷′ , 𝐸𝐷′ − 𝐸)𝑆𝐴2 (𝐸𝐴 , 𝐸𝐴 + 𝐸)𝑑𝐸
ℏ 𝑛4 𝑅 6
′

′)

(1.23)

Therefore, the rate of energy transfer can be expressed as:

Γ𝐹𝑅𝐸𝑇

2𝜋 𝜅 2 𝜇𝐷2 𝜇𝐴2
=
∫ 𝑆𝐷2 (𝐸𝐷′ , 𝐸𝐷′ − 𝐸)𝑆𝐴2 (𝐸𝐴 , 𝐸𝐴 + 𝐸)𝑑𝐸
4
6
ℏ 𝑛 𝑅

(1.24)

For fluorescence spectra 𝑓(𝜈) of D and A, we can consider

∫ 𝑓(𝜈)𝑑𝜈 = 1.

(1.25)

Using the Boltzmann distribution for a continuous spectrum we can re-write equation
(1.24) as:
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Γ𝐹𝑅𝐸𝑇

2𝜋 𝜅 2
=
∫ [𝜇𝐷2 ∫ 𝑔(𝐸𝐷′ )𝑆𝐷2 (𝐸𝐷′ , 𝐸𝐷′
4
6
ℏ 𝑛 𝑅
𝑑𝜈
− 𝐸) 𝑑𝐸𝐷′ ] . [𝜇𝐴2 ∫ 𝑔(𝐸𝐴 ) 𝑆𝐴2 (𝐸𝐴 , 𝐸𝐴 + 𝐸)𝑑𝐸𝐴 ]
ℏ

(1.26)

where 𝑔(𝐸) = 𝑒 −𝛽𝐸 is the Boltzmann factor of the fluorophore at thermal equilibrium
and ∫ 𝑔(𝐸) 𝑑𝐸 = 1 . Now, we can define Einstein’s A coefficient for spontaneous
emission from the final state |𝑓⟩ to the initial state |𝑖⟩ in terms of the dipole moment as
(37):

2

25 𝑛𝜋 3 𝜈 3 |𝜇𝑓𝑖 |
∫ 𝑓(𝜈)𝑑𝜈
𝐴𝑓𝑖 =
=
3𝑐 3 ℏ
𝜏𝑓
5

= ∫ 𝑑𝜈

(1.27)

3 3 2

2 𝑛𝜋 𝜈 𝜇
∫ 𝑔(𝐸𝑓 ) 𝑆𝑓2 (𝐸𝑓 , 𝐸𝑓 − 𝐸)𝑑𝐸𝑓
3𝑐 3 ℏ

where 𝜇⃗𝑓𝑖 = ⟨𝑓|𝜇⃗|𝑖⟩ = 𝜇⃗𝑆(𝐸𝑓 , 𝐸𝑖 ) is the transition dipole moment of the molecule for
transition from the excited state |𝑓⟩ to the ground state |𝑖⟩ and can be defined as:

𝜇⃗ = −𝑒⟨Φ𝑓 |𝑟⃗|Φ𝑖 ⟩

(1.28)

where |Φ𝑖 ⟩ and |Φ𝑓 ⟩ are the electronic initial and final states of the molecule
respectively, 𝑆(𝐸𝑓 , 𝐸𝑖 ) is the Frank codon factor, and 𝜏𝑓 is the fluorescence lifetime of the
molecule at the excited state |𝑓⟩. Therefore, using equation (1.27), we can express the
equation for fluorescence spectrum in the frequency domain as:
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𝑓(𝜈) =

25 𝑛𝜏𝑓 𝜋 3 𝜈3 𝜇 2
3𝑐 3 ℏ

∫ 𝑔(𝐸𝑓 ) 𝑆𝑓2 (𝐸𝑓 , 𝐸𝑓 − 𝐸)𝑑𝐸𝑓 .

(1.29)

Again, the Beer-Lambert law gives (37):

2

22 𝜋 2 𝜈|𝜇𝑓𝑖 | 𝑁𝐴
𝜀(𝜈) =
3000ln(10)𝑛ℏ𝑐

(1.30)

where 𝜀(𝜈) is the extinction coefficient of the molecule absorbing energy at frequency 𝜈
and 𝑁𝐴 is the Avogadro’s number. Using the definition of 𝜇⃗𝑓𝑖 along with the Boltzmann
factor we can write equation (1.30) for continuous distribution of energy as:

22 𝜋 2 𝜈𝜇 2 𝑁

𝐴
∫ 𝜀(𝜈)𝑑𝜈 = ∫ 𝑑𝜈 3000 ln(10)𝑛ℏ𝑐
∫ 𝑔(𝐸𝑖 ) 𝑆𝑖2 (𝐸𝑖 , 𝐸𝑖 + 𝐸)𝑑𝐸𝑖 .

(1.31)

Equations (1.30) and (1.31) give,

22 𝜋 2 𝜈𝜇 2 𝑁

𝐴
𝜀(𝜈) = 3000 ln(10)𝑛ℏ𝑐
∫ 𝑔(𝐸𝑖 ) 𝑆𝑖2 (𝐸𝑖 , 𝐸𝑖 + 𝐸)𝑑𝐸𝑖 .

(1.32)

Replacing 𝐸𝐷′ with 𝐸𝑓 in equation (1.29) and 𝐸𝐴 with 𝐸𝑖 in equation (1.32), equation
(1.36) can be written as:

Γ𝐹𝑅𝐸𝑇

9000𝜅 2 ln(10) 𝑐 4
𝑑𝜈 9000𝜅 2 ln(10) 𝑐 4
=
∫ 𝑓𝐷 (𝜈)𝜀𝐴 (𝜈) 4 =
𝐽(𝜈)
128𝜋 5 𝑛4 𝜏𝐷′ 𝑁𝐴 𝑅 6
𝜈
128𝜋 5 𝑛4 𝜏𝐷′ 𝑁𝐴 𝑅 6

(1.33)
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𝑑𝜈

where, 𝐽(𝜈) = ∫ 𝑓𝐷 (𝜈)𝜀𝐴 (𝜈) 𝜈4 is defined as the spectral overlap integral (4) and 𝜏𝐷′ is
the fluorescence lifetime of the donor. Since, in the absence of non-radiative emission of
the donor, there is only one de-excitation pathway, therefore the fluorescence lifetime of
the donor can be expressed as:
𝜏𝐷′ =

1
Γ 𝑟,𝐷

(1.34)

and the quantum yield of the donor can be expressed as:

𝑄𝐷 =

Γ 𝑟,𝐷
Γ 𝑟,𝐷
=
Γ 𝑟,𝐷 + Γ 𝑛𝑟,𝐷
𝜏𝐷

(1.35)

where 𝜏𝐷 is the life time of the donor which depends on both the radiative and the nonradiative energy transfer pathways. Equations (1.34) and (1.35) give:

1
𝜏𝑓

=

𝑄𝐷
𝜏𝐷

.

(1.36)

Plugging equation (1.36) in equation (1.33) and assuming R = R0, when Γ𝐹𝑅𝐸𝑇 = Γ 𝑟,𝐷 +
1

Γ 𝑛𝑟,𝐷 = 𝜏 , equation (1.33) can be written as:
𝐷

𝑅06 =

9000𝜅 2 ln(10) 𝑄𝐷 𝑐 4
𝐽(𝜈)
128𝜋 5 𝑛4 𝑁𝐴

Using equations (1.36) and (1.37), equation (1.33) can also be written as:

(1.37)
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Γ𝐹𝑅𝐸𝑇

1 𝑅 6
= ( )
𝜏𝐷 𝑅0

(1.38)

1.2.5 Dependence of orientation factor on the energy transfer
The rate of energy transfer in FRET is also known to depend on the orientations of the
interacting dipoles of donors and acceptors; hence, it is necessary to study the
dependence of energy transfer rate on the orientation factor of the interacting dipoles of
donors and acceptors. Using the symbols defined in Fig 1.2, the orientation factor (𝜅) as
defined in equation (1.4) can also be expressed as:

𝜅 2 = (cos 𝜃𝑇 − 3 cos 𝜃𝐷 cos 𝜃𝐴 )2
= (sin 𝜃𝐷 sin 𝜃𝐴 cos ∅ − 2 cos 𝜃𝐷 cos 𝜃𝐴 )2

(1.39)

where the angle between dipole moment of D and A and can be defined as:

cos 𝜃𝑇 = sin 𝜃𝐷 sin 𝜃𝐴 cos ∅ + cos 𝜃𝐷 cos 𝜃𝐴 .

(1.40)

Dale et al. (38) correlated the possible range of orientation factors to the
polarization of the dipoles by measuring the polarization of two randomly oriented
dipoles, D, and A at a fixed distance between them. Based on their measurement of
fluorescent anisotropy they calculated the possible range of 𝜅 2 . When the donor and
acceptor dipoles are perpendicular to each other, equation gives 𝜅 2 = 0 while for
collinear transition dipoles, 𝜅 2 = 4. In biological samples, there are always fluctuations
in the positions of donors and acceptors as well as in their orientations because the
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fluorophores are usually attached to the protein of interest via flexible linkers. Therefore,
actual value of 𝜅 2 is taken as 2/3, which is the average value of 𝜅 2 over time, or
ensemble. However, the assumption of 𝜅 2 = 2/3 can lead to a maximum error of ~35%
in the calculation of distance between the fluorophores (4). Clegg in 1996 (26) pointed
out that the validity of the assumption for 𝜅 2 = 2/3 depends on the experimental
conditions and the information extracted from the experiments.

1.3

Applications of FRET

The nonlinear dependence of FRET efficiency on distance makes FRET a powerful
technique to study the structure and dynamics of proteins and their interactions in living
cells. Tagging suitable fluorophores at particular sites of the proteins of interest allows
one to monitor protein-protein interactions. Technological advancements in the field of
fluorescence microscopy have widened the scope of FRET applications, for example, to
study the structure (39-41), oligomerization (16-18), conformational changes of
macromolecules (42), interaction between macromolecules (7, 14, 42, 43), and
biochemical events (44). NMR spectroscopy and high resolution X-ray crystallography
are widely used in determining three dimensional structures of proteins and other
biological macromolecules but are limited to non-living cells and, with a few notable
exceptions, are not applicable to quaternary structure determinations, especially when the
interactions are highly dynamic. Fluorescence microscopy, on the other hand, can be used
to unveil both spatial and temporal information of molecular structures in vivo (43). We
will review below only a few of the numerous applications of FRET.
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1.3.1 Determination of structure, stoichiometry, and conformation of protein and
nucleic acid complexes
FRET has attracted significant interest in the study of the structure, conformation, and
stoichiometry of proteins and nucleic acids due to the difficulties in the crystallization of
most of the membrane proteins. Additionally, the non-destructive nature of FRET
technique makes it the most suitable method to study proteins in their natural
environment. Cai et al. in 2007 revealed the structural organization and conformational
changes of kinesin-1 motor proteins, which drives long-distance intracellular transport
along microtubules (45). They showed that conformational changes from the inactive
state to the active state of kinesin-1 are required to perform motor activation. Raicu et al.
in 2009 (46) used spectrally resolved two-photon microscopy to determine the
stoichiometry of alpha-receptor, Ste2p, where they tagged the receptors with GFP2/CFP
as donor and YFP as acceptor and co-expressed in yeast cells. Based on the measured
apparent FRET efficiencies and a theoretical model proposed by the authors, they found
that Ste2p proteins form dimers.

Recently, Woz´niaka and coauthors quantitatively determined the unique 3D
structure of DNA and its dependence on DNA bending using FRET (47). They used a
Multiparameter Fluorescence Detection (MFD) method (48) to investigate 12 different
base-pairs (bp) of a double stranded DNA helix ranging from 5 to 27 bp at the interval of
every two bases. They labeled the bp using Alexa fluor 488 as the donor, and Cy5 as
acceptor and calculated the orientation factors for each pair using molecular dynamics
(MD) simulations. Using fluorescence lifetime as FRET analyzing method to calculate
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distances between various donor-acceptor pairs in terms of measured FRET efficiencies,
they were able to determine the bending and kinking of certain DNAs in all three
dimensions in terms of various kink parameters as described by the authors.

1.3.2 Application of FRET based biosensors for protein kinases
Biosensors are devices used to detect structure, function, and composition of
biomaterials. They are comprised of three essential components: i.e., the biomaterials, for
example, enzymes, antibodies, etc.; the detector such as optical, piezoelectric, or
electrochemical; and the electronics. The biosensor detector receives signal from
biomaterials for sensing, the signal received by the detector is then amplified and
transported to the appropriate device such as computer for display and analysis using
associated electronics. Some of the commonly used commercial biosensors are blood
glucose biosensors used for measuring blood glucose levels, canary in a cage used mostly
by miners for detection of toxic gases, and DNA sensors for the detection of pathogenic
and genetic diseases. With recent advances in biotechnology, biosensors are also used to
study many complicated phenomena of protein kinases such as their activity,
conformation, and regulation to name a few. Protein kinases play a critical role in signal
transduction and coordination of complex cellular mechanism. By adding a phosphate
group to the substrate proteins, they can change their functions by changing their activity,
cellular location, or binding with other proteins. Modification in other proteins by kinases
enzyme is realized through phosphorylation. Recently, FRET-based biosensors have been
used for the detection of protein kinases to study kinase regulations in living cells both
with spatial and temporal details. They are made by sandwiching a kinase-dependent
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molecular switch between the FRET pair. The conformation of the molecular switch
changes with phosphorylation. Thus monitoring FRET signal with time, kinase activity of
the proteins can be monitored (49). Mizutani et al. in 2010 developed a novel biosensor
called Pickles that enabled the evaluation of BCR-ABL kinase activity (50) in single
living cells using FRET based techniques to diagnose chronic myeloid leukemia (CML)
patients effectively and quickly (51).

1.3.3 SNP genotyping using FRET
Single nucleotide polymorphism (SNP) are considered as essential to the understanding
of the genetic basis of complex diseases. It is thought that more than 300,000 SNPs will
be required to understand whole genome association studies where 1.4 million SNPs have
already been identified. SNP genotyping is thus one of the critical steps in the detection
of SNPs. Several techniques, such as single strand conformation polymorphism (SSCP)
and restriction fragment length polymorphism (RFLP), have the disadvantages of being
expensive and involve multiple step processes. K. Takatasu et al. (52) in 2004
demonstrated a cost efficient technique for SNP genotyping using FRET. Their technique
uses fluorescently labeled mononucleotides as universal FRET reagents instead of
oligonucleotides thereby reducing time and cost of preparing fluorescently labelled
oligonucleotides. In this technique a green dye, fluorescein and a red dye, cys5 with
excitation/emission wavelengths of 494/517 and 650/667 nm respectively were used as
donors and acceptors. PCR amplified genomic DNA was incubated with allele-specific
primer in the presence of green and red dye-labeled mononucleotide and DNA
polymerase. Their finding showed that, when DNA fragments contained the sequence
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complementary to allele-specific primer, the extension of the primer with green and redlabeled mononucleotide occurred, resulting in red fluorescence emission due to FRET.
But in the absence of the extension reaction of the primer, the DNA fragments are not
complementary; hence, no FRET occurred. Thus SNP could be identified by measuring
of the red fluorescence after extension reaction. In a similar work, L. Dahan et al. in 2013
(53) used Allele specific FRET probes for SNP detection in mRNA in living cells. In
their work they proposed that FRET based probes can be very useful for SNP detection of
live cells because FRET based probes allows to differentiate bound and unbound probes
in living cells decreasing background which was considered as one of the major
challenges in SNP detection.

1.3.4 Distribution and transport of lipids
Lipid molecules are known to be the modulators for a large number of biological
processes and are thus by far an active field of research among cell biologists to
understand the transport and distribution of lipids throughout the body. It is understood
that the complex intracellular distribution of lipids are regulated by three general
mechanisms namely vesicular transport, monomer transport, and lateral diffusion (54).
Identification of the transport and distribution of lipids has been a difficult problem for
which several techniques have been proposed so far. FRET is one of the promising
successful techniques that have been applied for study of the transport mechanism of
lipids. Nicholas and Pagano in 1982 (55) used FRET to study the vesicle transport of
amphiphilic molecules such as phospholipids, fatty acids, and cholesterols. For the
resonance energy transfer studies, they used 7-nitro-2,1,3-benzoxadiazol-4-yl (NBD) acyl
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chain labeled lipids and Rhodamine B labeled phosphatidylethanolamine (N-Rh-PE) as
donors and acceptors respectively to monitor the rate transfer between two populations of
small vesicles. Their study showed that NBD-labeled lipids could be accurately predicted
using diffusion of soluble monomers as a function of both donor and acceptor model.
They also found that the rate constant for a given amphiphile depended on the lipid
compositions and concentration ratios of the vesicles. Velden et al. in 2013 reported
genetically encoded FRET sensor to study the bile acid transport in single living cells
(56). Bile acids are known to play an essential role in the absorption of dietary fats and
fat-soluble vitamins in intestines. Their findings showed that the bile acid FRET sensor
was sensitive to a range of physiological and pathophysiological bile acid species easily
targetable to different subcellular locations. They also demonstrated the reversible nature
and suitability of FRET sensor to study both import and export of protein molecules. This
application of FRET could be a significant step towards gaining the unique insight in the
dynamics of bile acid transport and signaling.

1.3.5 Study of G-protein coupled receptors/ligand interactions
G-proteins coupled receptors (GPCRs) are the largest family of membrane-integrated
proteins activated by ligands of varying size like small molecules, peptides, and even
proteins. Study of activation of GPCRs with particular ligand to perform certain functions
in cells is challenging. For many years, GPCRs have been considered to exist exclusively
as monomers in the plasma membrane. Upon ligand binding, they are considered to
change their conformations resulting in activation of the associated G-protein, further
cascading the signal to a second messenger (57, 58). This view has been challenged in a
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number of literatures showing that GPCRs can exist as a dimer and even as higher order
oligomers (59-62). The measurements based on FRET techniques provide a potentially
powerful way to study oligomeric/conformational changes in GPCRs upon ligand
binding. The discovery and introduction of fluorescent ligands and their interactions with
GPCRs have increased the capability of FRET based study of the detection and imaging
of the receptors in their native environment (63, 64). Fluorescent ligand and GPCR
interaction are now widely used for FRET measurements in two broad ways: (i)
interaction between ligand and receptor for signaling cascade, and (ii) FRET between two
labeled receptor-bound fluorescent ligands to investigate GPCRs both in transfected cells
and native tissues (63). Trucatti et al. in 1996 demonstrated the possibility of measuring
distances between ligand and receptor using different labeling sites on the receptor (64).
Prior knowledge of the distance separating the ligand and receptor was critical to this
study of ligand-receptor interaction. Another critical factor in the study of ligand-receptor
interaction is that the fluorescent ligand labeling should not alter the pharmacology of the
ligands owing to which Miller and co-workers performed several FRET studies using
agonists and partial agonists. In their studies, they performed steady-state FRET
measurements for various combinations of receptor-ligand complexes of cholecystokinin
receptors (63, 65, 66). Their finding showed several distances over which the orientation
of the ligand within the receptor can be determined. Additionally, similar studies
performed on secretin receptors showed the possibility to determine structural constraints
that allow modeling of extracellular ligand-receptor interactions (67). Lohse et al. (63)
demonstrated the ligand-receptor interaction in dynamic cellular environment. Their
finding showed both slow and fast components in receptor-ligand binding processes
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where the slow component was attributed to receptor activation, and the fast component
to simple bimolecular interaction between ligand and receptor respectively. Ilien et al.
(68) developed 96-well assay for binding of unlabeled ligands using dynamic interaction
studies in the muscarinic M1-acetylcholine receptor. Later, in 2009 Ilien et al. further
used dynamic interaction studies on M1-acetylcholine receptor to demonstrate two-step
binding process for small ligands to class A GPCRs (69). Albizu et al. (70) proposed a
novel technique based on FRET measurement between two differently labeled
fluorescent ligands to study receptor oligomerization in native tissues. Their finding
showed the existence of homo- and hetero-oligomeric receptors both in transfected cells
and native tissues. They also showed the existence of oxytocin receptor oligomers in
mammary glands. The study of receptor-ligand interactions is continually advancing
showing great applications of FRET in the study of cellular mechanisms in their complex
environments. In the most recent development, Leyris et al. (71) used the combination of
fluorescent ligands and N-terminally fused SNAP-tag GPCRs with a lanthanide based
fluorophore substrate for SNAP-tag labeling that was found to reduce significantly the
signal-to-noise ratio in Time Resolved-FRET measurements that can be used for highthroughput screening.

1.3.6 Other applications of FRET
It can be seen from above discussions that FRET is an important tool for the study of
biological processes which not only helps in understanding various physiological
processes, but can also be helpful in future drug developments. In a recent study,
Rajagopal et al. (72) developed a super color-coding method for large scale multiplexing

29
of biochemical assays using standard fluorescence. Multiplexing is the simultaneous
amplification of two or more DNA targets in a single reaction vessel, and is carried out
using uniquely labeled probes for each target for gene detection. The available techniques
are known to detect a maximum of 4 - 6 genes (73). However, the method developed by
Rajagopal et al. has the capability to predict theoretically unlimited number of
independent targets with any combination of biochemical assays in a reaction vessel. The
method provided easy access to 12-plex assays compared to 4-plex assays that are
currently being used. It was proposed that the theory when combined with FRET can
further help in expanding the encoding set that can increase the number of gene detection
in a large combination of biochemical assays.

Apart from biological applications, FRET also finds its application in diverse
fields such as electronics, nanotechnology, as well as optical, electron, and mass
spectroscopy and photographic processes. Coffey et al. (74) proposed a mechanism of
long-range FRET-based charge transfer from a donor to acceptor in organic solar cells
that were otherwise understood to be mainly governed by charge diffusion process which
can better help to understand and improve the solar cell performance in certain types of
solar cells. Bose et al. (75) for the first time performed time-resolved cryogenic FRET in
densely packed quantum dot films using single photon counting set up. Their finding
showed 94% energy transfer efficiency for donor dots showing a promising step towards
photovoltaic and quantum communication. Kelley et al. (76) developed zinc chlorophyll
derivative that can mimic the photosynthetic process. They found the FRET as an
additional energy transfer mechanism to already known ultrafast energy transfer process

30
existing within cyclic self-assembled chlorophyll tetramers that can help to improve the
charge transfer process and hence the efficiency of solar cells. Halivni et al. (77)
presented a detailed study on the effect of nanoparticle dimensionality on FRET in
nanoparticle-dye conjugated system. Their investigation showed that both the size and the
geometry of nano-dimensional system can affect the FRET efficiency significantly. The
results can be found promising in using FRET for a wide variety of applications based on
nanomaterials such as bio-sensing, spectroscopy, and energy harvesting materials. Lee et
al. (78) studied the dynamics of multilayer DNA films using FRET. The DNA films were
assembled on silica particles with alternating layers of homopolymeric diblocks (Poly
A15G15 and Poly T15C15) with fluorophore, TAMRA (Poly A15G15-TAMRA) and
quencher, BHQ2 (Poly T15C15-BHQ2). Their study showed rearrangements in DNA
films confirming the dynamics through spontaneous hybridization and are considered to
have significant applications in drug discovery and bio-sensing. Busch et al. (79) reported
an in vivo spectral multiplexing approach for imaging of different disease-related
biomarkers using near infra-red FRET imaging. The technique finds its relevance in
imaging multiple disease causing molecules in vivo instead of just one molecule. They
demonstrated the success of their method by showing FRET measurements on coupled
fluorophores DY-682 and DY-505 as donors and DY-782 as acceptors along with the
antibody IgG. Their technique can be particularly useful in the identification of several
pathological conditions such as inflammation, cancer, and neurodegenerative diseases.
Wang et al. (80) proposed the use of the photoacoustic microscopy technique for imaging
of FRET that produces heat and acoustic waves.

Their study showed increased

penetration depth for FRET imaging compared to confocal microscopy along with the
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benefits of three-dimensional imaging with scalable resolution. Their technique can be
particularly useful as a biomedical tools for in vivo FRET studies. Liu et al. (81) proposed
a highly sensitive and selective technique for cysteine detection in FAM
(carboxyfluorocein) tagged single stranded DNA (ssDNA) and graphene oxide using
FRET. They showed significant fluorescence quenching due to FRET in non-covalently
assembled FAM-ssDNA and graphene oxide. A decrease in fluorescent intensity was
found with the increase in cysteine concentration improving the sensitivity for cysteine
detection in DNA.
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Experimental techniques for measuring FRET

As already discussed in Chapter 1, FRET is one of the widely used techniques that has
the capability to study molecular processes in subnanometer resolution because of its
versatility, sensitivity and specificity. Compared to other techniques such as X-ray
diffraction, nuclear magnetic resonance, and electron microscopy, FRET-based
fluorescence microscopy offers the advantage of studying both fixed and live cells with
improved spatial (angstrom) and temporal (nanosecond) resolution. Several FRET
techniques based on wide-field confocal microscopy, fluorescence lifetime imaging
microscopy (FLIM), fluorescence correlation spectroscopy (FCS), two photon
microscopy, total internal reflection microscopy (TIRF), and polarization anisotropy have
continuously been advancing enabling the study from single molecules to live-animals.
This chapter provides an overview of some popular FRET-based fluorescence
microscopic techniques along with their advantages and limitations, with emphasis on a
spectrally resolved two-photon microscope developed in our lab. Common to all
fluorescence microscopic techniques, FRET measurements also require protein tagging
with fluorescent probes. Most of the FRET pairs used for tagging proteins of interest
come from a class of naturally fluorescent proteins called green fluorescence proteins
(GFPs) and their variants. A brief review on the variants of GFPs as FRET pairs and
their significance in fluorescence microscopy is also given in this chapter.
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2.1

Green fluorescence proteins (GFPs) and its variants

The green fluorescent protein, originally found in the Aequorea victoria jellyfish, is a
protein consisting of 239 amino acid residues and a molecular mass of 26.9 kDa. GFP is
known to exhibit green fluorescence when exposed to blue or violet light (1). Various
fluorescent proteins are known to be present in several coelenterates such as Aequorea,
Phialidium, and Renilla (2, 3). Because of their advantageous ptotophysical properties,
fluorescent proteins are often used as fluorescent markers or “tags” to protein of interest
for the study of numerous aspects in cell biology, neurobiology, and ecology (4). By
monitoring the location of the GFP tag, using a fluorescence microscope, information
regarding the protein of interest if also ascertained.

Figure 2.1 Schematic depiction of the green fluorescence protein (GFP). On the left, the entire GFP with
fluorophore at the center is shown, while on the right, a cutaway portion of the GFP is shown, revealing the
central fluorophore distinctively. The yellow ribbons and pink helices represent 𝜷 – sheets and 𝜶 helices,
respectively. The image is taken from (5).

The benefit of using GFPs for protein tagging stems from the fact that they are
naturally formed by cyclization of the peptide backbone without using other cofactors for
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syntheses. Therefore, they do not alter the normal function or localization of their fusion
partner (1). Additionally, localization of GFPs does not require fixation or
permeabilization for substrate entry, making it an extremely useful candidate for the
study of cellular dynamics in living cells (6). GFPs have a barrel-like structure comprised
of eleven 𝛽-sheets. Six 𝛼 helices run diagonally through the center of the barrel as shown
in Fig. 2.1. The chromophore is at the center of the 𝛽 sheet barrel, which is the portion of
the known for its fluorescence. The fluorophore of GFP is not a separately synthesized
prostethic group; rather it is composed of amino acid residues 65-67 (ThreononeTyrosine-Glycine) within the polypeptide chain.

2.1.1 GFP as fluorescence marker
The most successful application of GFPs stems from its use as a fluorescent marker of a
non-fluorescent protein. The gene encoding the GFP is fused in frame to the gene of the
protein of interest, and the resulting gene is expressed in cells or an organism. Thus,
GFPs are mostly used as a tag or as an indicator in cell biology to monitor the expression
level and localization of the proteins in a subcellular region (3, 7). In FRET studies, two
different types of GFPs are generally used: one as a donor, and one as an acceptor, which
are fused to the same, or different proteins of interest to study homo-, and heterointeractions respectively. By monitoring the energy transfer efficiency (FRET efficiency)
occurring between the donor and acceptor, the distance between the proteins tagged with
donors and acceptors can be determined.
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2.1.2 GFP classes
Based on the distinctive components of the chromophores, GFPs are divided into seven
different classes with each class containing distinct sets of excitation and emission
spectra (8), (3).
(i) Class 1 GFPs are widely known as wild-type (wt) GFPs, have the most
complex spectra among all GFPs. The co-existence of neutral-phenol and anionic-phenol
chromophores of the wild-type GFPs gives two peaks in their excitation spectra: one,
dominant peak at 395 nm (due to a neutral chromophore) with an emission peak at 504
nm and second, a minor peak (almost three times lower) at 470 nm (due to anion
chromophore) with emission at 506 nm. The UV light source used to excite wt-GFPs at
395 nm can damage the tissues. In addition, the detected signals contain a significant
contribution from cellular auto-fluorescence. These problems can be avoided using the
second excitation peak, however it is not very efficient since only 15% of the class I
proteins contain anionic chromophore.
(ii) Class 2 GFPs with phenolate anions in chromophores are very commonly used
among all classes of GFPs because they were first known group of brighter fluorophores
with simple spectra. They were mutated to suppress the 395 nm excitation peak of wtGFP and enhance the 470 nm excitation peak by five to six fold, so named as enhanced
GFP (EGFP). The mutation shifts the excitation peak to 488-490 nm with an emission
peak at 509-511 nm.
(iii) Class 3 GFPs with a neutral phenol in the chromophore is mutated to
eliminate the anionic chromophore resulting the excitation and emission wavelengths at
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399 and 511 nm respectively. This class of GFPs is advantageous to use because of their
largest separated excitation and emission spectra among the classes.
(iv) Class 4 GFPs are also known as yellow fluorescent protein (YFP) due to the
extended tail of their emission spectrum in the yellow wavelength range giving an overall
yellowish appearance. They are mutated by stacking an aromatic ring next to the
phenolate anion of the chromophore resulting an increase of the excitation and emission
spectrum up to 20 nm. Depending on the combinations of aromatic residues used at the
amino acid (AA) positions of 65, and 203, there are different fluorophores named as eYFP, Venus, Citrine etc. included in this group of GFPs. The members of this group
differ in their brightness and slightly in their excitation and emission spectra in the range
of 508 - 516 nm, and 518 - 529nm respectively.
(v) Class 5 GFPs are produced by substituting Trp with Tyr at the AA position 66
making a new chromophore with indole (9) instead of phenol. This class of GFPs are
commonly called cyan fluorescent proteins (CFPs) because of their excitation and
emission wavelengths of 436 and 485 nm respectively, example includes Cerulean.
(vi) Class 6 also named as blue fluorescent proteins (BFP) results from the
mutation replacing Tyr with His at position 66 (9) shifting its excitation and emission
wavelength to shorter than Trp66 in class 5 GFPs. They have excitation at 383 nm and
emission at 447 nm, so the emission is blue.
(vii) Class 7 is developed with mutation of Phe at 66 giving shortest excitation
and emission wavelengths among the classes at 360 and 442 nm respectively. This class
is very little investigated because of its lack of practical applications.
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2.1.3 Selection of FRET pairs
As discussed in chapter 1, the FRET efficiency depends on the Förster distance, R0
(distance of 50% energy transfer efficiency) that is governed by many parameters such as
the overlap of donor emission and acceptor excitation spectra, quantum yield of the
donor, extinction coefficient of acceptor, etc. (10). Therefore, it is important to consider
the spectroscopic properties of donor and acceptor in choosing GFP variants as workable
FRET pairs.

Selection of an appropriate donor and acceptor pair, from among the wide range
of available fluorophores, which satisfies the necessary conditions needed to observe
FRET, is identified as one of the prerequisites for improving the accuracy and resolution
of FRET measurement. Since the discovery and characterization of purified GFPs by
Shimomura, active efforts in molecular biology have been going on to identify and
develop suitable FRET pair fluorophore with improved brightness, photostability,
maturation speed, and efficiency.

The most important condition for choosing fluorophores as a FRET pair is that the
excitation spectrum of the acceptor should overlap appreciably with the emission
spectrum of the donors. The amount of overlap is calculated using the spectral overlap
integral defined in equation (1.33). While spectral overlap is the utmost importance in
choosing a FRET pair, there do exist a number of other important concerns which must
be taken in to account: (i) fluorescent proteins fused to the proteins of interest should be
non-toxic to the cells; (ii) they should be bright enough to be able to detect by the

44
instrument while overcoming the signal of auto-fluorescence; (iii) while studying
oligomerization of proteins, it is important to tag the monomeric form of a fluorescent
protein to the protein of interest so that the fluorophore doesn’t promote oligomerization;
(iv) the fluorescent proteins should be insensitive to the environmental conditions of the
cells in vivo measurements in order to correctly interpret the effect of environment on the
protein of interest; (v) while performing multicolor FRET experiments using filter-based
methods, it is important to have minimum spectral cross-talk and bleed-through between
the fluorophores and (vi) if a high power laser is used as the excitation source in the
measurement technique, it is critical to choose the photo-stable fluorophores to minimize
the effect of photo-bleaching.

Depending on the imaging techniques, the GFP classes that are used as FRET
pairs are BFP-GFP, GFP-YFP, and CFP-YFP as donors-acceptors respectively (10). The
BFP fluorophores suffers from the disadvantages of having both the lowest quantum
yield and also the lowest photostability among all GFP variants (9). Because of its
excitation peak in UV-range, the emission spectrum of BFP includes a significant
contribution from cellular auto-fluorescence which adds signal, and hence increase the
amount of noise in intensity measurements (11). To address these problems, BFP was
replaced by CFP family members as donors and in order to minimize spectral cross-talk
(described later in this chapter) for CFP-GFP excitation spectrum, fluorophores from
YFP class are chosen as an acceptors. Another advantage of CFP-YFP as a FRET pairs
are its calculated R0 value of ~ 5 nm whereas for BFP-GFP pair, it is 4 nm making it
feasible to detect FRET for larger donor-acceptor distance. The most commonly used
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CFP-YFP FRET pairs include: Cerulean-Venus, Cerulan-Citrine, ECFP-EYFP etc. Also,
a recently developed GFP based FRET pair, GFP2-YFP proved as useful FRET pair
particularly for spectral FRET coupled with linear unmixing method (described in section
2.3.4) due to its low spectral cross-talk and spectral bleed-through and larger spectral
overlap integral (12). GFP2 is a modified version of wt-GFP with a F64L substitution
that significantly increases the brightness. It has similar excitation and emission peak at
396 and 504 nm respectively as wt-GFP2. Recent developments in technology have
helped in cloning red fluorescent proteins (RFPs) from corals that make it possible to use
fluorophore with higher excitation spectra as donors (YFPs) and RFPs as acceptors which
can be a better choice in terms of avoiding auto-fluorescence (13).

2.2

Challenges in FRET measurements

There are several experimental issues that can challenge FRET measurements leading to
a misinterpretation of the results. With the advancement in recent technologies, several
microscopic techniques are applied to measure FRET at different levels of precision and
accuracy.

2.2.1 Widely used assumptions in FRET measurements
FRET based measurements use several assumptions and these needed to be taken care of
to interpret the results accurately. For example, it is assumed that there is always a nonradiative resonance energy transfer between donor and acceptor and the probability of
reabsorption of the donor emission fluorescence by the acceptor is neglected (14, 15).
This phenomenon is less probable in a system of low fluorophore density, but cannot be
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neglected when fluorophore density is very

high (14). A second commonly used

assumption in FRET measurements is that, it is anticipated that the properties of the
FRET pair will not change when tagged with other biological molecules of interest. Also
the molecular interaction between FRET pairs as well as with the surrounding molecules
is always neglected but these interactions can change the overall properties of the FRET
(15).

Apart from the above mentioned assumptions there are several common problems
that are generally addressed and are widely studied which include spectral cross talk and
spectral bleed-through, non-specific FRET, mixture of fluorophore populations, variable
expression levels of energy donors and acceptors, relative brightness of the fluorophores,
auto-fluorescence, detector saturation, optical noise, and photo-bleaching. Each of these
problems is discussed in more detail below.

The ideal condition of FRET is that the excitation spectrum of acceptor and
emission spectrum of the donor should overlap with each other significantly without
overlap of excitation, or emission spectra of both the fluorophores, which is rarely true in
reality. Due to relatively small Stokes’ shift of GFP variants, there is always overlap of
excitation, and emission spectra of GFP variant FRET pairs (16). The overlap of the
excitation spectra of donor and acceptor is called spectral cross talk while the overlap of
the emission spectra is termed as spectral bleed-through. The plot displayed in Fig. 2.2.
shows a FRET pair with both an appreciable spectral cross talk as well as spectral bleedthrough, illustrated by the grey and red shaded regions, respectively. Due to spectral cross
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talk, both donor and acceptor are excited to a different extent at the same excitation
wavelength resulting in contamination of FRET signal by direct excitation of the
acceptor. Similarly, due to spectral bleed-through donor emission is detected through the
acceptor channel. These two artifacts affect and complicate the value of FRET calculated
from the signal contaminated by these effects. Spectral cross talk and bleed through is
usually determined by comparing the fluorescence intensities of three different types of
samples i.e., donor-only sample, acceptor-only sample, and a sample with both donor and
acceptor (FRET pair). All the three samples are excited at the donor excitation
wavelength, and the emission is measured at the acceptor emission channel. Measuring
the emission spectra of the donor and calculating its quantum yield in the wavelength
range of the acceptor emission channel determines the extent of spectral cross talk. The
contribution of spectral bleed-through is determined from the extinction coefficient of the
acceptor fluorophore at the donor excitation wavelength and the relative excitation light
intensity of both donor and acceptor (15). The signals due to spectral cross-talk and
bleed-through are then subtracted from the measured signal at acceptor channel; the
resulting signal thus contains signal purely from the FRET. But information about the
dynamics is lost in the process since it is not possible to measure the crosstalk and bleed
through signal simultaneously using the same sample as used for FRET measurement.
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Figure 2.2 Schematic representation of normalized excitation and emission spectrum of a donor (D) and
acceptor (A) (not in scale). Solid and dotted lines represent excitation and emission of D (cyan) and A
(yellow). Shaded area shown in black, and red color represents spectral cross-talk, and spectral bleedthrough respectively.

Another problem occurring in FRET measurements is the requirement of high
level of the fluorescence signal. It is true that the level of fluorescence signal can be
increased by either increasing the power of excitation light or by increasing the number
of fluorophores in the sample. However, each of these solutions brings problems to their
own. Increasing the excitation intensity can lead to extensive photobleaching of the
sample and is also restricted by the upper limit of the excitation power of the measuring
system. Increasing the number of fluorophores, on the other hand, decreases the
intermolecular distances between the fluorophores. As the intermolecular distance
between fluorophores decreases, the probability of a number of unassociated donors and
acceptors being within distances close enough for FRET to occur increases. This effect is
often referred to as non-specific or stochastic FRET, leads to FRET occurring between
non-interacting proteins. This non-specific FRET is usually detected through the
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dependence of FRET on fluorescent intensity which is usually determined by plotting the
measured FRET values vs. the intensity of either donor or acceptor (15). Also, donor to
acceptor ratios outside the range of 1:10 and 10:1 also limits the detection of FRET
signals (17).

The measured FRET efficiency values are also affected by having undesired
fluorophore combinations, such as uncoupled fluorophores or like fluorophore pairs
within the fluorophore population (18). The occurrence of fluorescence from such
fluorophore combinations contributes to the overall measured fluorescence intensities,
but because no FRET is occurring to these entities, a decrease in the actual FRET
efficiency value occurs. The error in the measured FRET efficiency can be pronounced in
a system of mixed fluorophore population with varying expression levels in cells where
the concentrations of donor and acceptors vary remarkably. The quantification of
extraneous signal from the fluorescence of undesired fluorophores can be performed by
measuring the fractional decrease or increase in the donor and acceptor intensities
respectively (18). Finally, the optical noise or background noise when studying single
molecule detection because of low signal to noise ratio (15).

2.3

Experimental techniques to measure FRET

In vivo FRET spectroscopy has become widely used in last 30 years since it is very
sensitive and relatively easy to perform. Since FRET techniques can resolve the distance
up to molecular level (< 10nm) irrespective of the scale of the sample, FRET is also
dubbed by Stryer as the spectroscopic or molecular ruler (19). In vivo FRET experiments,
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however, are often difficult to interpret because of the complexity of living biological
systems. Successful quantitative measurements and interpretation of data requires
availability of correct control experiments and the ability to choose the best methods on
particular samples (20). Some of the widely used FRET techniques with their advantages
and limitations are discussed in this section.

2.3.1

Sensitized emission

Sensitized emission is one of the most widely used techniques for the measurement of
FRET, being applicable to study both live and fixed cells. In this method, the sample for
FRET measurement is excited at an excitation wavelength known to excite the donor, and
emission is measured through the acceptor channel. In most cases, it is difficult to isolate
the activity of single fluorophores due to the artifacts of spectral crosstalk and bleedthrough as described in section 2.2.2. The measured signal contains the signal arising due
to FRET along with that from direct excitation of the acceptor and also from the donor
emission spectrum because of spectral cross-talk and bleed-through respectively. In order
to minimize artifacts caused by bleed-through and cross-talk, three different
measurements are performed one on each of the three different types of samples: donoronly samples, acceptor-only sample and sample with both donor and acceptor (FRET
pair) as discussed before. The signals obtained from donor-only and acceptor-only are
then subtracted from the measured spectra containing both donor and acceptor, the
resulting signal thus contains signals purely from FRET. It is important to keep all
experimental parameters such as detector/amplifier gain, emission wavelength window,
zoom, scan speed, pinhole size etc. the same for all three samples. Though promising,
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this method suffers from the disadvantage of low intensity, environmental susceptibility
and chemical and photochemical instability (21). The method also requires extensive
image processing, making the process laborious and more prone to errors (21).
Additionally, the controls used for the measurement are different samples, hence FRET
measurement for an unknown stoichiometry as well as for the system with continuously
changing concentrations of donors, and acceptors become extremely difficult, limiting its
application for the study of complex cellular environment and their dynamics (21).

2.3.2 Fluorescence lifetime imaging microscopy (FLIM)
Fluorescence spectroscopy measurements can be divided into two broad classes, namely
steady state and time resolved. Steady state measurement use a constant illumination of
the sample. It is well known that the excitation/de-excitation phenomena occur on the
nanosecond (ns) scale, therefore the steady state is reached immediately after light
exposure hence the term steady state. Time-resolved measurements, on the other hand,
use short pulses of less than a ns so that the molecular phenomena can be recorded before
the excited fluorophore reaches the ground state (4). Steady state is thus considered as the
time average of such several short phenomena. Though complex and expensive, time
resolved techniques in many cases are more useful compared to steady state
measurements. The time resolved measurement contains information about the anisotropy
of the sample that is helpful for determining the shape and flexibility of macromolecules,
information which is lost in steady state measurements. Additionally, the time resolved
measurements contain several significant pieces of information such as the ability to
detect multiple lifetimes of one molecule show more than one conformation of a
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molecule. It also reveals the distribution of acceptors around donors and quenching
phenomena.
Time resolved spectroscopy is known to measure the lifetime of the excited state
of a molecule. The excited state lifetime can be understood as the amount of time taken
by the excited-state population to decay to its ground state and is also known as decay
time (4). Lifetime can also be defined as the average amount of time a fluorophore
remains in its excited state after excitation. The following relation is used to obtain the
value of lifetime (4):
∞

∫ 𝑡𝑒𝑥𝑝(−𝑡⁄𝜏)𝑑𝑡
〈𝑡〉 = 0∞
∫0 𝑒𝑥𝑝(−𝑡⁄𝜏) 𝑑𝑡

(2.1)

where t is time, and τ is the average lifetime of the excited state.

The most common instruments used for lifetime measurements are time-resolved
fluorescence spectroscopes whereby the fluorescence intensity decay over time is
recorded, and the average lifetime is calculated by calculating the slope of the plot of log
I(t) vs. t. The other technique used is the frequency-domain measurement where the
sample is excited with intensity-modulated light varied at high frequency typically of the
order of MHz so that its reciprocal becomes comparable to the reciprocal of the decay
time of the sample.

With the technology advancements it is now possible to create images for a
lifetime using fluorescence lifetime imaging microscopy (FLIM) which has gained
significant popularity in biological sciences. The underlying principle of FLIM is based
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on the image contrast for different lifetimes that are presented on a color scale with
height representing the local delay times (22). FLIM measurements are independent of
concentrations of fluorophores and their corresponding intensities; the color contrast is
purely based on the different decay times of donors, and acceptors mixed together in a
complex environment. FLIM can be used to record images both in time and frequency
domains similar the time-resolved spectroscopy. This technique can be particularly useful
for FRET measurements since FRET requires the transfer of energy from a donor to
acceptor decreasing donor’s lifetime while increasing the lifetime of acceptors. The
lifetime difference occurring due to the transfer of energy can thus be easily recorded
using FLIM even in the presence of multiple donors and acceptors where local image
contrast can provide information regarding lifetimes of each donor and surrounding
acceptors.

Though useful, FLIM measurements are slow compared to the timescale of
molecular diffusion due to its characteristics of point-to-point measurements that may
alter the molecular makeup of an image pixel during measurement (21). Additionally,
FLIM is limited to determine stoichiometry only for dimers since it relies on averaging
signals from several pixels in order to increase signal to noise ratio. For a system
containing higher order oligomers than dimers, averaging over multiple pixels results in
accumulation of large number of lifetimes coming from oligomers with different size and
shape; due to this effect it is almost impossible to fit the experimental data with multiple
exponential decay functions (23).
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2.3.3 Fluorescence correlation spectroscopy
Fluorescence correlation spectroscopy (FCS) is an advanced spectroscopic technique that
has recently found great interest in the field of biochemistry, biophysics, and
biotechnology. FCS is based on time-dependent fluctuations of fluorophores in a small
volume of the sample under thermal equilibrium (24). Unlike, fluorescence spectroscopy,
the parameter of interest for FCS is not the emission intensities of fluorophores, but the
spontaneous fluctuations in the emission intensities occurring due to the physical and
chemical changes of the sample of interest.

Due to the high sensitivity of the

measurement, FCS cannot be performed on samples with a high concentration and large
volume. The typical focal volume used for the measurement is about one femtoliter (25)
and the typical concentrations ranging from 10-9 M – 10-6 M. The general principle
underlying the FCS technique is to measure intensity fluctuation over time; the rate of the
intensity fluctuation depends on the fluorophore diffusion rate. If the rates of fluorophore
diffusion are high, a rapid increase and decrease in the fluorescent emission intensity is
observed, while if the diffusion rate is slow, fluctuations are observed to be slower. The
autocorrelation function is usually calculated by the amplitude and speed of the
fluctuations which carries information on relative weights and characteristics time scales
of different transitions in the system (25). The height of the correlation function vs.
correlation time curve is used to calculate the average number of fluorophores as they are
inversely proportional to each other while the diffusion coefficients of fluorophores are
estimated by the position curve on time axis.
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The technique of Förster resonance energy transfer (FRET) technique is well
known for the study of conformational changes in proteins and has found significant
promise in the field of biological sciences. Since FRET’s sensitivity to distance is high
(in the order of sixth power), continuously changing distances between FRET pairs
(donors and acceptors) can lead to fluctuations in the emission intensities occurring due
to the different amount of energy transfers between donors and acceptors. Because of
this, the techniques of FCS and FRET appear to complement one another well. Torres et
al used FCS technique to study the fluctuations caused in FRET due to continually
changing distances and had demonstrated the promise of the FCS-FRET method to study
the conformational dynamics of biomolecules (26). Though promising, this method
suffers from several challenges that still needs to be addressed. Along with the samples
containing the FRET pair, the FCS-FRET measurement requires an identical sample
containing the donor molecule. The measurement of both samples must be performed
under identical optical conditions with precisely controlled confocal volume for each
sample. This task has proved to be difficult in practice, limiting the large scale
applications of FCS.

2.3.4 Spectral imaging with linear unmixing
In FRET spectral imaging is a branch of imaging techniques where a complete spectrum
of the donor and acceptor fluorophore can be acquired at every location of the imaged
sample. Spectral imaging coupled with linear unmixing is an improvised version of
sensitized emission, which relies only on donor excitation followed by the acquisition of
the entire spectrum of donor and acceptor at the same time. Since the measured spectrum
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contains signal from both donor and acceptor; spectral unmixing using elementary
spectra of the donor and acceptor is required to calculate individual contributions from
donors and acceptors (27).

Thus using spectral imaging, it is possible to acquire

complete spectral information at once instead of using sets of filters for different
bandwidth regions for donors and acceptors, hence it is widely used in the field of FRET
biosensors and the study of oligomerization and dynamics of protein-protein interaction
(28-31). Also, this method contributes significantly to overcome spectral bleed-through,
spectral cross-talk and cellular autofluorescence that are potential problems in FRET
based imaging methods (32). Details about the method of spectral imaging are described
in section 2.4.2. While spectral imaging offers significant advantages to FRET
spectrometry, the experimental set up requires specialized mode-locked solid state laser
for multiphoton excitation that is relatively costly limiting its commercial potential. (23).

2.3.5 Fluorescence polarization imaging
Fluorescence polarization (FP) imaging technique is a very sensitive technique capable of
studying the size, folding, and stabilization of proteins as well as the viscosity of
cytosols. This technique relies on selective excitation of the fluorophores based on the
direction of their dipole moments. Each molecule in a cluster of fluorophores has their
respective transition dipole moments oriented in a specific direction to the molecular
axis. A certain number of molecules in the group can have their dipole moments arranged
in a certain angular distribution that can be excited when polarized light is incident on it.
The emissions from these excited molecules also have their emission dipole moments
distributed in certain angular range. The change in orientations of excited and emitted
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dipole moments provide the measure of anisotropy of the molecules. The emission can be
depolarized in many ways. Examples include but are not limited to rotational diffusion
and complete randomization. FP imaging is well known to predict the size of proteins
(33) where the fluorophores are tagged to the proteins. If a protein is large, it takes a long
time to change its conformation, thereby slowing down the rate of emission polarization
from the tagged fluorophore. Conversely, if the protein is small, the rate of emission
polarization will be faster, providing an accurate detail on the size of the molecule.
Additionally, this can also provide information about how a protein folds and reaches its
stabilized state (33). On the other hand, if biomolecules are dispersed in a viscous
medium, the change in emission polarization rate will be slower compared to the ones in
less viscous medium, helping to predict the viscosity of the biomolecular environment.

FP imaging is particularly helpful in homo-FRET measurements. Homo-FRET is
defined as FRET occurring between the same species of molecules. The identification of
homo-FRET is not possible in spectrally resolved measurements or FLIM, since there is
no change in either the emission intensity of the donor or the lifetime of the fluorophore
during resonance energy transfer is observed (34). The FP technique is found to be useful
in this regard, since the fluorophores that can be excited by polarized light exhibit highly
polarized emissions compared to the fluorophore emissions occurring via homo FRET. In
biological sciences, detection of homo-FRET is more significant than hetero-FRET since
it can allow the study of protein oligomerization, and heterogeneity in lipid-order, in
complex cell environment (34). FP techniques can provide misleading results occurring
from changes in polarization due to other factors such as the use of high numerical
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aperture (NA > 1) objective lens and change in orientation of fluorophores during
measurement (35).

2.3.6 Total internal reflection fluorescence microscopy (TIRF)
Total internal reflection fluorescence microscopy (TIRF) is a highly useful technique for
studying phenomenon occurring at the cell surface providing useful insights over
extracellular, and intracellular events occurring near the cell surface. The significant
advantage of TIRF is that it can measure the fluorescence in an extremely thin region at
the interface of two media without much background noise. As the name implies, TIRF
works on the principle of total internal reflection of incident light. When the light travels
from denser to rarer medium, the refracted light bends away from the incidence normal.
At a certain angle of incidence the refracted light becomes perpendicular to the normal of
incidence; this is called the critical angle. At angles larger than the critical angle, all
incident light gets totally reflected back into the same medium; this is referred to as total
internal reflection. Even though the light undergoing total internal reflection does not
enter into the second medium, it does generate an exponentially decaying electric field in
the lower refractive index medium adjacent to the interface of two media called as an
evanescent wave (36). The generated field has the same frequency as the incident light.
These evanescent wave has a penetration depth of ~ 100 nm and can excite a fluorophore
which resides in the vicinity of the interface without affecting the molecules far from the
interface eliminating the background. Recently, TIRF microscopy has been combined
with FRET to both develop biosensors, and study the interactions of G-protein coupled
receptors both in vivo and in vitro (37, 38). Although TIRF incorporated in two-photon
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microscopy is an excellent tool to investigate dynamics of many proteins and small
molecules on the cell surface with high resolution, its application is limited only to
surface the of a cells.

2.4

Linear and non-linear optical microscopy

2.4.1 Single photon vs. multi-photon excitation
The most commonly known absorption phenomena in spectroscopy is single photon
absorption where a photon with energy in the UV or visible region is used to excite
electrons from the ground state to the excited state. If the energy of one photon is
equivalent to the energy gap between the ground and excited state, it is said to be
absorbed by the system i.e.,
𝐸𝑓 − 𝐸𝑖 =

ℎ𝑐
𝜆𝐴

(2.2)

where Ef is the energy of the excited state |𝑓⟩, Ei is the energy of ground state |𝑖⟩, h is
Planck’s constant, c is the speed of light, and 𝜆𝐴 is the excitation wavelength as shown in
Fig 2.3a. When the single photon in the system is replaced by two photons of less energy
(with equal or unequal wavelength) whose sum adds up to the energy gap of the
molecule, a similar excitation as single photon is observed but with less energetic
photons, this phenomenon is known as two-photon absorption. The corresponding
transition is given as:
𝐸𝑓 − 𝐸𝑖 =

ℎ𝑐
ℎ𝑐
+
𝜆𝐴1 𝜆𝐴2

where 𝜆𝐴1 and 𝜆𝐴2 are the excitation wavelengths of two photons.

(2.3)
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Figure 2.3 Representation of single and two photon excitation energy level diagram and absorption cross
section. (a) Energy level diagram of a molecule. |𝒊⟩, and |𝒇⟩, represent ground and first excited state of the
molecule, respectively. Solid arrows represent single (blue) and two (red) photon absorption and emission
(green). (b) Schematic to show single and 2-photon excitation cross-section shown by bright green color of
a solution of fluorescence molecules color in a transparent tube represented by dark green color.

Two-photon absorption, however, depends on the intensity of the incident light,
which is supposed to be significantly high for the phenomenon to occur. The strength of
absorption is proportional to the square of the incident photon intensity that is parabolic
in behavior and hence is a non-linear absorption process. The absorption coefficient of
one-photon absorption is given by the Beer Lambert’s law, which is

𝐼 = 𝐼0 𝑒 −𝛼𝑐𝑥

(2.4)
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where I0 is the intensity of incident light, 𝛼 is the absorption coefficient (cross-section), c
is the concentration and x is the light path length, whereas for the two-photon absorption
the Beer Lambert’s law changes to:
𝐼𝐼 =

𝐼0
1 + 𝛽𝑐𝑥𝐼0

(2.5)

where 𝛽 is the two-photon absorption coefficient (cross-section). The one-photon
absorption cross-section is measured in the units of cm2 while two-photon absorption
cross-section is measured in GM (Göppert-Mayer) unit where, 1GM = 10-50 cm4sec/photon.

The transition probabilities of single-photon and two-photon absorptions are
provided by the following equations (39):

𝑃𝑜𝑛𝑒−𝑝ℎ𝑜𝑡𝑜𝑛 ∼ |⟨𝑓|𝐸⃗⃗𝛾 . 𝑟⃗|𝑖⟩|

2

(2.6)

and
2

𝑃𝑡𝑤𝑜−𝑝ℎ𝑜𝑡𝑜𝑛

⟨𝑓|𝐸⃗⃗𝛾 . 𝑟⃗|𝑚⟩⟨𝑚|𝐸⃗⃗𝛾 . 𝑟⃗|𝑓⟩
∼ |∑
|
𝜀𝛾 − 𝜀𝑚

(2.7)

𝑚

where 𝐸⃗⃗𝛾 . 𝑟⃗ is electric dipole interaction energy, |𝑖⟩, |𝑓⟩, and |𝑚⟩ are the initial, final, and
intermediate states respectively, 𝜀𝛾 and 𝜀𝑚 are the photon energies corresponding to the
field 𝐸⃗⃗𝛾 and the energy difference between mth state and the ground state respectively.
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There are several advantages of two-photon absorption (TPA) microscopy
compared to single-photon absorption (SPA) confocal microscopy (39, 40):
(i) TPA microscopy uses photons with wavelengths in the near infrared region
which are significantly less absorbed by biological tissues compared to UV, and visible
wavelengths. Therefore, attenuation of excitation light from scattering is reduced because
scattering cross-sections decreases with increasing wavelength. The low absorption of
infrared light by the biological samples can also help to probe the sample with increased
depth.
(ii) Since TPA cross-section is smaller compared to SPA cross-section, therefore,
the absorption occurs only at the focal plane of the sample (see Fig. 2.4b). Hence, better
resolution is obtained along with reduced photobleaching, and photodamage commonly
observed with the SPA confocal microscopy.
(iii) TPA can also help in rejection of excitation light as well as Raman scattering
since it uses two photon excitation wavelengths, which is nearly half the excitation
wavelength of single photon ensuring wide separation between excitation, and emission
wavelengths.
(iv) TPA microscopy doesn’t need a pinhole aperture to reject out-of-focus light,
thereby minimizing signal loss, which is significant in SPA confocal microscopy.

While TPA microscopy presents several advantages, it also suffers from a few
disadvantages. For instance, TPA suffers from lower spatial resolution when compared to
confocal microscopy. Also, it lacks versatility because confocal microscopy can generate
images based on refractive index variation in addition to the fluorophore distribution,
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which is not possible through TPA microscopy. Nevertheless, TPA has found promising
applications in biological sciences such as in physiology, neurobiology, embryology, and
tissue imaging and it is expected that future applications can be even more promising. For
example, in the field of cellular biology, TPA can potentially be used for noninvasive
optical biopsy procedure which that require high speed imaging (40).

2.4.2 Two-photon optical micro-spectroscope (OptiMiS)
Fig. 2.4 shows a schematic of a two-photon optical micro-scope (OptiMiS) system
designed and built in our lab. The components of the system include a solid state laser
(VerdiTM, coherent Inc., CA, USA., 532 nm), sub-ten femtosecond pulsed Ti: Sapphire
laser (KM labs, CO, USA, wavelength range 780-860 nm with FWHM of 120 nm), fixed
mirrors, a telescope, computer-controlled orthogonal x-y scanning mirrors (Nutfield
Technology Inc., NH, USA), scanning lens, short pass dichroic mirror, relay lens, bandpass filter (1 nm bandwidth), transmission grating, short pass filter, an EM-CCD camera,
tube lens, infinity corrected oil immersion objective (Nikon Instruments Inc. NY, 100X
magnification, N.A. = 1.43) and x-y-z sample stage.
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Figure 2.4 Schematic of an optical micro-spectroscope (OptiMiS). The optical components of the
microscope are indicated in the figure. The schematic is reconstructed from (27, 41)

As shown in the illustration, the Ti:Sapphire laser

generating sub-ten

femtosecond pulses of near infra-red (NIR) light (780-860 nm) which after passing
through the beam expander is directed to the computer controlled x-y scanning mirrors
through a fixed mirror. The light beam is directed by the scanning mirrors before being
reflected by the short pass dichroic mirror. The beam is focused to a diffraction-limited
spot on the sample by an infinity corrected objective. The back propagating fluorescence
generated at every single voxel of the sample is collected by the objective and passes
through the short pass dichroic mirror, which allows the passage of fluorescent light
having shorter wavelength , 660 nm, through it and reflects back the infrared light that is
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reflected back from the sample. The fluorescent light passing through the dichroic mirror
then passes through a relay lens to the transmission grating which disperses the light into
its spectral components, and then finally falls on the detector (EM-CCD camera). The
short pass filter attached to the camera rejects any residual infrared light back propagated
along with the fluorescent light. The spot is then scanned over the sample by moving the
computer-controlled x-y scanning mirrors. The spectral component of the fluorescence
emission from each of the scanned spots in the sample form a line on the detector along
one direction (referred to as the y-direction hereafter) after passing through the
transmission grating. Thus after scanning the entire x-range (line), the detector provides a
2D image for each line scanned on the sample. The x-dimension of the sample
corresponds to the actual x-dimension of the sample while the y-dimension corresponds
to the spectral dimension i.e. the wavelength (𝜆). Many line scans are then performed
with different y-values and scanned throughout the sample using x-y scanning mirrors.
The individual images corresponding to each line scan is then reconstructed to obtain the
final spectral image.

There are several advantages of the OptiMiS setup. First, the fast acquisition of an
entire spectrally resolved image requires only a single laser scan of the sample, since the
whole spectrum corresponding to each x-line scan is acquired at once. Second, the
capability to perform transmission based imaging; the setup uses a halogen lamp placed
above the microscope slide and a narrow-band interference filter inserted in the light path
before the transmission grating helping to remove the blur caused by diffraction grating.
Third, better signal to noise ratio because the number of photons reaching the detector is

66
larger than the number of photons in other two-photon confocal microscope using
pinholes since signals are cut by pinholes. The second generation of OptiMiS utilizes a
line scan rather than a point scan by replacing the x-scanning mirror with a cylindrical
mirror; this allows the entire x range of the sample to be illuminated with the excitation
beam simultaneously, rather than scanning each pixel. This recent development of trueline scan improve the speed and sensitivity by two orders of magnitude while conserving
the spectral information (42). The image reconstruction algorithm was written in C++ and
is described in section 2.4.4.

2.4.3 Spectral calibration
Spectral calibration is an important step for the accurate interpretation of the data. As
described in section 2.4.2, y-pixels correspond to spectral dimension. Therefore, in order
to reconstruct the real image from the snapshots taken at different y-pixels, it is critical to
assign the correct wavelength to each y-pixel. Thus, the microscope must be calibrated
using a standard sample with known fluorescence emission spectrum before data
acquisition. The standard sample is an aqueous solution of 2 mM fluorescein sodium salt
(Uranine, Fischer Scientific, IL). The full set of x-line scans is performed on the standard
sample where the scanning parameter Δ𝑦 is adjusted based on previous knowledge such
that the shift in the spectrum is one pixel for every y-increment of x-y scanning mirror
position. The obtained images are then reconstructed using a reconstruction algorithm
described in section 2.4.3 and the reconstructed image is processed in ImageJ utilizing
inbuilt ascending order and stacked functions for background correction. In order to
double check the correct assignment for the value of Δ𝑦, we sampled the measured

67
spectrum of the uranine scan at three different regions (generally the top, middle and
bottom) of the reconstructed images. Non-overlapping spectrum or shifted spectrum at
different regions indicates incorrect value of Δ𝑦 and hence the value of Δ𝑦 is adjusted
until the spectrum of fluorescein at all three regions of the reconstructed image overlap
perfectly with one another. Knowing that the y (spectral) pixels positions in the camera is
linearly related to the wavelength of the emitted photons, a linear relationship between
the reconstructed image and the corresponding wavelength was established having
following relationship

𝜆𝑖 = 𝑚(𝑖 − 𝑖𝑚𝑎𝑥 ) + 𝜆𝑚𝑎𝑥

with

𝑚=

(𝜆𝑚𝑎𝑥 − 𝜆1/2 )
(𝑖𝑚𝑎𝑥 − 𝑖1/2 )

(2.8)

(2.9)

where, 𝜆𝑖 corresponds to the ith wavelength of reconstructed image, 𝜆𝑚𝑎𝑥 and 𝜆1/2 are
maximum and half maximum wavelengths of the emission intensities of fluorescein
respectively, and 𝑖𝑚𝑎𝑥 and 𝑖1/2 are the reconstructed image numbers corresponding to
maximum and the half maximum intensities of the fluorescence.

2.4.4 Image reconstruction
The real spectral images were obtained by using a simple reconstruction algorithm after a
correlation of wavelengths with y-pixel was determined. The algorithm steps are
described using Fig. 2.5. Each image represents full ‘x’ line scan, the laser being centered
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at a particular y-pixel (i.e. wavelength). Each row in the ‘y’, or spectral dimension
represents a wavelength. The entire spectral range is divided into 10 equally spaced
wavelengths separated by Δ𝑦. Therefore spectral resolution is determined by wavelength
value corresponding to Δ𝑦 pixels. The highest spectral resolution is set to be 1 nm,
however for faster acquisition, spectral resolution can be decreased by increasing Δ𝑦 in
the integral increment as required. The x-line scans are performed after each increment of
Δ𝑦 within the scanning range starting from top to bottom along the y-direction. As shown
in Fig. 2.5a, let us assign the wavelengths as 𝜆1 , 𝜆2 , 𝜆3 ,…., 𝜆10 for the first line-scan
represented by Image#1. After the x-y scanning mirror is moved by an increment of Δ𝑦 in
y-direction, the first wavelength in Image#2 corresponds to the second wavelength in
image#1 and so on. Thus, in order to reconstruct the image of entire scanning region at a
particular wavelength, rows from all the images corresponding to the wavelength needed
to be stacked. For e.g., to reconstruct the image for wavelength, 𝜆5 , rows corresponding
to wavelength 𝜆5 from all the images are stacked as shown in Fig. 2.5b. Fig 2.5c shows
an example of the reconstructed image of a CHO cell expressing Cerulean at a certain
wavelength as represented by 𝜆5 . Thus reconstructed algorithm provides spectrally
resolved images at various wavelengths, which are further processed for calculation of
FRET parameters.
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Figure 2.5 Visualization of image reconstruction algorithm from the individual scans. (a) Scanning
algorithm showing three consecutive images for entire x-scanning range at three consecutive y-centers of
focused laser. Row number defines different equally spaced wavelengths of separation, 𝜟𝒚. (b)
Reconstruction algorithm of image for a certain wavelength, 𝝀𝟓 . (c) Reconstructed images of a CHO cell
expressing Cerulean at a certain wavelength, 𝝀𝟓 .
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Chapter 3. Experimental verification of Förster Resonance
Energy Transfer (FRET) theory using optical micro-spectroscopy
(OptiMiS) and fluorescence reference standards

Förster Resonance Energy Transfer (FRET) is a radiationless photophysical process of
energy transfer from an excited donor (D) to its nearby (< 10 nm) acceptor (A) via
dipole-dipole interaction (1-3). The theory that describes this process, introduced by
Förster (4-6), has so far been widely used and confirmed in particular with regard to the
dependence of the efficiency of energy transfer (FRET efficiency) from D to A on the
sixth power of the distance between D and A (2, 3). By inserting fluorescent proteins
(FP), which can act as D and A, at particular locations of the protein of interest, the
distance between the tags and hence between the interacting parts of the proteins can be
determined. This approach is used to study associations of macromolecules such as
proteins (7-9). However, generalizing and testing the FRET theory for oligomeric
complexes containing multiple donors and acceptors has only become possible in recent
years (10-12). Therefore, many aspects of it are yet to be investigated. Koushik et al. (13)
reported that kinetic theory of FRET failed to predict the ensemble FRET efficiency of
oligomers. To this end this chapter deals with an overview of the FRET theory (9, 10)
and also testing the kinetic theory of FRET for linked fluorescent proteins that form
dimeric, trimeric, and tetrameric combinations located in the cytoplasm or at the plasma
membrane. The cytoplasmic probes were fused combinations of a donor (Cerulean, C),
an acceptor (Venus, V), and a chromophore-deficient Venus-like molecule that cannot
absorb or transfer energy (Amber, A) namely, ACVA, VCAA, ACAV, and VCVV
respectively (13). The membrane-bound probes, developed in house, were fused dimers
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and trimers of GFP2 (or G2, for short) (14) and YFP (or Y) (15) which we call here G2Y,
YG2, and YG2Y. The FRET efficiencies for all the dimer, trimer, and tetramer constructs
were measured experimentally using an optical micro-spectroscopic (OptiMiS) system
(12, 16). According to the theory (10), the FRET efficiency of a tetramer with multiple
donor and acceptors such as VCVV can be predicted from that of analogues that contain
a single donor and acceptor (e.g., ACVA, ACAV, and VCAA); also, the apparent FRET
efficiency of a trimer such as YG2Y can be predicted from the pair-wise FRET efficiency
that corresponds to that of dimers such as G2Y and YG2. By comparing the measured and
predicted FRET efficiencies, we are able to test the generality of all the aspects of the
FRET theory describing multimeric complexes.

3.1

Overview of FRET theory

In recent years, quantitative FRET studies have evolved in mainly two directions: (1)
estimation of intermolecular distances between interacting proteins in a protein complex
from the energy transfer efficiency and Förster distance; (2) determination of the
stoichiometry or the quaternary structure of protein complexes by measuring intensities
of donor and acceptor in presence and absence of FRET. In the first type of application,
FRET efficiencies of protein complexes can be obtained from measurements of
fluorescence intensity (17) as well as from fluorescence lifetime imaging (3, 18). The
second line of investigation, is based on fluorescence intensity measurements, which
have recently evolved into a method for stoichiometry and quaternary structure
determinations of protein complexes in living cells (12). The DNA of the proteins of
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interest is fused to the genes of the fluorescent proteins and inserted into cells for
expression of the corresponding fusion proteins.

3.1.1 FRET efficiency for dimeric complexes
In this section, we will overview the elementary theory of FRET, with an aim to derive
expressions for FRET efficiencies of oligomeric complexes. For simplicity, let us first
consider a donor-acceptor pair. In the absence of FRET, an optically excited fluorophore
loses some of its excitation energy through vibrational relaxation and comes to the lowest
vibrational energy level of the excited state from where it can be de-excited to the ground
state either through radiative or non-radiative emissions. The quantum yield of the
fluorophore, i.e., the rate of photon emission by the excited fluorophore can be expressed
as (9, 10):
𝑄𝑋 =

Γ 𝑟,𝑋
Γ 𝑟,𝑋 + Γ 𝑛𝑟,𝑋

(3.1)

where Γ 𝑟,𝑋 and Γ 𝑛𝑟,𝑋 are the rates of radiative and non-radiative energy transfer of
excited fluorophore, respectively; X stands for either donor (D) or acceptor (A). The
lifetime of the fluorophore can also be defined in terms of the de-excitation rate constants
as:

𝜏𝑋 =

Γ 𝑟,𝑋

1
+ Γ 𝑛𝑟,𝑋

(3.2)
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When an acceptor molecule is located in the vicinity of an excited donor, another
possible pathway for de-excitation of the donor is through FRET. In this case, the donor
is de-excited to its ground state by transferring its energy non-radiatively, through
interaction between its transition dipole, and a dipole induced into the nearby acceptor.
The quantum yield (𝑄 𝐷𝐴 ) and lifetime (𝜏 𝐷𝐴 ) of donor in presence of FRET can be
expressed, by modifying equations 3.1 and 3.2, as follows:

𝑄 𝐷𝐴 =

Γ 𝑟,𝐷

(3.3)

Γ 𝑟,𝐷 + Γ 𝑛𝑟,𝐷 + Γ𝐹𝑅𝐸𝑇

and
𝜏 𝐷𝐴 =

1
Γ 𝑟,𝐷

+

Γ 𝑛𝑟,𝐷

+ Γ𝐹𝑅𝐸𝑇

,

(3.4)

where Γ 𝐹𝑅𝐸𝑇 is the rate of energy transfer from the excited donor to the unexcited
acceptor and can be defined as:

Γ 𝐹𝑅𝐸𝑇 = (Γ 𝑟,𝐷 + Γ 𝑛𝑟,𝐷 ) (

𝑅06
1 𝑅06
)
=
( )
𝑟6
𝜏𝐷 𝑟6

(3.5)

where 𝑅0 is the Förster distance (i.e., distance between the donor and acceptor for which
the energy transfer rate is 50%) and r is the distance between donor and acceptor (2, 3,
19). It is worth mentioning that FRET affects only the excitation of acceptor, while deexcitation of acceptor is independent of the way acceptor gets excited (9). Hence, the
quantum yield and lifetime of the acceptor remain unchanged in FRET. The energy
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transfer efficiency of the donor excited through FRET can be expressed in terms of the
rate constants as:
𝐸=

Γ 𝐹𝑅𝐸𝑇
Γ 𝑟,𝐷 + Γ 𝑛𝑟,𝐷 + Γ𝐹𝑅𝐸𝑇

(3.6)

or,
𝐸
Γ 𝐹𝑅𝐸𝑇
= 𝑛𝑟,𝐷
1−𝐸 Γ
+ Γ𝐹𝑅𝐸𝑇

(3.7)

Plugging equation (3.5) into equation (3.6) we get,

𝐸=

Γ

𝐹𝑅𝐸𝑇

Γ𝐹𝑅𝐸𝑇
+ Γ𝐹𝑅𝐸𝑇
𝑅06
( 6)
𝑟

𝑅6
( 60 )
𝑅06
𝑟
=
= 6 6
𝑅06
𝑟 +𝑅0
1 + ( 6)
𝑟

(3.8)

while by plugging equations (3.4) and (3.5) into (3.8), we obtain the following
expressions for FRET efficiency in terms of the lifetime of excited donors in presence
and absence of energy acceptors:
𝐸 = 1−

𝜏 𝐷𝐴
𝜏𝐷

(3.9)

Combining equations (3.1) (for X = D) and (3.3) with (3.6), we obtain a relation between
the FRET efficiency and the quantum yields of the donor in the presence and absence of
acceptor (or FRET):
𝑄 𝐷𝐴 = 𝑄 𝐷 (1 − 𝐸)

(3.10)
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This equation indicates that the donor emission decreases as a result of the energy
transfer to the acceptor.
3.1.2 FRET efficiency for multimeric complexes
Here we will overview a kinetic theory of FRET introduced recently (10). According to
that theory, the FRET efficiency of a multimeric complex consisting of donors and
acceptors, can be generalized in terms of a pair-wise FRET efficiency, or the efficiency
between a certain donor-acceptor pair.

Figure 3.1: Schematic representation of an oligomer (a pentamer in this example) with two donors (D) and
three acceptors (A) and their possible configurations. (a) Possible energy transfer pathways from the donors
to the acceptors in the oligomers. Solid, dashed and wavy arrows represent FRET, radiative and nonradiative energy transfer. (b) Ten possible configurations of the pentamer shown in (a). Figure, adapted
from (10).

Considering an oligomer containing n subunits (or protomers), with k of them being
identical donors and n-k identical acceptors, there exist k pathways for the donors to lose
excitation energy through radiative emission of a photon or non-radiative de-excitation
(due to the interaction with the environment) and n-k different ways of losing excitation
energy via FRET with nearby acceptors (see Fig. 3.1 (a) as an example of all possible
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energy transfer pathways from a pentamer with two donors and three acceptors). If the
number of possible configurations of an oligomer is represented by q (see Fig. 3.1 (b),
where q = 10 ), the quantum yield of the ith donor can be expressed as (9, 12):

𝐷𝐴
𝑄𝑖,𝑘,𝑛,𝑞
=

Γ 𝑟,𝐷
𝑄𝐷
=
𝐹𝑅𝐸𝑇
𝐹𝑅𝐸𝑇
𝑟,𝐷 + Γ 𝑟𝑛,𝐷 )
Γ 𝑟,𝐷 + Γ 𝑛𝑟,𝐷 + ∑𝑛−𝑘
1 + ∑𝑛−𝑘
𝑗=1 Γ𝑖,𝑗,𝑞
𝑗=1 (Γ𝑖,𝑗,𝑞 ⁄Γ

(3.11)

6

0
0
𝐹𝑅𝐸𝑇
where Γ𝑖,𝑗,𝑞
= (Γ 𝑟,𝐷 + Γ 𝑛𝑟,𝐷 )(𝑅𝑖,𝑗,𝑞
⁄𝑟𝑖,𝑗,𝑞
) is the energy transfer rate of ith donor to jth

acceptor through FRET. Since the orientation factor for individual donor-acceptor pairs
in an oligomer might be different (2, 3), the Förster distance can also be different for each
pair of donors and acceptors. The FRET efficiency for the ith donor can be defined as:

𝑛−𝑘

𝐸𝑖,𝑘,𝑛,𝑞 = ∑
𝑗=1

where 𝐸𝑖,𝑗,𝑞 =

𝑛−𝑘

𝐹𝑅𝐸𝑇
⁄Γ 𝑟,𝐷 + Γ 𝑟𝑛,𝐷
Γ𝑖,𝑗,𝑞
𝐹𝑅𝐸𝑇
𝑟,𝐷 + Γ 𝑟𝑛,𝐷 )
1 + ∑𝑛−𝑘
𝑗=1 (Γ𝑖,𝑗,𝑞 ⁄Γ

𝑟,𝐷 +Γ𝑟𝑛,𝐷
Γ𝐹𝑅𝐸𝑇
𝑖,𝑗,𝑞 ⁄Γ
𝐹𝑅𝐸𝑇 𝑟,𝐷 +Γ𝑟𝑛,𝐷 )
1+∑𝑛−𝑘
𝑗=1 (Γ𝑖,𝑗,𝑞 ⁄Γ

=

0
0
⁄𝑟𝑖,𝑗,𝑞
(𝑅𝑖,𝑗,𝑞
)

= ∑ 𝐸𝑖,𝑗,𝑞

(3.12)

𝑗=1

6

0
0
1+∑𝑛−𝑘
𝑗=1 (𝑅𝑖,𝑗,𝑞 ⁄𝑟𝑖,𝑗,𝑞 )

6

is the FRET efficiency of ith

donor and jth acceptor. Equation (3.12) is also called the kinetic model of FRET. Using
𝐷𝐴
equation (3.12), equation (3.11) can also be written as 𝑄𝑖,𝑘,𝑛,𝑞
= 𝑄 𝐷 (1 − 𝐸𝑖,𝑘,𝑛,𝑞 ), which

is similar to equation (3.10).
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3.1.3 Experimental determination of FRET efficiency using filter-based methods
The standard experimental method for determining FRET efficiencies of protein
complexes using optical filters of a certain bandwidth is described in this section. Fig.
3.2 shows a mixture of two populations of fluorophores consisting of donors and
acceptors of energy. When the distances between donors and acceptors are significantly
larger than the Förster radius (Fig. 3.2 (a)) and the mixture is subjected to light with
wavelength 𝜆𝑒𝑥 , which excites the donors significantly and only rarely excites the
acceptors, the emission intensity at the emission wavelength of acceptor will provide high
signal from the donors and low signal from the acceptors and donors, as shown in Fig.
3.2 (c). If some donors and acceptors are within the range of Förster distance (3), as
illustrated in Fig. 3.2 (b), the donors can excite their nearby acceptors by transferring
their energy non-radiatively, and the emission intensity at the emission wavelength of
acceptors, 𝜆𝑒𝑚 , will be dominated by acceptor emission as shown in Fig. 3.2 (d). The
measured emission intensity can thus be expressed as:

𝐼 𝑚 (𝜆𝑒𝑥 , 𝜆𝑒𝑚 ) = 𝐼 𝐷 (𝜆𝑒𝑥 , 𝜆𝑒𝑚 ) + 𝐼 𝐴 (𝜆𝑒𝑥 , 𝜆𝑒𝑚 ).

(3.13)

Now, representing the intensity lost by the donor due to FRET and that gained by the
acceptor as 𝐼 𝐷 (𝜆𝑒𝑚 , 𝐹𝑅𝐸𝑇) and 𝐼 𝐴 (𝜆𝑒𝑚 , 𝐹𝑅𝐸𝑇), respectively, the above equation may be
re-written as:

𝐼 𝑚 (𝜆𝑒𝑥 , 𝜆𝑒𝑚 ) = 𝐼 𝐷𝐴 (𝜆𝑒𝑥 , 𝜆𝑒𝑚 ) + 𝐼 𝐴𝐷 (𝜆𝑒𝑥 , 𝜆𝑒𝑚 )
=𝐼

𝐷 (𝜆

𝑒𝑥 , 𝜆𝑒𝑚 )

−𝐼

𝐷 (𝜆

𝑒𝑚 , 𝐹𝑅𝐸𝑇)

+𝐼

𝐴 (𝜆

𝑒𝑥 , 𝜆𝑒𝑚 )

+

𝐼 𝐴 (𝜆𝑒𝑚 , 𝐹𝑅𝐸𝑇)

(3.14)
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where 𝐼 𝐷𝐴 (𝜆𝑒𝑥 , 𝜆𝑒𝑚 ) and 𝐼 𝐴𝐷 (𝜆𝑒𝑥 , 𝜆𝑒𝑚 ) are the emission intensities of the donor in the
presence of acceptors and vice versa.

Figure 3.2: Schematic representation of the effect of FRET on a mixture of donors (D) and acceptors (A)
excited at the maximum excitation wavelength of the donors. (a) Mixture of D and A separated by
distances > 10 nm. Donors and acceptors are shown in dark green color and light yellow color respectively
representing excitation of the donors and no energy transfer to the acceptors. (b) If some donors, and
acceptors are within the Förster distance from one another; the donors become dimmer and the acceptor
brighter due to energy transfer. (c), (d) Excitation (dashed lines) and emission (solid lines) spectra of
donors (green) and acceptors (yellow). (c) Strong emission peak for donor and weak emission peak for
acceptor corresponding to the situation (a) results in low signal detected at the emission wavelength of
acceptor. (d) Weak emission peak for donor while strong emission peak for acceptor corresponding to the
situation (b) results in detection of high signal. This image is adopted from (9)

Equation (3.14) shows that the measured emission intensity depends on the
excitation wavelength. For most of the fluorophores used as good FRET pairs (i.e., for
which there is a significant overlap between the emission spectrum of the donor and the
excitation spectrum of the acceptor), a relatively short Stokes shifts result in the
excitation of acceptors to different degrees at the excitation wavelengths of donor and
vice versa. This effect is called spectral cross-talk (20) and should be avoided in FRET
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studies. Choosing the FRET pair which has well separated spectrum is a solution to the
spectral cross-talk, however, this decreases the spectral overlap integral (J(𝜆)) (3) of the
fluorophores reducing the ability to detect FRET signals. Many of the intensity-based
measurements methods rely on emission and detection filters to measure the fluorescence
intensity of one fluorophore in presence and absence of the other. These filter-based
methods need at least two different detection wavelengths: one, 𝜆𝑒𝑚,1 , at which donor to
acceptor emission ratio is maximum (i.e. acceptor emission in negligible) and at other,
𝜆𝑒𝑚,2 where it is minimum (donor emission is negligible). Accordingly, we can
approximate equation (3.14) as:

𝐼 𝑚 (𝜆𝑒𝑥 , 𝜆𝑒𝑚,1 ) ≅ 𝐼 𝐷𝐴 (𝜆𝑒𝑥 , 𝜆𝑒𝑚,1 ) = 𝐼 𝐷 (𝜆𝑒𝑥 , 𝜆𝑒𝑚,1 ) − 𝐼 𝐷 (𝜆𝑒𝑚,1 , 𝐹𝑅𝐸𝑇)

(3.15)

and
𝐼 𝑚 (𝜆𝑒𝑥 , 𝜆𝑒𝑚,2 ) ≅ 𝐼 𝐴𝐷 (𝜆𝑒𝑥 , 𝜆𝑒𝑚,2 ) = 𝐼 𝐴 (𝜆𝑒𝑥 , 𝜆𝑒𝑚,2 ) + 𝐼 𝐴 (𝜆𝑒𝑚,2 , 𝐹𝑅𝐸𝑇)

(3.16)

Equations (3.15) and (3.16) are used to calculate the apparent FRET efficiencies in terms
of donor quenching and acceptor sensitized emission (3, 9, 10) as:

𝐷𝑞
𝐸𝑎𝑝𝑝
≡

𝐴𝑠𝑒
𝐸𝑎𝑝𝑝
≡

𝐼 𝐷 (𝜆𝑒𝑚,1 , 𝐹𝑅𝐸𝑇)
𝐼𝐷 (𝜆𝑒𝑥 , 𝜆𝑒𝑚,1 )

𝐼 𝐴 (𝜆𝑒𝑚,2 , 𝐹𝑅𝐸𝑇)
𝐼 𝐴 (𝜆𝑒𝑥 , 𝜆𝑒𝑚,1 )

=1−

=

𝐼 𝐷𝐴 (𝜆𝑒𝑥 , 𝜆𝑒𝑚,1 )
𝐼𝐷 (𝜆𝑒𝑥 , 𝜆𝑒𝑚,1 )

𝐼 𝐴𝐷 (𝜆𝑒𝑥 , 𝜆𝑒𝑚,2 )
𝐼 𝐴 (𝜆𝑒𝑥 , 𝜆𝑒𝑚,2 )

−1

(3.17)

(3.18)
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The disadvantage of the above method is spectral bleed-through (see detail
discussion in section 2.1) (9). Additionally, in order to determine the intensities from
donors in the absence of acceptors (𝐼 𝐷 ) and the acceptors in absence of donors (𝐼 𝐴 ), one
needs to perform acceptor photobleaching and separate measurement of samples
containing acceptors only (9, 17), respectively. In the method based on acceptor
photobleaching, the donor is also bleached to a certain extent, and this can affect the
apparent FRET efficiency determination. Additionally, the same sample cannot be used
more than once in experiments relying on acceptor photobleaching, which prevents the
applicability of this method to dynamic studies that require monitoring the evolution of
the protein complex in time.

3.1.4 Determination of FRET efficiency from spectrally resolved fluorescence
intensity measurements
In this section, we will overview the theory of the method of spectrally resolved FRET
imaging (12), and we will also introduce an original contribution, which is related to
extraction of spectral components from a composite spectrum consisting of three
different species of fluorescent molecules.

The proteins of interest are tagged by the fluorescent molecules that act as donors
and acceptors and are transfected to the cells. Cells co-expressing both donor and
acceptor tagged proteins are excited at the excitation wavelength of donor and emission
spectrum is collected at every pixel of the scanning area. In order to extract the donor and
acceptor signals from the composite spectrum at every pixel, first we measure the
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fluorescence intensities of the samples containing donors only, and acceptors only. The
acquired donor and acceptor emission spectra are normalized by their maximum intensity
in order to get the elementary spectrum of donors,

𝐼𝐷 = [

𝑖1𝐷

𝜆𝑒𝑚,1

….
𝑖𝑛𝐷
]
… . 𝜆𝑒𝑚,𝑛

(3.19)

and acceptors,
𝐼𝐴 = [

𝑖1𝐴

𝜆𝑒𝑚,1

….
𝑖𝑛𝐴
],
… . 𝜆𝑒𝑚,𝑛

(3.20)

where i1,….,in are the normalized intensities corresponding to the emission wavelengths
λem,1,….,λem,n (9) The emission spectrum at every pixel of the image of the sample
containing both donors and acceptors may be written as:

𝐼𝑚 = [

𝑖1𝑚

𝜆𝑒𝑚,1

….
….

𝑖𝑛𝑚

𝜆𝑒𝑚,𝑛

]

(3.21)

or,
𝑛

𝐼

𝑚

=

∑ 𝑖𝑗𝑚
𝑗=1

𝑛

=𝑘

𝐷𝐴 (𝜆

𝐷
𝑒𝑥 ) ∑ 𝑖𝑗
𝑗=1

𝑛

+𝑘

𝐴𝐷 (𝜆

𝐴
𝑒𝑥 ) ∑ 𝑖𝑗

(3.22)

𝑗=1

The parameters kDA, and kAD are the emission intensities for D in the presence of A, and
for A in presence of D respectively and is determined using least square method (17, 21).
At every pixel the measured intensity 𝑖 𝑚 is fitted linearly by adjusting the fitting
parameters 𝑘 𝐷𝐴 (𝜆𝑒𝑥 ) and 𝑘 𝐴𝐷 (𝜆𝑒𝑥 ). The square of the fitting residual at any pixel is
given by
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𝑛

2

𝑅 =

2
∑(𝑖𝑗𝑚 )
𝑗=1

+ (𝑘

𝐷𝐴 (𝜆

𝑒𝑥 ))

2

𝑛

2
∑(𝑖𝑗𝐷 )
𝑗=1

+ (𝑘

𝐴𝐷 (𝜆

𝑒𝑥 ))

2

𝑛

∑(𝑖𝑗𝐴 )

2

𝑗=1

𝑛

+ 2𝑘

𝐷𝐴 (𝜆

𝑒𝑥

)𝑘 𝐴𝐷 (𝜆

𝐷 𝐴
𝑒𝑥 ) ∑ 𝑖𝑗 𝑖𝑗

(3.23)

𝑗=1
𝑛

− 2 ∑ 𝑖𝑗𝑚 {𝑘 𝐷𝐴 (𝜆𝑒𝑥 )𝑖𝑗𝐷 + 𝑘 𝐴𝐷 (𝜆𝑒𝑥 )𝑖𝑗𝐴 }
𝑗=1

For the best-fitted curve, the fitting residual should reach a minimum, i.e., the partial
derivatives of the square of the fitting residual with respect to the fitting parameters
𝜕(𝑅)2

𝜕(𝑅)2

𝑘 𝐷𝐴 (𝜆𝑒𝑥 ) and 𝑘 𝐴𝐷 (𝜆𝑒𝑥 ) should be zero, i.e., 𝜕(𝑘 𝐷𝐴 ) = 0 and 𝜕(𝑘 𝐴𝐷) = 0.
Or
𝑛

2
𝑘 𝐷𝐴 (𝜆𝑒𝑥 ) ∑(𝑖𝑗𝐷 )
𝑗=1

𝑛

𝑛

+ 𝑘 𝐴𝐷 (𝜆𝑒𝑥 ) ∑ 𝑖𝑗𝐷 𝑖𝑗𝐴 − ∑ 𝑖𝑗𝑚 𝑖𝑗𝐷 = 0
𝑗=1

𝑗=1

𝑛

𝑛

(3.24)

and
𝑛

𝑘

𝐴𝐷 (𝜆

𝐴 2
𝑒𝑥 ) ∑(𝑖𝑗 )
𝑗=1

+𝑘

𝐷𝐴 (𝜆

𝐷 𝐴
𝑒𝑥 ) ∑ 𝑖𝑗 𝑖𝑗
𝑗=1

− ∑ 𝑖𝑗𝑚 𝑖𝑗𝐴 = 0.

(3.25)

𝑗=1

In matrix form the above two equations can be written as:

[

∑𝑛𝑗=1(𝑖𝑗𝐷 )

2

∑𝑛𝑗=1 𝑖𝑗𝐷 𝑖𝑗𝐴

∑𝑛𝑗=1 𝑖𝑗𝐷 𝑖𝑗𝐴
∑𝑛𝑗=1(𝑖𝑗𝐴 )

2] [

∑𝑛𝑗=1 𝑖𝑗𝑚 𝑖𝑗𝐷
𝑘 𝐷𝐴 (𝜆𝑒𝑥 )
]
=
[
].
∑𝑛𝑗=1 𝑖𝑗𝑚 𝑖𝑗𝐴
𝑘 𝐴𝐷 (𝜆𝑒𝑥 )

(3.26)
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2

∑𝑛𝑗=1(𝑖𝑗𝐷 )
𝑘 𝐷𝐴 (𝜆 )
[ 𝐴𝐷 𝑒𝑥 ] = [
𝑘 (𝜆𝑒𝑥 )
∑𝑛 𝑖 𝐷 𝑖 𝐴

Therefore,

𝑗=1 𝑗 𝑗

∑𝑛𝑗=1 𝑖𝑗𝐷 𝑖𝑗𝐴
∑𝑛𝑗=1(𝑖𝑗𝐴 )

−1

2]

[

∑𝑛𝑗=1 𝑖𝑗𝑚 𝑖𝑗𝐷
∑𝑛𝑗=1 𝑖𝑗𝑚 𝑖𝑗𝐴

].

(3.27)

Solving the above matrix inversion, provides the expressions of each of the fitting
parameters as:

2

∑𝑛𝑗=1(𝑖𝑗𝐴 ) ∑𝑛𝑗=1 𝑖𝑗𝑚 𝑖𝑗𝐷 − ∑𝑛𝑗=1 𝑖𝑗𝐷 𝑖𝑗𝐴 ∑𝑛𝑗=1 𝑖𝑗𝑚 𝑖𝑗𝐴

𝑘 𝐷𝐴 (𝜆𝑒𝑥 ) =

2

2

∑𝑛𝑗=1(𝑖𝑗𝐷 ) ∑𝑛𝑗=1(𝑖𝑗𝐴 ) − (∑𝑛𝑗=1 𝑖𝑗𝐷 𝑖𝑗𝐴 )

(3.28)

2

2

𝑘 𝐴𝐷 (𝜆𝑒𝑥 ) =

∑𝑛𝑗=1(𝑖𝑗𝐷 ) ∑𝑛𝑗=1 𝑖𝑗𝑚 𝑖𝑗𝐴 − ∑𝑛𝑗=1 𝑖𝑗𝐷 𝑖𝑗𝐴 ∑𝑛𝑗=1 𝑖𝑗𝑚 𝑖𝑗𝐷
2

2

∑𝑛𝑗=1(𝑖𝑗𝐷 ) ∑𝑛𝑗=1(𝑖𝑗𝐴 ) − (∑𝑛𝑗=1 𝑖𝑗𝐷 𝑖𝑗𝐴 )

(3.29)

2

The presence of a third fluorescent dye will modify the expression of the measured
intensity as:

𝑛

𝐼

𝑚

=

𝑛

∑ 𝑖𝑗𝑚
𝑗=1

=

𝑘 𝐷𝐴 (𝜆𝑒𝑥 ) ∑ 𝑖𝑗𝐷
𝑗=1

𝑛

+

𝑘 𝐴𝐷 (𝜆𝑒𝑥 ) ∑ 𝑖𝑗𝐴
𝑗=1

𝑛

+𝑘

𝐹 (𝜆

𝐹
𝑒𝑥 ) ∑ 𝑖𝑗

(3.30)

𝑗=1

where 𝑘 𝐹 is proportional to the emission intensity of the third fluorophore. Proceeding in
a similar way as shown above, the fitting parameters corresponding to the lowest fitting
residual may be expressed as:

𝑘

𝐷𝐴 (𝜆

𝑒𝑥 ) =

(𝑌𝑍 − 𝑅 2 )𝐴 + (𝑄𝑅 − 𝑍𝑃)𝐵 + (𝑃𝑅 − 𝑌𝑄)𝐶
𝑋𝑌𝑍 + 2𝑃𝑄𝑅 − 𝑋𝑅 2 − 𝑌𝑄 2 − 𝑍𝑃2

(3.31)
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𝑘

(𝑄𝑅 − 𝑍𝑃)𝐴 + (𝑋𝑌 − 𝑄 2 )𝐵 + (𝑃𝑄 − 𝑋𝑅)𝐶
𝑒𝑥 ) =
𝑋𝑌𝑍 + 2𝑃𝑄𝑅 − 𝑋𝑅 2 − 𝑌𝑄 2 − 𝑍𝑃2

(3.32)

(𝑅𝑃 − 𝑌𝑄)𝐴 + (𝑃𝑄 − 𝑋𝑅)𝐵 + (𝑋𝑌 − 𝑃2 )𝐶
𝑒𝑥 ) =
𝑋𝑌𝑍 + 2𝑃𝑄𝑅 − 𝑋𝑅 2 − 𝑌𝑄 2 − 𝑍𝑃2

(3.33)

𝐴𝐷 (𝜆

𝑘

𝐹 (𝜆

where 𝐴 = ∑𝑛𝑗=1 𝑖𝑗𝑚 𝑖𝑗𝐷 , 𝐵 = ∑𝑛𝑗=1 𝑖𝑗𝑚 𝑖𝑗𝐴 , 𝐶 = ∑𝑛𝑗=1 𝑖𝑗𝑚 𝑖𝑗𝐹 , 𝑃 = ∑𝑛𝑗=1 𝑖𝑗𝐷 𝑖𝑗𝐴 , 𝑄 = ∑𝑛𝑗=1 𝑖𝑗𝐷 𝑖𝑗𝐹 ,
2

2

2

𝑅 = ∑𝑛𝑗=1 𝑖𝑗𝐴 𝑖𝑗𝐹 , 𝑋 = ∑𝑛𝑗=1 𝑖𝑗𝐷 , 𝑌 = ∑𝑛𝑗=1 𝑖𝑗𝐴 and 𝑍 = ∑𝑛𝑗=1 𝑖𝑗𝐹 .

The above three quantities can be used to determine the total number of photons emitted
by the donor, 𝐹 𝐷𝐴 (𝜆𝑒𝑥 ), the acceptor, 𝐹 𝐴𝐷 (𝜆𝑒𝑥 ), and a third fluorophore, if present,
𝐹 𝐹 (𝜆𝑒𝑥 ), i.e.,
𝐹 𝐷𝐴 (𝜆𝑒𝑥 ) = 𝑘 𝐷𝐴 (𝜆𝑒𝑥 ) ∫ 𝑖 𝐷 (𝜆𝑒𝑚 )𝑑𝜆𝑒𝑚 = 𝑘 𝐷𝐴 (𝜆𝑒𝑥 )𝑤 𝐷

(3.34)

𝐹 𝐴𝐷 (𝜆𝑒𝑥 ) = 𝑘 𝐴𝐷 (𝜆𝑒𝑥 ) ∫ 𝑖 𝐴 (𝜆𝑒𝑚 )𝑑𝜆𝑒𝑚 = 𝑘 𝐴𝐷 (𝜆𝑒𝑥 )𝑤 𝐴

(3.35)

𝐹 𝐹 (𝜆𝑒𝑥 ) = 𝑘 𝐹 (𝜆𝑒𝑥 ) ∫ 𝑖 𝐹 (𝜆𝑒𝑚 )𝑑𝜆𝑒𝑚 = 𝑘 𝐹 (𝜆𝑒𝑥 )𝑤 𝐹

(3.36)

where 𝑤 𝐷 , 𝑤 𝐴 , 𝑤 𝐹 are the integrals of the elementary emission spectra of donor,
acceptor, and the third fluorophore.
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As we have seen in sections 3.1.1 and 3.1.2., due to FRET, the donor intensity is
quenched while acceptor intensity is enhanced; these effects may be expressed
mathematically as:
𝐹 𝐷𝐴 (𝜆𝑒𝑥 ) = 𝐹 𝐷 (𝜆𝑒𝑥 ) − 𝐹𝐷𝐹𝑅𝐸𝑇

(3.37)

𝐹 𝐴𝐷 (𝜆𝑒𝑥 ) = 𝐹 𝐴 (𝜆𝑒𝑥 ) + 𝐹𝐴𝐹𝑅𝐸𝑇

(3.38)

where, the quantities 𝐹 𝐷 (𝜆𝑒𝑥 ) and 𝐹 𝐴 (𝜆𝑒𝑥 ) are the numbers of photons emitted
following excitation by light of wavelength 𝜆𝑒𝑥 , 𝐹𝐷𝐹𝑅𝐸𝑇 is the loss in donor emission due
to FRET, and 𝐹𝐴𝐹𝑅𝐸𝑇 is the gain in acceptor emission due to FRET. Therefore, the FRET
efficiency can also be defined as the extent to which the donors are quenched by
acceptors as a result of FRET, that is:

𝐸𝑎𝑝𝑝 =

𝐹𝐷𝐹𝑅𝐸𝑇
𝐹𝐷 (𝜆𝑒𝑥 )

(3.39)

Equations (3.37) and (3.38) can be justified using equation (A.10) and (A.11). If NFRET is
the total number of excitations, donor can emit 𝑄𝐷 𝑁 𝐹𝑅𝐸𝑇 = 𝐹𝐷𝐹𝑅𝐸𝑇 photons in absence of
FRET while the acceptor can emit 𝑄𝐴 𝑁 𝐹𝑅𝐸𝑇 = 𝐹𝐴𝐹𝑅𝐸𝑇 photons in presence of FRET.
Therefore we can write,
𝑄𝐷 𝐹𝐷𝐹𝑅𝐸𝑇 = 𝑄𝐴 𝐹𝐴𝐹𝑅𝐸𝑇
or

(3.40)
𝐹𝐷𝐹𝑅𝐸𝑇 =

𝑄𝐴 𝐹𝑅𝐸𝑇
𝐹
𝑄𝐷 𝐴
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Assuming that the acceptors are not excited directly by light (i.e., 𝐹 𝐴 (𝜆𝑒𝑥 ) ≈ 0), and
using equations (3.37), (3.38) and (3.40), the apparent FRET efficiency equation of a
molecular complex is given by the following expression:

𝐸𝑎𝑝𝑝 =

1
𝑘𝐷𝐴 𝑤 𝐷
1 + 𝐷 𝐴𝐷 𝐴
𝑄 𝑘 𝑤
𝑄𝐴

(3.41)

This equation is used to determine the FRET efficiency at each pixel in a fluorescence
image using a single scan o the sample at a single excitation wavelength, and it
circumvents difficulties associated with the classical filter-based method described in the
previous section.

3.1.5 Apparent FRET efficiency in the presence of direct excitation of the
acceptor
To determine the apparent FRET efficiency (equation 3.41) one always aims to choose an
excitation wavelength of the laser that excites the donor maximally while minimizing the
acceptor excitation. In reality, there is no single wavelength that can excite the donor
significantly to detect FRET without exciting acceptor to some extent. Thus, in the
presence of non-negligible direct excitation of the acceptor (𝑖. 𝑒. , 𝐹 𝐴 (𝜆𝑒𝑥 ) ≠ 0), equation
(3.41) becomes,
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𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑
𝐸𝑎𝑝𝑝

𝑄 𝐷 𝐴𝐷
[𝐹 (𝜆𝑒𝑥 ) − 𝐹 𝐴 (𝜆𝑒𝑥 )]
𝑄𝐴
=
𝐹𝐷𝐴 (𝜆𝑒𝑥 ) + 𝐹𝐷𝐹𝑅𝐸𝑇

𝑄 𝐷 𝐴𝐷
[𝑘 (𝜆𝑒𝑥 )𝑤 𝐴 − 𝐹 𝐴 (𝜆𝑒𝑥 )]
𝑄𝐴
=
𝑄𝐷
𝑘𝐷𝐴 (𝜆𝑒𝑥 )𝑤 𝐷 + 𝐴 {𝐹 𝐴𝐷 (𝜆𝑒𝑥 ) − 𝐹 𝐴 (𝜆𝑒𝑥 )}
𝑄

(3.42)

For FRET standards shown in section 3.2 below, k = 1 and [𝐴] = [𝐷] = 0, [𝐴]𝐴 =
[𝐷]𝐷 = 0 and [𝐴]𝐷 = 𝑥𝜇𝑜𝑙𝑖𝑔𝑜 , where x is the number of acceptors linked to donors in a
construct. Therefore, the total number of photons emitted by the acceptors excited by
laser at wavelength 𝜆𝑒𝑥 can be expressed as (10):

𝐹 𝐴 (𝜆𝑒𝑥 ) = Γ 𝑒𝑥,𝐴 𝑄 𝐴 𝜇𝑜𝑙𝑖𝑔𝑜 𝑛𝑃𝐴

(3.43)

Also, the number of photons emitted by the acceptors in presence of FRET can be
expressed as:
𝐹𝐴𝐹𝑅𝐸𝑇 = Γ 𝑒𝑥,𝐴𝐷 [𝐴]𝐷 𝑄 𝐴 ,

(3.44)

Using equations (3.43) and (3.44) we can write:

𝐹 𝐴𝐷 (𝜆𝑒𝑥 ) = 𝑄 𝐴 {Γ 𝑒𝑥,𝐴 𝜇𝑜𝑙𝑖𝑔𝑜 𝑛𝑃𝐴 + Γ 𝑒𝑥,𝐷 𝜇𝑜𝑙𝑖𝑔𝑜 𝐸𝑎𝑝𝑝 }

(3.45)

From equation (3.35) and (3.45), we can write the concentration of FRET standards in the
cells in terms of its apparent FRET efficiency as:
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𝜇𝑜𝑙𝑖𝑔𝑜 =

𝑘 𝐴𝐷 𝑤 𝐴
𝑄 𝐴 {Γ 𝑒𝑥,𝐴 𝑛𝑃𝐴 + Γ 𝑒𝑥,𝐷 𝐸𝑎𝑝𝑝 }

(3.46)

Insertion of the above equation into equation (3.43) gives,

𝐹 𝐴 (𝜆𝑒𝑥 ) =

Γ 𝑒𝑥,𝐴 𝑛𝑃𝐴 𝑘 𝐴𝐷 𝑤 𝐴
= 𝑘 𝐴𝐷 𝑤 𝐴 𝛼𝐴
Γ 𝑒𝑥,𝐴 𝑛𝑃𝐴 + Γ 𝑒𝑥,𝐷 𝐸𝑎𝑝𝑝

Γ𝑒𝑥,𝐴 𝑛𝑃𝐴

where 𝛼𝐴 = Γ𝑒𝑥,𝐴𝑛𝑃

𝐴 +Γ

𝑒𝑥,𝐷 𝐸
𝑎𝑝𝑝

(3.47)

. Since the excitation rate constants of donors and acceptors

are directly proportional to their respective extinction coefficients (ε𝐷 , ε𝐴 ), the expression
for 𝛼𝐴 becomes
𝛼𝐴 =

ε𝐴 𝑛𝑃𝐴
=
ε𝐴 𝑛𝑃𝐴 + ε𝐷 𝐸𝑎𝑝𝑝

1
1
1 + 𝐴 𝑛𝑃 𝐸𝑎𝑝𝑝
ε
𝐴
ε𝐷

(3.48)

Therefore, equation (3.42) may be written as:

𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑
𝐸𝑎𝑝𝑝

𝑄 𝐷 𝐴𝐷 𝐴
𝑘 𝑤 [1 − 𝛼𝐴 ]
1 − 𝛼𝐴
𝑄𝐴
=
=
𝐷
𝑄
𝑘𝐷𝐴 𝑤 𝐷 𝑄 𝐴
𝑘 𝐷𝐴 𝑤 𝐷 + 𝐴 {𝑘 𝐴𝐷 𝑤 𝐴 − 𝑘 𝐴𝐷 𝑤 𝐴 𝛼𝐴 } 1 − 𝛼𝐴 + 𝐴𝐷 𝐴 𝐷
𝑄
𝑘 𝑤 𝑄
=

1
𝑄𝐴
1
1 + 𝐴𝐷 𝐴 𝐷
𝑘 𝑤 𝑄 (1 − 𝛼𝐴 )
𝑘𝐷𝐴

𝑤𝐷

Let
1 − 𝐸𝑎𝑝𝑝
𝑘 𝐷𝐴 𝑤 𝐷 𝑄 𝐴
=𝑐=
𝐴𝐷
𝐴
𝐷
𝑘 𝑤 𝑄
𝐸𝑎𝑝𝑝

(3.49)
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Then,

𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑
𝐸𝑎𝑝𝑝
=

1
1
1+𝑐1−𝛼

(3.50)

𝐴

Using a Taylor series expansion for 𝛼𝐴 ≪ 1 (i.e., assuming that the direct excitation of
the acceptor is small), equation (3.49) can be simplified to

𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑
𝐸𝑎𝑝𝑝
= 𝐸𝑎𝑝𝑝 [1 − (1 − 𝐸𝑎𝑝𝑝 )𝛼𝐴 ]

(3.51)

The above equation gives apparent FRET efficiency for configuration sample, which is
corrected for direct excitation of the acceptor.

3.2

Materials and methods

3.2.1 FRET standards expressed in the cytoplasm
To test the above FRET theory, we used two different types of FRET constructs, one type
that could be expressed in the cytoplasm and one which could be expressed in the
membrane of mammalian cells.

The first type of constructs, which were expressed in the cytoplasm were a
generous gift from Dr. Steven Vogel (NIH). Fig. 3.3 shows the set of FRET standards
engineered by Koushik et al. (13) using Cerulean (22) as a donor, Venus (23) as an
acceptor and Amber (24), a Venus like molecule mutated in order to prevent a
fluorophore formation and therefore cannot participate in FRET, but was used to mimic
the configuration of tetramers while behaving as a dimer in the process of energy
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transfer. The tetramers shown in Fig. 3.3 were used in order to test kinetic theory, while a
dimer, Amber-5-Cerulean (A5C) was used to obtain the emission spectrum of the donor
(Cerulean). The cloning and construction of monomeric fluorescent proteins Cerulean
(C), Venus (V) and Amber (A) and artificial dimer Amber-5-Cerulean (A5C) and
heterotetramers: Amber-5-Cerulean-5-Venus-6-Amber (ACVA), Venus-5-Cerulean-5Amber-6-Amber (VCAA), Amber-5-Cerulean-5-Amber-6-Venus (ACAV), Venus-5Cerulean-5-Venus-6-Venus (VCVV) were described elsewhere (13) where numbers 5
and 6 represent number of amino acids in the linker.

Figure 3.3: Schematic of the cytoplasmic FRET standards. Cerulean (C) as donor linked to the acceptor,
Venus (V) and dark Venus like molecule, Amber (A) by amino acid linker shown by curved lines
connecting C, V, and A (13).

3.2.2 Generation of monomeric, dimeric and trimeric fluorescent proteins
The second category of constructs, which can be expressed in the membrane of
mammalian cells, was developed by our collaborators from the laboratory of Prof. James
W. Wells at the University of Toronto. The first 7 residues of the N terminus of the subunit type i1 (Gi1) in heterotrimeric G proteins (25, 26) comprise a motif (Met-GlyCys-Thr-Leu-Ser-Ala) that introduces myristoyl (M) and palmitoyl (P) group at the
second and third residues, respectively. The complementary DNA (cDNA) coding for
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this sequence, the proceeding 25 residues of Gi1 and the 6 bases corresponding to the
BamH1 restriction site were fused upstream of the cDNA coding for either GFP2 (MPGFP2) or eYFP (MP-eYFP).

Fluorescent proteins were concatenated through the

addition of 6 bases corresponding to the BspE1 restriction site at the 3’ end of the former
and latter fusions, to create the dimeric variants MP-GFP2-eYFP (G2Y) and MP-eYFPGFP2 (YG2), respectively. A further 6 bases corresponding to the AgeI restriction site
were added at the 3’ end of MP-eYFP-GFP2 to generate a trimeric variant, MP-eYFPGFP2-eYFP (YG2Y). All fusions were ligated into the pcDNA3.1+ vector. Sequences
were confirmed by DNA sequencing.

Figure 3.4: Schematic representation of dimeric and trimeric membrane FRET constructs. The addition of a
myristoylation and palmitoylation sequence derived from Gi1 at the N terminus anchors the fluorescent
proteins to the plasma membrane. Dimeric fluorescent proteins are linked by serine and glycine (SG)
residues and eYFP in the trimeric configuration is linked by threonine and glycine (TG) residues.

3.2.3 Cell culture and Transfection
Chinese hamster ovary (CHO) cells were grown in Dulbecco’s Modified Eagle’s Medium
(DMEM) without sodium pyruvate, supplemented with 10% fetal bovine serum (FBS), 2
mM L-glutamine, 1% penicillin/streptomycin and 1% non-essential amino acids. The
cells were cultured and seeded 48 hours before imaging in 6-well plates (each well of 3.5
cm diameter) at a density of 15 – 20k cells/cm2 and maintained at 37 ºC in a humidified
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environment with 5% CO2. After 24 hours, when the cells were 40-45% confluent, each
dish or each well of 6-well plate was transfected with 2 µg of plasmid DNA with 10 µl
Lipofectamine 2000 (Invitrogen, USA) diluted in 250 µl of OptiMEM (Invitrogen, USA)
medium. The transfection procedure followed was similar to as described by Pisterzi et
al. (27). Control cells with no plasmids (mock) were also cultured. Approximately 24
hours after transfection, medium of the cells grown in 6-well plate were removed and 250
µl of OptiMEM was added. The cells from each well were then lifted manually using cell
scrapers and collected in 1 mL Eppendorf tubes. About 10 µl of cell suspension in
OptiMEM was placed on microscope glass slide with a 0.3 mm cover slide on it and used
for imaging. To image the cells using our latest version of OptiMiS (16) with an inverted
microscope, the cells were also cultured in 3.5 mm petri dishes with 0.3 mm glass bottom
cover slide in it at density 8 - 10k cells/cm2 and transfected same way. The cells cultured
in dishes were used directly for imaging without lifting.

3.2.4

Optical micro-spectroscopy

Spectrally resolved fluorescence imaging of samples were performed at room
temperature using a spectrally resolved two-photon microscope (SR-TPM) (12). A
femtosecond Ti-Sapphire laser (KM Labs, Boulder, CO) of 80 MHz pulse repetition rate
and tunable wavelength of 780-820 nm was used as the excitation energy source. The
laser was focused through an infinity corrected oil immersion objective (x100
magnification, NA 1.4, Nikon Instruments, Melville, NY) to a diffraction limited spot of
the samples. The light emitted from the samples was projected onto a cooled electronmultiplying CCD camera (EMCCD; Andor, iXon 897) after passing through a
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transmission grating. Our later experiments were performed using (OptiMiS) (16)
attached to a Ti-Sapphire laser (Tsunami) with a tunable range of 690-1040 nm, 80 MHz
repetition rate and < 100 fs pulse width. This instrument was improvised to have line
scan (28) rather than the point scan resulting in two orders higher magnitude of
acquisition speed compared to a point laser.

3.2.5 Elementary emission spectra of donor and acceptor
CHO cells expressing A5C were imaged using OptiMiS with 800 nm as the excitation
wavelength and an average power of ~ 200 mW for line scan measured after microscope
objective and ~ 20 mW for point scan measured before the scanning head SR-TPM. The
spectrally resolved images collected by the CCD camera at one pixel apart in spectral
dimension were reconstructed as described by Raicu et al. (12) to get the spectral images
at various wavelengths of the spectral range. Similarly, CHO cells expressing VCVV
were excited at 1020 nm (where Cerulean cannot be excited) using similar power in order
to obtain the Venus spectrum.

Fig. 3.5 represents the spectral images of representative CHO cells individually
expressing A5C and VCVV at different emission wavelengths. The background-corrected
average intensity (averaged over certain non-zero intensity pixels as shown by circles in
the images of Fig. 3.5) of the spectral images were calculated and normalized in order to
obtain the elementary emission spectra of donor and acceptor as shown by the cyan and
yellow curve, respectively, of Fig. 3.5. The normalized donor, and acceptor spectrum of
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membrane constructs were obtained by imaging CHO cells expressing individually GFP2,
and YFP using laser of ~ 600 mW and tuned at 800 nm and 970 nm respectively.

Figure 3.5: Spectral images of a representative CHO cell expressing the cytoplasmic constructs A5C or
VCVV, with Cerulean as a donor and Venus as an acceptor of energy. Cyan and yellow plots are the
elementary spectra of Cerulean and Venus averaged over bright pixels of a certain region of interest (shown
as a red circle in each spectral image).

3.2.6 Analysis of FRET images and FRET efficiency calculation
CHO cells expressing the membrane and cytoplasmic FRET standards were imaged using
the optical micro-spectroscope. The normalized elementary spectra of the donor and
acceptor, previously determined, were used to unmix the spectrally resolved images at
every pixel of the imaged section of the cell expressing the FRET constructs by adjusting
the fitting parameters 𝑘 𝐷𝐴 (𝜆𝑒𝑥 ) and 𝑘 𝐴𝐷 (𝜆𝑒𝑥 ) to minimize error as described in section
3.1.4. Thus at every pixel of the imaged section of the cell, the donor fluorescence
intensity in the presence of acceptor 𝑘 𝐷𝐴 (𝜆𝑒𝑥 ) and the acceptor fluorescence intensity in
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the presence of donor 𝑘 𝐴𝐷 (𝜆𝑒𝑥 ) were calculated. The 𝑘 𝐷𝐴 (𝜆𝑒𝑥 ) and 𝑘 𝐴𝐷 (𝜆𝑒𝑥 ) values
along with the quantum yields and spectral integration of the emission spectrum (𝑤 𝐷 ,
𝑤 𝐴 ) of donor and acceptor were used in equation (3.41) to calculate the apparent FRET
efficiency map (Eapp). To avoid instrumental and other background noise in the Eapp
image, a threshold was used for 𝑘 𝐷𝐴 (𝜆𝑒𝑥 ) and 𝑘 𝐴𝐷 (𝜆𝑒𝑥 ) values.

3.3

Results and discussion

3.3.1 Measured and predicted FRET efficiency of cytoplasmic constructs
The kinetic model of FRET theory was tested using cytoplasmic FRET standards; cells
transfected with ACVA, VCAA, ACAV, and VCVV were imaged and apparent FRET
efficiency maps were obtained as described in section 3.6. Fig. 3.6 shows donor
fluorescence intensity in the presence of acceptor (kDA), acceptor fluorescence intensity in
the presence of donor (kAD) and apparent FRET efficiency map (Eapp) of representative
CHO cells expressing either ACVA, VCAA, ACAV, and VCVV. The Eapp histograms as
shown in Fig. 3.6 were obtained by binning the Eapp pixels according to their value with
bin size 0.01 (in the scale of 1) and plotting the number of pixels in each bin against Eapp.
The FRET efficiency histogram is then integrated and averaged over the number of bright
pixels to calculate the average FRET efficiency of the imaged section of the cell. The
values of the FRET efficiency averaged over a number of cells (represented by n below)
for each construct for 9 different days of experiments is listed in Table 3.1. The measured
average FRET efficiency for dimers ACVA, VCAA, and ACAV was found to be 0.53 ±
0.04 (n=114), 0.60 ± 0.05 (n=95), and 0.45 ± 0.06 (n=116) respectively. The tetramer,
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VCVV with one donor and three acceptors had measured FRET efficiency of 0.80 ± 0.05
(n=96).

Figure 3.6: Photomicrograph of CHO cells expressing cytoplasmic tetramers. The three images on left
show special distribution of the donor intensity in the presence of acceptor ( kDA), acceptor intensity in
presence of donor (kAD) and apparent FRET efficiencies ( Eapp) of a representative CHO cells transfected
with ACVA, VCAA, ACAV, and VCVV. Histograms (right) show the number of pixels vs. Eapp obtained
from the FRET efficiency map (Eapp image) of corresponding cells.

The apparent FRET efficiency of VCVV can also be predicted using the known
energy transfer efficiencies of ACVA, VCAA, and ACAV, by plugging equation (3.7,)
into equation (3.12) and using i=1 for the number of donor and j=1 for the number of
acceptors. This gives:
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𝐸𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑 = ∑
𝑗

𝐸𝑗 ⁄1 − 𝐸𝑗
1 + ∑𝑗 (𝐸𝑗 ⁄1 − 𝐸𝑗 )

(3.52)

where j=ACVA, VCAA, or ACAV. The error of the predicted value of VCVV was
calculated using the method of propagation of errors as:

𝑑𝐸𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑
𝑑[ln(𝐸𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑 )] =
=
𝐸𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑

∑𝑗

𝑑𝐸𝑗
(1 − 𝐸𝑗 )

2

𝐸𝑗
𝐸𝑗
{∑𝑗
} {1 + ∑𝑗
}
(1 − 𝐸𝑗 )
(1 − 𝐸𝑗 )

(3.53)

The predicted FRET efficiency of VCVV was found to be 0.77 ± 0.05, which was same
as the measured FRET efficiency of VCVV within the limits of experimental errors.

Table 3.1: Measured and predicted apparent FRET efficiencies of cytoplasmic constructs

Cytoplasmic constructs

Eapp

𝑬𝒄𝒐𝒓𝒓𝒆𝒄𝒕𝒆𝒅
𝒂𝒑𝒑

ACVA

0.53 ± 0.04
(n = 114)

0.45 ± 0.04
(n = 114)

VCAA

0.60 ± 0.05
(n = 95)

0.53 ± 0.06
(n = 95)

ACAV

0.45 ± 0.06
(n = 116)

0.36 ± 0.07
(n = 116)

VCVV

0.80 ± 0.05
(n = 96)

0.72 ± 0.07
(n = 96)

VCVV predicted

0.77 ± 0.05

0.72 ± 0.07
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All the measured and predicted Eapp values of VCVV for 9 different days of experiment
are listed in Table A.1. in appendix A. A paired Student’s t-test for the mean values of
measured and predicted FRET efficiencies (listed in Table A.1) returned the t value (twotailed) of 2.20 corresponding to the probability of 0.20 for the measured and predicted
FRET efficiencies to be statistically insignificant (critical value = 0.05). Thus, results for
Student’s t-test suggested that the differences in measured and predicted FRET
efficiencies are within the standard deviations for each of the two sets.

3.3.2 Measured and predicted FRET efficiencies of membrane constructs
We have also tested the kinetic theory of FRET using our spectral FRET method and the
membrane constructs YG2, G2Y and YG2Y. Fig. 3.7 shows the donor fluorescence
intensity in the presence of acceptor (kDA), acceptor fluorescence intensity in the presence
of donor (kAD) and apparent FRET efficiency map of representative CHO cells expressing
YG2, G2Y and YG2Y. The FRET efficiency histogram and average FRET efficiency for
each cell were calculated the same way as mentioned in section 3.7.1.

The measured FRET efficiencies of YG2, G2Y, and YG2Y averaged over n cells
as for each construct and the predicted FRET efficiency for YG2Y are listed in Table 3.2.
The predicted FRET efficiency for the YG2Y construct was calculated using the
measured FRET efficiencies of YG2 and G2Y in equation (3.52). The measured and
predicted FRET efficiency of the trimer YG2Y were found to be the same within
experimental error.
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Figure 3.7: Photomicrographs of CHO cells expressing membrane dimers and trimers. First, second, and third column
show intensity map of donor in the presence of acceptor (kDA), acceptor in presence of donor (kAD) and the distribution
of apparent FRET efficiencies (Eapp) of a representative CHO cells transfected with dimers (YG2 and G2Y) and trimers
(YG2Y). The apparent FRET efficiency (Eapp) histograms obtained by binning Eapp values in the bin interval of 0.01
and plotting against Eapp are shown on the right.

Table 3.2: Measured and predicted Eapp values for the membrane constructs

Eapp
0.49 ± 0.07
(n = 48)

𝑬𝒄𝒐𝒓𝒓𝒆𝒄𝒕𝒆𝒅
𝒂𝒑𝒑
0.43 ± 0.08
(n = 48)

YG2

0.41 ± 0.10
(n = 48)

0.34 ± 0.11
(n = 48)

YG2Y

0.61 ± 0.06
(n = 49)

0.54 ± 0.07
(n = 49)

YG2Y - predicted

0.62 ± 0.13

0.56 ± 0.17

Membrane constructs
G2Y
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3.3.3 Apparent FRET efficiency corrected for direct excitation
The contribution to acceptor signal resulting from direct excitation of acceptors was
ignored in the calculation of apparent FRET efficiency (Eapp) of the FRET standards
listed as Eapp in Table 3.1 and 3.2. As discussed in section 3.1.5, direct excitation of
acceptor scan contribute towards the increase of measured FRET efficiencies of the
FRET constructs. It was expected that the measured FRET efficiencies of the constructs
with multiple acceptors can be significantly affected because of direct excitation of
acceptors. Therefore, we have corrected the measured apparent FRET efficiencies of the
individual constructs using equation (3.51).

The extinction coefficient of Venus at the excitation wavelength of ~ 400 nm
were obtained by calculating absorbance ratio at 400 and 515 nm respectively using the
absorption spectrum of Venus (29) and multiplying the ratio by the extinction coefficient
of 92.2 x 103 M-1cm-1 at its excitation maximum of 515 nm (23). Similarly, the extinction
coefficient of Cerulean at 400 nm was calculated using the absorption spectra (29) and
extinction coefficient (22) of Cerulean. For the cytoplasmic tetramers with single donor
and acceptor (ACVA, VCAA, and ACAV) the number of fluorophores (n) and the
probability of acceptors (PA) in each construct was 2 and 1/2 respectively while for
VCVV n, and PA was 4 and 3/4 respectively. Using these parameters in equations (3.48)
and (3.51) the apparent FRET efficiencies of each cell were calculated. The corrected
apparent FRET efficiencies of the constructs averaged over the number of cells are listed
𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑
as 𝐸𝑎𝑝𝑝
in Table 3.1. The corrected apparent FRET efficiency of VCVV and its

predicted FRET efficiency calculated using corrected FRET efficiencies of ACVA,
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VCAA and VCVV in equation (3.52) suggested that they were same in the range of
experimental error.

Similar procedure was followed to correct the apparent FRET efficiencies of the
membrane proteins. The extinction coefficients used for GFP2 and eYFP at their
respective excitation maximum 400 nm and 515 nm were 30.0x103 M-1cm-1 (30) and
83.4x103 M-1 cm-1 (23). The values of PA and n for G2Y and YG2 were 1/2 and 2 and
those for YG2Y were 2/3 and 3 respectively. The corrected FRET efficiencies for each
construct averaged over the number of cells are listed in Table 3.2. The measured FRET
efficiencies of YG2Y was found to be same as the predicted FRET efficiency of YG2Y
using kinetic model of FRET.

3.3.4 Testing the effect of cellular viability on the FRET efficiency
From the measured and predicted apparent FRET efficiency values of VCVV and YG2Y,
as shown in Table 3.1 and Table 3.2 respectively, it was observed that measured and
predicted FRET efficiencies for the tetramer VCVV and trimer YG2Y were the same
within the limits of the experimental errors. However, we performed a further experiment
to test the effect of viability of the cells and expression level of proteins in the cells on
apparent FRET efficiency. Since pH can be different for dead or live cells based on the
ambient environment of the cells and quantum yields of fluorophores depend on pH,
hence the change in pH in the environment of dead, and living cells can influence the
measured FRET efficiency.
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In order to investigate the effect of the cell vitality on the FRET efficiency we used a blue
dye called cascade blue (Cascade Blue® Acetyl Azide, Trisodium Salt, Invitrogen),
which is impermeable to the plasma membrane of cells. The single photon excitation
maximum of cascade blue is 400 nm. The presence of cascade blue inside cells indicated
a broken cell membrane or a dead cell. In order to test whether there is a difference in
apparent FRET efficiencies of dead and living cells a 2 µM solution of cascade blue in
distilled water was added to each sample before imaging. The imaged section of cells
were unmixed using elementary emission spectrum of Cerulean, Venus and Cascade blue
and the fluorescence intensities of donor in the presence of acceptor (kDA), acceptor in
presence of donor (kAD), and intensity of cascade blue in presence of both donor and
acceptor (kF) was calculated as described by the equations (3.31) – (3.33).

Figure 3.8: Photomicrograph of CHO cells expressing cytoplasmic construct, VCAA in presence of cascade
blue. Images shown are two dimensional map of donor fluorescence intensity in the presence of acceptor
(kDA), acceptor in presence of donor (kAD), and cascade blue intensity in presence of donor and acceptor ( kF).
First row shows the image of a live CHO cell expressing VCAA while the second row shows the image for
a dead cell. Distribution of apparent FRET efficiency map ( Eapp) for both type of cells shows similar FRET
efficiencies.
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First and second row of Fig. 3.8 shows the kDA, kAD, and kF map of a representative dead
and living cells respectively. Distribution of Eapp map shows similar values of FRET
efficiency for both the dead, and living cells. The average Eapp values for living and dead
cells shown in Fig. 3.8 are 0.60 ± 0.07 and 0.62 ± 0.11 respectively. We also calculated
Eapp values for each cell individually, and depending on the cascade blue intensity inside
the cells; they are divided into dead, and living cell category. Based on these results, we
concluded that apparent FRET efficiencies were independent of cells either being dead or
alive. In other words, change in pH did not change the quantum yields of the
fluorophores remarkably to change their apparent FRET efficiencies.

3.3.5 Investigation of stochastic FRET
For high expression levels of our FRET standards, the donor can transfer its energy via
intermolecular FRET to nearby acceptors of adjacent complexes (31). The effect is
known in the literature as stochastic FRET. Theoretically, stochastic FRET will be
dominant for VCVV since more acceptors from the adjacent proteins are available to the
donor to have intermolecular FRET. In order to test this effect, we performed an
experiment using cytoplasmic tetramers ACVA, VCAA, ACAV, and VCVV at different
expression level of the proteins. Cells were imaged after 6, 10, and 16 hours of
transfection. Since each construct contains only one donor, therefore, expression of donor
in each cell is a representation of expression level of the construct that can be calculated
using equation, 𝐹 𝐷 (𝜆𝑒𝑥 ) = 𝑘 𝐷𝐴 (𝜆𝑒𝑥 )𝑤 𝐷 + 𝑘 𝐴𝐷 (𝜆𝑒𝑥 )𝑤 𝐴.
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Figure 3.9: FRET efficiency (Eapp) vs. log (FD) for cytoplasmic tetramers. (a) Each data point represents
a cell of VCVV (open circle), VCAA (closed circle), ACVA (open triangle) and ACAV (closed
triangle). The solid lines passing through the data points represents linear fitting of log ( FD) values for
each construct. (b) The data points are averaged over a certain range of log ( FD) shown in Table A.2.
The standard deviations are shown by vertical lines through each data point on the plot. (c) Closed
circles represent difference in measured and predicted FRET efficiencies of VCVV for log ( FD) ranges
listed in Table A.3, vertical line through each point shows error for each data point.

Fig. 3.9 (a) shows the variation of average FRET efficiencies (Eapp) with log (FD)
for ACVA, VCAA, ACAV, and VCVV where each data point represents one cell. We
also divided the entire range of log (FD) for each construct into six divisions and
calculated the average values of log (FD), Eapp, and standard deviation for each range as
shown in Table A.2 in appendix I and plotted in Fig. 3.9 (b). Fig. 3.9 (c) shows plot of the
difference in measured, and predicted apparent FRET efficiencies for VCVV (ΔEapp)
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against each interval of log (FD) as shown in Table A.3 in appendix A.2. The error
calculated using the method of propagation of error for ΔEapp is also listed in Table A.3
and shown by the error bar in Fig. 3.9c. A paired Student’s t-test performed to check the
statistical significance of dependence of ΔEapp values with log (FD) gave the t value of
2.3 corresponding to the probability of 0.78 for the dependence of the difference between
the measured and predicted FRET efficiencies to be statistically insignificant (critical
value = 0.05). The graph shown in Fig. 3.9 (a), (b) & (c) for each construct shows that
apparent FRET efficiency increases with the increase in expression level of proteins
(constructs), although based on the Student’s t-test the difference between the measured
and predicted values for VCVV is independent of the expression level. From these
observations, we concluded that for the agreement between measured and predicted
FRET efficiencies for VCVV or YG2Y is very robust and independent of whether
intramolecular FRET is contaminated by intermolecular (or stochastic) FRET.

3.4

Conclusion

The theory of FRET based on fluorescence lifetime imaging techniques have so far been
widely investigated to probe protein-protein interactions. However, the study of
oligomerization and stoichiometry of protein complexes through intensity-based
measurements have only emerged recently. The technique based on spectrally resolved
two-photon microscopy proposed by Raicu et al. has recently attracted wide attention
owing to its ability to investigate the quaternary structure of macromolecules in living
cells.
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Using this method, we tested the kinetic FRET theory for multimeric complexes
using protein standards expressed both in the cytoplasm and in the membrane. The results
showed that the measured average FRET efficiencies of the membrane trimer, YG2Y, and
cytoplasmic tetramer, VCVV, using the theory based on the approximation of negligible
direct excitation of acceptors were same as the predicted FRET efficiencies using kinetic
theory of FRET within the range of experimental error. Our corrected theory for the
calculation of FRET efficiency involving direct excitation of acceptor showed changes in
the measured values of average FRET efficiencies of the individual constructs while the
difference between the measured and predicted FRET efficiencies of YG2Y and VCVV
remained the same.

Our results disagreed with those of Koushik et al., which indicated significant
discrepancies between the measured and predicted FRET efficiencies for VCVV. We
tested the possibility that the excess in energy transfer for VCVV reported by Koushik et
al. (13) based on the change in pH resulting from the change in the ambient environment
for living and dead cells. The results based on the fact that the cell was dead if its plasma
membrane were broken did not show any difference in average FRET efficiencies for
dead and living cells.

We further investigated the effect of stochastic FRET on the measured FRET
efficiencies. The results showed that the FRET efficiencies increased with increase in the
expression levels of proteins encoding the fluorescence probes. However, there was no
difference in between the measured and predicted FRET efficiencies for VCVV even for
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the highest expression level. This result suggested that stochastic FRET, when present
were already incorporated into the measured FRET efficiencies and accounted for by the
theory.

In light of these facts, we conclude that the discrepancies found by Vogel’s group
between the measured and predicted FRET efficiencies was possibly due to an
unidentified systematic error in their experiments and/or data analysis.
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Chapter 4. Quaternary structure determination of the muscarinic
M3 acetylcholine receptors at the plasma membrane
4.1

Biological system of interest

4.1.1 G-proteins
The guanosine nucleotide-binding proteins commonly referred to as G-proteins are a
class of membrane proteins that serve as intermediaries for communicating signals
between cells and extracellular compounds such as hormones and neurotransmitters (1,
2). The G-proteins, when coupled with numerous membrane receptors in cells, serve as
vital components in transferring signals to the cells generating diverse biological
responses (3). The heterotrimeric G-proteins are composed of three subunits encoded by
distinct genes, α, β, and γ, each existing in several isoforms that together make hundreds
of combinations of G-proteins. The binding of G-protein with certain receptors lead to
target specific physiological processes in response to external stimuli that is largely
governed by the specific combinations of α, β, and γ subunits (4, 5).

4.1.2 G-protein coupled receptors
G-protein coupled receptors (GPCRs) are the largest class of membrane proteins that
allows a wide variety of signal transmission from outside to inside of a cell. They receive
signals from their ever changing environment and transfer it inside the cells by activating
G-proteins coupled to them triggering biological responses to specific stimuli (6).

GPCRs are known to consist of seven transmembrane alpha helices that are
spanned along the width of the plasma membrane and hence it is also termed as seven-
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transmembrane receptor (6, 7). The seven transmembrane segments are connected by
three intra- and extra-cellular loops. The portion of a GPCR outside the cell receives
extracellular signals transferring it to the inside of the cell where it interacts with the Gprotein coupled to the receptor for complete signal transduction from outside to inside of
the cell. The functional diversity of GPCRs is due to their ability to bind to a broad range
of ligands, such as small organic compounds, peptides, and proteins. The ability of GPCR
to bind to specific ligand not only helps in the signal transduction process but also makes
GPCR as a target of several drugs (8).

Based on their sequence homology and functional similarity, GPCRs are
classified into several families (9-12). Attwood and Findaly (13) proposed seven
hydrophobic domains of GPCRs based on their amino acid sequence. Latter, Kolakowski
(14) introduced A – F and O classifications for GPCRs. The classification was made on
the basis of receptor binding to G-proteins. All those receptors that were proven to bind
with G-proteins were classified in A – F family while remaining seven transmembrane
spanning proteins were assigned to O (other) family. Fredriksson et al. (15) divided the
known and predicted 802 human GPCRs in five main families’ viz. Glutamate,
Rhodopsin, Adhesion, Frizzled/Taste2 and Secretin popularly known as GRAFS. The
major difference between previous, and recent nomenclature introduced by Fredriksson et
al. is the division of family B into Secretin and Adhesion family. Recent nomenclature
system includes extended total number of unique receptors and also recently discovered
bitter Taste2 receptors (16).
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4.1.3 Signal transduction mechanism through G-protein coupled receptors
The first step involved in the action of a GPCR for signal transduction is specific
activation of the receptor through binding of ligands such as hormones, and
neurotransmitters at the cell surface (5, 17-21). The signal transduction mechanism is
shown schematically in Fig. 4.1.

Figure 4.1: Schematic showing signal transduction mechanisms through GPCRs. The figure is adapted
from (22).

The binding of a ligand to a GPCR leads to conformational changes in the
receptor allowing it to function as a guanine-nucleotide exchange factor (GEF) catalyzing
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the exchange of GTP with GDP bound to Gα of G-protein (8-12). The Gα subunit bound
to the GTP dissociates from Gβγ dimer and the receptor. Both Gα-GTP and Gβγ subunits
then bind and regulate the appropriate effector system activating different signal
cascades. The system is then deactivated when intrinsic GTPase activity of α-subunit
hydrolyzes GTP to GDP mediated by GTPase-activating proteins, allowing it to reassociate with Gβγ and start a new cycle (8-12).

4.1.4 Muscarinic acetylcholine receptors
Muscarinic acetylcholine receptors (mAChRs) are members of class A GPCRs that
regulate numerous fundamental functions in peripheral and central nervous system (PNS
and CNS, respectively). Acetylcholine is synthesized in a reaction of acetyl coenzyme A
(acetyl CoA) and choline in a nerve terminal by choline acetyltransferase. Acetylcholine
is stored in the nerve terminal and released into the synapse upon nerve depolarization.
Acetylcholine thus produced is received by the acetylcholine receptors. There are two
types of acetylcholine receptors: (i) nicotinic receptor that is responsive to agonist
nicotine (C10H14N2) and (ii) muscarinic receptor that is responsive to the agonist
muscarine (C9H20NO2+) (23). Different types of muscarinic acetylcholine receptors bind
to specific G-proteins inside a cell to cascade signals from outside to inside of the cells.

Riker and Wescoe (24) first reported the existence of muscarinic receptor
subtypes. Because of diversified functions of muscarinic receptors at various locations,
and their potential therapeutic applications for various diseases like asthma, intestinal
disorder, functions of the urinary bladder, and Alzheimer’s diseases, studies based on
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classifications of muscarinic receptors have attracted wide interest. The research
presented by Peralta et al. suggested that human mAChRs contain at least four subtypes
(M1 – M4) which are different in their structures, affinity to various ligands, and their
pattern to tissue specific expression (25). Later, Bonner et al. cloned and expressed a fifth
human receptor in mammalian cells that is closely related to M3 (26). Based on the
mAChRs coupling with different types of G-proteins, they are divided into two broad
classes: first, M1, M3, and M5 that are preferentially coupled to Gαq/11 type of G-proteins
and second, M2 and M4, which activate Gαi/0 type of G-proteins (27-31). M1, M4, and M5
receptors are present mainly in CNS while M2 and M3 are present both in CNS and PNS
(31). CNS muscarinic receptors mainly regulate behavioral, sensory, and autonomic
processes and are responsible for many diseases such as Alzheimer’s diseases,
Parkinson’s diseases, depressions, and schizophrenia. The PNS receptors are mainly
present on the effector tissues innervated by parasympathetic nerves and are mainly
responsible for a decrease in heart rate, increase in glandular secretion, and smooth
muscle contractility (31).

Among the five different types of muscarinic receptors, type-3 muscarinic
receptors (M3Rs) are present mainly in smooth muscles, endocrine and exocrine glands,
lungs, pancreas, and the brain. In CNS, M3Rs induce emesis. M3Rs that are expressed in
certain regions of the brain influence insulin homeostasis regulation. The mutations of
M3Rs cause urinary bladder diseases and prune belly-like syndrome which are the
frequent causes of progressive renal failure in children (32). Sjögren's syndrome is a
chronic autoimmune disease where the immune cells attack and destroy the exocrine
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glands because of unknown reasons (33). Although the diagnosis of the diseases are yet
to be understood, researchers reported that antibodies of agonist M3Rs are detected in
patients attacked by the Sjögren's syndrome and were proposed to contribute to
pathogenesis (34). Under-expression of either the M3 or the M2 receptors in smooth
muscles cause disorder of the smooth muscle organs leading to paralysis ileus (35). Apart
from the above-mentioned chronic diseases, M3Rs are also involved in several other
diseases such as type 2 diabetes, obesity, peptic ulcer disease, irritable bowel syndrome,
and gastrointestinal spasms. It is, therefore, important to understand the structural and
functional form of these receptors and their mutations.

Since more than single subtype of mAChRs are present at any location of CNS or
PNS and to date there is no specific ligand that activates specific mAChR, it is not clear
so far whether a single or multiple subtypes of receptors are responsible for a particular
disease. Researchers have been trying to develop agonists and antagonists for subtype
selective mAChRs for the treatment of various diseases, but these receptors have highly
subtype selective orthosteric binding sites (31, 36), which is one of the major challenges
for the medicinal chemist to develop subtype specific orthosteric ligands. This
complicates the discovery of novel drug particular for a specific subtype of mAChRs
causing their side effects by blocking/activating multiple mAChRs. Recently, research
has been focused on developing novel drugs that can bind to target mAChRs through
allosteric mechanism due to their high selectivity and effectiveness. Hence, these drugs
are more target specific and have less side effects (36, 37). Most of the mAChRs have
two allosteric binding sites, and the allosteric ligands have no effect on the receptors in
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the absence of the agonists (36, 37). Recent findings of AC-42 (38, 39) and Ndesmethylclozapine (40) which can very selectively activate M1 mAChRs, raised the
hope of possible discovery of specific mAChR subtype binding ligands by targeting
allosteric receptor sites (31).

Apart from these findings, it is also critical to understand the quaternary structure
of these receptors in their native environment to help to understand the functional forms
and diversities of these receptors and their responses to specific drugs. Many questions
need to be addressed for the drug discovery; a few among them are: (a) whether or not
they oligomerize to bind to specific ligands? (b) How do they respond to the ligands or
drugs i.e., do they undergo any changes in the quaternary organizations? In other words,
do the ligands regulate their quaternary size, and shape from one form to the other? (c)
Does the expression level of the receptors in cells change their affinity for the ligands?
To address the above questions we have described a method in the following section
where we used muscarinic acetylcholine receptors type 3 (M3Rs) as our biological system
of interest.

4.2

Oligomerization of muscarinic M3 acetylcholine receptors

(This research was originally published in Biochemical Journal. S Patowary,
E Alvarez-Curto, T R Xu, J D Holz, Julie A. Oliver, G Milligan and V Raicu, The
muscarinic M3 acetylcholine receptor exists as two differently sized complexes at the
plasma membrane. Biochem. J. (2013); 452: 303–312 © The Biochemical Society).
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4.2.1 Review of GPCR’s oligomerization
G protein-coupled receptors (GPCRs) are the largest family of transmembrane proteins in
the human genome and the most utilized as the targets for small molecule drugs and
medicines (11). In recent times, a series of atomic level X-ray structures of members of
the large class of rhodopsin-like GPCRs (41-46) has appeared to provide support for the
historical view, based on analysis of the binding of such drugs, that these receptors exist
as monomeric, non-interacting polypeptides. Despite this, there has been a persistent
literature consistent with GPCRs existing as dimers or higher-order oligomers (47, 48).
Gratifyingly for champions of this proposal, recent X-ray structures of the chemokine
CXCR4 receptor have provided strong evidence of a substantial dimer interface involving
elements of transmembrane domains V and VI (49). Moreover, the structure of the µopioid receptor shows a dimeric 4-helix bundle interface provided by many of the
residues of transmembrane domains V and VI as well as a further, less extensive,
interface provided by elements of transmembrane domains I and II along with the
intracellular element often designated ‘helix VIII’ (50). These interfaces potentially allow
the presence of tetrameric or even higher-order organization (50) and suggest that at least
a subset of the rhodopsin-like GPCRs form quaternary structures with avidity sufficient
to be maintained throughout detergent-mediated solubilization and preparation for
crystallization trials.

Support for the presence of GPCR dimers and/or higher-order quaternary
complexes in intact cells and tissues has been derived from studies involving techniques
ranging from fluorescence recovery after photobleaching (51) to approaches employing

121
resonance energy transfer (52-55). Despite this, the functional significance of GPCR
quaternary structure remains uncertain, although a substantial number of studies have
shown the importance of dimeric/oligomeric interactions for the proper maturation and
cell surface delivery of class A receptors (56-58) and are consistent with interactions
occurring at an early stage in GPCR synthesis.

Although certain commentators have championed the primacy of monomeric or
oligomeric forms of rhodopsin-like GPCRs (59, 60), it is not obvious that a single state
must exist at the exclusion of others. Studies based on fluorescence recovery after
photobleaching and antibody-based tethering of a GPCR have provided evidence for
dynamic interactions between individual protomers, and for the extent of the interaction
varying between even closely related class A GPCRs (51). Furthermore, studies that have
begun to develop single molecule tracking have provided evidence of association and
disassociation of what appear to be GPCR quaternary complexes (60-62). Herein we have
assessed this hypothesis in cells engineered to express a form of the muscarinic M3
acetylcholine receptor (M3R) tagged with an energy acceptor to remain at a constant
amount, whilst levels of an energy donor-tagged form of a mutationally modified version
of this receptor (Tyr149Cys, Ala239GlyM3R) could be titrated from an inducible locus
(63). Specifically, we investigated the quaternary organization and degree of stability of
M3R at the plasma membrane. This was achieved by using measurement and analysis,
within a suitable theoretical framework (64, 65), of distributions of apparent FRET
efficiencies, Eapp (or Eapp histograms), across FRET images of individual cells expressing
proteins of interest (54). The quaternary structure of the complex is identified from the
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number and relative disposition of peaks within an Eapp histogram, which constitutes a
veritable “FRET spectrum” associated with a specific quaternary structure. The
separation of dimer from tetramer signals is achieved using a method here introduced that
takes into account the amplitudes of the individual peaks in the Eapp histogram. Data
analysis indicates that, at the plasma membrane, homomers of the M3R exist as a mixture
of dimers and rhombic tetramers whilst biochemical studies support dynamic
interchanges between such complexes.

4.2.2 Materials and methods
4.2.2.1 Cell models
Flp-InTM T-RExTM 293 cells constitutively expressing FLAG-M3R-Citrine and also
harboring Myc-Tyr149Cys, Ala239GlyM3R-Cerulean at the Flp-InTM T-RExTM locus that
provides tetracycline inducible expressions were generated previously and described fully
(63). Cells were grown in Dulbecco’s Modified Eagle’s Medium (DMEM) without
sodium pyruvate, supplemented with 10% organic fetal bovine serum (FBS, PAA
Laboratories Inc, Dartmouth, MA), 2 mM L-glutamine, 1% penicillin/streptomycin, 10
g mL-1 blasticidin, 200 g mL-1 hygromycin B, and 1 mg mL-1 G418. Equivalent cells
able to express either FLAG-M3R-Citrine or Myc-Tyr149Cys, Ala239GlyM3R-Cerulean
in isolation from the Flp-InTM T-RExTM locus were generated and maintained in the same
way, but without G418. Cell lines were maintained at 37 °C in a humidified environment
with 5% CO2. 72 hours prior to imaging, the cells were sub-cultured and seeded at
48,000-60,000 cells/cm2. The cells were approximately 70% confluent after 48 hours of
growth, at which time fresh medium, containing doxycycline at concentrations as
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indicated, was added to the cells for an additional 24 hours incubation. The cells were
then non-enzymatically lifted using Cellstripper (Mediatech Inc., Manassas, VA) and resuspended in 1 mL Opti-MEM (Life Technologies, Grand Island, NY) for imaging.

4.2.2.2 Cell-surface biotinylation
Cells were seeded on plates previously coated with poly-D-lysine and washed with icecold borate buffer (10 mM boric acid, 154 mM NaCl, 7.2 mM KCl, and 1.8 mM CaCl2,
pH 9.0) and incubated on ice with 1 mL of 0.8 mM EZ-Link sulphosuccinimidyl 2(biotinamido)ethyl-1,3-dithiopropionate (Pierce Chemical, Rockford, IL) in borate buffer
for 15 min. The cells were then rinsed with a solution of 0.192 M glycine and 25 mM
Tris, pH 8.3, to quench the excess biotin, and lysed with RIPA buffer (50 mM HEPES,
150 mM NaCl, 1% Triton X-100, and 0.5% sodium deoxycholate, 10 mM NaF, 5 mM
EDTA, 10 mM NaH2PO4, 5% ethylene glycol, pH 7.4). Lysates were centrifuged for 30
min at 14,000 g, and the supernatant was recovered. Cell surface-biotinylated proteins
were isolated using 50 µL of ImmunoPure immobilized streptavidin (Pierce Chemical,
Rockford, IL) and rotating for 1 hour at 4 °C. Samples were subsequently centrifuged,
and the streptavidin beads were washed three times with RIPA buffer. Finally, the
biotinylated proteins were eluted with 50 µL of SDS sample buffer for 1 h at 37 °C, and
SDS-PAGE and Western blotting were performed.

4.2.2.3 Cell lysates, PAGE, and immunoblotting
Cells were washed once in cold PBS and harvested with ice-cold RIPA buffer
supplemented with Complete Protease Inhibitor Cocktail (Roche Diagnostics, Mannheim,
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Germany). Extracts were passed through a 25-gauge needle and incubated for 15 min at 4
°C while spinning on a rotating wheel. Cellular extracts were then centrifuged for 30 min
at 14,000 g and the supernatant was recovered. Samples were heated at 65 °C for 15 min
and subjected to SDS-PAGE analysis using 4–12% BisTris gels NuPAGE, (Life
Technologies,

Grand

Island,

NY)

and

MOPS

buffer.

Proteins

were

then

electrophoretically transferred onto nitrocellulose membranes that were blocked for 45
min in 5 % fat-free milk in TBST (1x Tris-buffered saline containing 0.1 % (v/v) Tween
20) and subsequently incubated with the required primary antibody overnight at 4 °C.
Incubation with the appropriate horseradish peroxidase-linked IgG secondary antiserum
was performed for 2 hours at room temperature. Immunoblots were developed by
application of enhanced chemiluminescence substrate (Pierce Chemical, Rockford, IL).

4.2.2.4 Proximity ligation assay (PLA)
Cells were seeded on 0-thickness glass cover slips previously coated with poly-D-lysine.
PLA (66) was performed on cells maintained with or without doxycycline induction
using the Duolink II Detection Kit (Olink Bioscience, Uppsala, Sweden). The antibodies
used in this study were monoclonal mouse anti-FLAG M2 and rabbit anti-FLAG (Sigma
Aldrich Co Ltd), and 9B11 mouse anti-Myc and rabbit anti-Myc (Cell Signaling
Technology, Nottingham, UK).

4.2.2.5 Two-photon fluorescence microscopy
Approximately 10 L of a suspension of cells in Opti-MEM medium was placed on a
microscope slide and covered with a coverslip. A spectrally resolved two photon
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microscope (SR-TPM) was used to acquire the spectral images as described (54). Briefly,
a femtosecond Ti:Sapphire laser (KM Labs, Boulder, CO) was used as excitation energy
source. Laser pulses with spectra approximately 20 nm wide (full-width half-maximum)
were focused through an infinity-corrected oil immersion Plan Apochromat objective
(×100 magnification, NA = 1.4; Nikon Instruments, Melville, NY) to a diffraction-limited
spot onto the sample. The back-propagating fluorescence emitted by the sample was
projected through a transmission grating onto a cooled electron-multiplying CCD camera
(EMCCD; Andor, iXon 897).

4.2.2.6 Elementary emission spectra for the FRET pair
Cells harboring Myc-Tyr149Cys, Ala239Gly M3R-Cerulean or FLAG-M3R-Citrine and
induced with 100 ng mL-1 doxycycline were imaged with the SR-TPM using 800-nm
excitation light. Average powers of the order of 35 mW and 60 mW (measured before the
scanning head of the microscope) were used for Cerulean and Citrine, respectively. The
average emission spectra obtained from several cells were normalized to obtain
elementary emission spectra of donor (D, Cerulean) and acceptor (A, Citrine). Due to the
negligible Citrine excitation by the 800-nm laser light (note that Citrine has single photon
absorption wavelength at 516 nm (66), the Citrine emission was very dim even at
comparatively higher excitation power. Therefore, its spectrum contained cellular autofluorescence in the lower wavelength region. In order to correct for this artifact, the
measured spectrum was fitted with three Gaussian functions, viz. a broad Gaussian at
lower wavelengths corresponding to cellular auto-fluorescence, and two other closely
spaced Gaussians corresponding to the two spectral components usually seen in Citrine
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emission, were used to fit the measured spectrum of cells expressing FLAG-M3R-Citrine.
After the fitting, the first Gaussian was subtracted from the total measured spectrum to
obtain the auto-fluorescence corrected emission spectrum of Citrine. For cross-checking,
the emission spectrum of Citrine was also measured using a similar spectrally-resolved
two-photon microscope equipped with a Ti-Sapphire laser (Tsunami, Spectra Physics)
tuned to ~ 900 nm wavelength.

4.2.2.7 Image analysis
Spectral images obtained from cells co-expressing inducible Myc-Tyr149Cys,
Ala239GlyM3R-Cerulean and constitutive FLAG-M3R-Citrine that had been treated with
different concentrations of doxycycline were unmixed using the D and A elementary
spectra, determined as described above, to obtain the donor fluorescence intensity in
presence of acceptor (kDA) and the acceptor fluorescence intensity in presence of donor
(kAD) at every pixel of the imaged section of the cell (54, 65). The spatial distribution map
of FRET efficiencies was computed from the kDA and kAD values by using the following
equation (3.41): QD (=0.62) (67), and QA (=0.76) (66). Eapp distributions (i.e., the number
of pixels showing a certain FRET efficiency value), or histograms, were computed by
binning the apparent FRET efficiency values of all pixels (bin size, 0.01) and plotting
their histograms. Only the pixels in regions of interest around the cellular membrane were
included in the analysis. To reduce the probability that pixels characterized only by
instrumental noise contribute to the distribution of FRET efficiencies, a threshold value
was used for the kDA and kAD images.
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Expression level of donor-tagged M3R was determined by comparing the
measured fluorescence intensity of the donor corrected for FRET to the fluorescence
emission of a standard fluorescent solution of purified YFP (prepared as described
elsewhere (68)), based on knowledge of absorption cross sections and the quantum yields
of the two fluorophores (69, 70). All the procedures related to spectral unmixing, as well
as computation of FRET efficiencies and donor-only fluorescence intensities were
computer-coded using MatLab (The MathWorks, Inc., Natick, MA).

4.2.2.8 Estimation of the protein expression level
From the kDA and kAD values determined from spectral unmixing, we computed the
fluorescence of the donor in the absence of acceptor using the formula 𝐹 𝐷 = 𝑘 𝐷𝐴 𝑤 𝐷 +
𝑘 𝐴𝐷 𝑤 𝐴 𝑄𝐷 /𝑄 𝐴 , where all the symbols are as defined in section 3.1.4. Then we calculated
the average donor fluorescence in the absence of FRET. In order to obtain an order of
magnitude estimate of the donor concentration inside the cells, we used the following
expression, derived from the expression for the number of photons generated by a twophoton absorption process (71):

𝐹 𝑥 𝜎𝑠 𝑄𝑠 𝑡𝑑𝑠 𝑁𝐴𝑠 4 𝑃𝑠 2 𝑓𝑠 2 𝜏𝑥 𝜆𝑥 2

𝐶𝑥 = 𝐶𝑠 [ 𝑠
],
𝐹 𝜎𝑥 𝑄𝑥 𝑡𝑑𝑥 𝑁𝐴𝑥 4 𝑃𝑥 2 𝑓𝑥 2 𝜏𝑠 𝜆𝑠 2

(4.1)

where C is the molar concentration, F is the average fluorescence intensity of the donors
in the absence of energy transfer, σ is the two-photon absorption cross-section, Q is the
quantum yield, td is the pixel dwell time of the scanning system, NA is the numerical
aperture of the microscope objective, P is the average excitation light power, f is the

128
repetition rate of the laser pulse, τ is the laser pulse duration (50 fs for the KM Labs laser
used in the FRET study and 170 fs for the MaiTaiTM laser used for concentration
calibration—see below), and λ is the excitation wavelength, while the subscripts s and x
stand for standard solution and for the unknown concentration (of donor-tagged
molecules). The average fluorescence intensity of a fluorescent standard consisting of an
aqueous solution of YFP (10 M concentration) was determined using a separate
microscope Zeiss Axio Observer (Zeiss, Thornwood, NY) equipped with an OptiMiSTM
module (Aurora Spectral Technologies, Bayside, WI) and an ultrashort-pulse laser
(MaiTaiTM, Spectra Physics, Santa Clara, CA) tuned to 960 nm. The solution of YFP
was prepared as described elsewhere (68). The absorption cross sections and the quantum
yields were obtained from the literature (69, 72).

Using this method, we estimated the donor concentrations, which varied between
1.1 and 2.5 x 105 molecules per cell, for doxycycline concentrations ranging from 0.5 to
100 ng mL-1. The ratios of donor to acceptor concentrations determined from fitting the
bar chart of peak areas allowed us to then compute the concentration of acceptors, which
varied between 1.9 x 105 and 7.1 x 104 molecules per cell as the doxycycline
concentration was changed between 0.5 to 100 ng mL-1. From this, the total expression
level of M3R was determined to only slightly vary from just under 3 x 105 to 3.2 x 105
receptors per cell with doxycycline concentration.
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4.2.2.9 Fitting of FRET efficiency distributions to quaternary structure models
The Eapp histograms obtained as described above were simulated with various quaternary
structure models using Microsoft Excel. The best fit of the model to the experimental
data was achieved by minimizing the fitting residual defined as:

𝑒𝑠 =

∑𝑖|𝐸𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙𝑖 − 𝑆𝑖𝑚𝑢𝑙𝑎𝑡𝑒𝑑𝑖 |
,
∑𝑖 (𝐸𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙)𝑖

(4.2)

where ‘Experimental’ stands for the experimentally observed number of occurrences of a
certain FRET efficiency value (plotted on the vertical axis in the histograms), ‘Simulated’
is the simulated value for the ‘Experimental’ data, and ‘i’ is a summation index
corresponding to individual data points.
The bar chart representing the average areas under the peaks in the histograms at a
certain doxycycline concentration were fitted with the simulated rhombus tetramer model
by minimizing the following fitting residual:

2

𝑅𝑒𝑠 = ∑(𝐸𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙𝑗 − 𝑆𝑖𝑚𝑢𝑙𝑎𝑡𝑒𝑑𝑗 ) ,

(4.3)

𝑗

where ‘j’ is the bar number in the graph (j=1,3,4,5, i.e., starting from left and excluding
the second peak), ‘Experimentalj’ is the height of a certain bar, ‘j’, which represents the
average cumulative area under the Gaussian corresponding to the jth peak for all the cells,
and ‘Simulatedj’ represents the predicted height for each bar, according to the model
described in the Fig. 4.2 caption.
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4.2.3 Results
4.2.3.1 Determination of the largest quaternary structure of M3R at the plasma
membrane
We have previously generated (63) Flp-InTM T-RExTM 293 cells to constitutively express
an N-terminally FLAG epitope-tagged form of the human M3R that had the yellow
fluorescent protein Citrine linked in-frame to its C-terminal tail (FLAG-M3R-Citrine).
These cells also harbor at the Flp-InTM T-RExTM locus a N-terminally Myc epitopetagged form of the M3R with the cyan fluorescent protein Cerulean at the C-terminus and
in which the ligand binding pocket had been engineered by mutation of two residues to
allow selective activation by the synthetic chemical clozapine N-oxide (CNO) rather than
the natural ligand acetylcholine (Myc-Tyr149Cys, Ala239GlyM3R-Cerulean). The FlpInTM T-RExTM locus allows expression of different amounts of (Myc-Tyr149Cys,
Ala239GlyM3R-Cerulean) (i.e., donor) to be achieved following addition of varying
concentrations of the inducer doxycyline whilst levels of FLAG-M3R-Citrine remain
constant (63). Despite defining the presence of M3R homomers in these cells upon
induction of Myc-Tyr149Cys, Ala239GlyM3R-Cerulean, previous studies were unable to
effectively assess the location, the size of such complexes or their stability over time (63).
This cell line therefore provided a direct link to the previous work whilst the
pharmacological selectivity of the wild type and variant form of the M3R allowed
potential selective activation of the component parts of identified multimers (see later).

To probe oligomerization of M3R at the cell surface, we use herein an optical
micro-spectroscopic technique and FRET for probing interactions with image-pixel
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resolution (54). This method provides distributions of FRET efficiencies for individual
cells (rather than average values), avoids information washing caused by diffusion of
molecules during the measurements, and is nearly insensitive to stochastic (or bystander)
FRET (60), which only introduces a low, broad background in the FRET efficiency
distributions (73).

Figure 4.2: FRET-based analysis of Flp-InTM T-RExTM 293 cells expressing Myc-Tyr149Cys,
Ala239GlyM3R-Cerulean (inducible) and FLAG-M3R-Citrine (constitutive). (a) Photomicrograph of a cell
showing donor fluorescence in the presence of acceptor (kDA), acceptor fluorescence in the presence of
donor (kAD), and the apparent FRET efficiency distribution map ( Eapp) computed, using Eq. 4.1, from the
values of kAD and kDA at each pixel. (b) Distinct configurations of donors and acceptors within a
parallelogram (or rhombus)-shaped tetramer and their apparent FRET efficiencies. (c) Eapp histograms
obtained from pixels representing the plasma membrane of the cell shown in (a) (open circles/dotted lines)
and the theoretical best fit (thick solid line) with a sum of five correlated Gaussian peaks (shown separately
as thin solid lines) whose positions are given by a single adjustable parameter, Ep (=0.18) via the rhombus
tetramer model shown in (d). This figure was reproduced from (74)
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Initially, individual Flp-InTM T-RExTM 293 cell lines with induced expression of
only Myc-Tyr149Cys, Ala239GlyM3R-Cerulean (energy donor) or only FLAG-M3RCitrine (energy acceptor) were imaged to determine the elementary spectra of donors and
acceptors. These elementary spectra were used to unmix spectrally-resolved images of
cells expressing both donors and acceptors to obtain donor fluorescence intensity in the
presence of acceptors (kDA) and acceptor fluorescence intensity in the presence of donors
(kAD), as described in section 4.2.2.7. Co-expression of differing ratios of MycTyr149Cys, Ala239GlyM3R-Cerulean and FLAG-M3R-Citrine was accomplished by
inducing these cells for 24 hours in the presence of different concentrations of
doxycycline. Fig. 4.2 (a) shows kDA and kAD images of a representative cell expressing
both variants of M3R as well as the spatial map of apparent FRET efficiencies (Eapp) as
computed from the kDA and kAD images. Eapp histograms were obtained by binning the
Eapp image pixels according to their value (bin size, 0.01) and plotting the number of
pixels in each bin against Eapp (Fig. 4.2 (c)).

The Eapp histograms obtained were incompatible with the oligomeric form of the
M3R being a simple dimer, for which a single peak is expected in the histogram
(however, please see the Discussion section). The Eapp histogram for the plasma
membrane area of the cell was analyzed using a FRET theory (64) for oligomeric
complexes with various sizes and geometries (54, 65). Fig. 4.2 (c) shows the results of a
simulation using the parallelogram (or rhombus) tetramer model illustrated in Fig. 4.2
(b). The pair-wise FRET efficiency, characterizing the energy transfer in a single donor
and acceptor pair (Ep), was used as an adjustable parameter which determines
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simultaneously the positions of the five Gaussian peaks in the experimental data. As seen
in Fig. 4.2 (c), the rhombus tetramer properly describes the peaks in the Eapp histogram of
the complexes localized at cell surface.

Simulations using a rhombus hexamer model (presented in Table 4.1) provided
similarly good fits. However, of the twenty different peaks predicted by the hexamer
model, only those peaks having the same positions as obtained from the simulations with
a tetramer were needed to achieve a good, unique fit. That means that, in fact, the
rhombus tetramer is the natural result of attempts to fit the data using higher order
oligomers.

Table 4.1: Eapp peaks predicted by a parallelogram hexamer model. This table was reproduced from (74)

Peak Number

Eapp = f (Ep)

1

2
𝐸
5 𝑝

2

3
𝐸
5 𝑝

3

1
1 𝐸𝑝
𝐸𝑝 +
4
2 1 + 𝐸𝑝

4

4
𝐸
5 𝑝

Configurations
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5

1
2 𝐸𝑝
𝐸𝑝 +
3
3 1 + 𝐸𝑝

6

1
1 𝐸𝑝
𝐸𝑝 +
2
2 1 + 𝐸𝑝

7

𝐸𝑝

8

𝐸𝑝
1
𝐸𝑝 +
4
1 + 𝐸𝑝

9

3
1 𝐸𝑝
𝐸𝑝 +
4
2 1 + 𝐸𝑝

10

𝐸𝑝
1
𝐸𝑝 +
2
1 + 𝐸𝑝

11

𝐸𝑝
2
𝐸𝑝 +
3
1 + 2𝐸𝑝

12

1
4 𝐸𝑝
𝐸𝑝 +
3
3 1 + 𝐸𝑝

13

1
3 𝐸𝑝
𝐸𝑝 +
2
2 1 + 2𝐸𝑝

14

𝐸𝑝
1
2 𝐸𝑝
𝐸𝑝 +
+
3
3 1 + 𝐸𝑝 1 + 2𝐸𝑝
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15

2𝐸𝑝
1 + 𝐸𝑝

16

𝐸𝑝
4 𝐸𝑝
+
3 1 + 𝐸𝑝 1 + 2𝐸𝑝

17

𝐸𝑝
3 𝐸𝑝
+
1 + 𝐸𝑝 2 1 + 2𝐸𝑝

18

𝐸𝑝
2𝐸𝑝
+
1 + 𝐸𝑝 1 + 3𝐸𝑝

19

3𝐸𝑝
1 + 2𝐸𝑝

20

2𝐸𝑝
1 + 3𝐸𝑝

Flp-InTM T-RExTM 293 cells grown on glass coverslips and induced or not to
express Myc-Tyr149Cys, Ala239GlyM3R-Cerulean demonstrated the presence of a
substantial proportion of FLAG-M3R-Citrine at or close to the cell surface in both
situations, and the appearance of Myc-Tyr149Cys, Ala239GlyM3R-Cerulean at a similar
location only in doxycycline-induced cells. Merging of such images demonstrated the
co-localization of the two forms of M3R at the level of light microscopy (Fig. 4.3). To
ensure that these two forms of M3R were actually at the plasma membrane with the Nterminal region located extracellularly, and potentially participating in an oligomeric
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complex, we employed proximity ligation assays (PLA) using anti-Myc and anti-FLAG
antibodies as the primary detection agents. These also confirmed that the two forms of
M3R were in close apposition, and while specificity of the PLA was confirmed by a lack
of signal in cells in which expression of Myc-Tyr149Cys, Ala239GlyM3R-Cerulean had
not been induced (Fig. 4.3).

+ dox

- dox

citrine

cerulean

citrine

PLA

merge

PLA

Figure 4.3: Cell surface location and proximity of energy donor and acceptor forms of M 3Rs. Flp-InTM
T-RExTM 293 cells expressing FLAG-M3R-Citrine were uninduced (- dox) or treated with 100 ng mL-1
doxycycline (+ dox) for 24 hr to induce expression of and Myc-Tyr149Cys, Ala239Gly M3R-Cerulean.
Images of the individual receptor forms and overlay of images to display co-localization at the cell
surface are shown. Proximity ligation assays conducted on doxycycline-induced cells indicated close
apposition of the two variants (red) and the extracellular location of the epitope tags while equivalent
studies performed on non-induced cells demonstrated the requirement for both variants to be present to
generate the signal. This figure was reproduced from (74).

In light of all these findings, and with the application of Occam’s razor, we
hypothesize that the rhombus tetramer is the largest quaternary structure formed by M3Rs
at the plasma membrane. Separate control experiments, which incorporated FRET
standards, confirmed that the detected oligomers are not artifacts potentially introduced
by the present methods (54, 75, 76).
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4.2.3.2 Do tetramers represent the only quaternary structure at the plasma
membrane?
Next, we assessed whether smaller structures (such as dimers and trimers) may coexist
with tetramers. By inducing the cells with different doxycycline concentrations (0.5 ng
mL-1, 1.0 ng mL-1, 10.0 ng mL-1, and 100 ng mL-1), differing ratios of Myc-Tyr149Cys,
Ala239Gly M3R-Cerulean and FLAG-M3R-Citrine concentrations were achieved in the
cells. At least thirty cells for each doxycycline concentration were imaged and their Eapp
histograms were analyzed using the method described above. The areas under each
individual Gaussian (with dimensions of pixels x percentage of Eapp or, simply, pixels)
were averaged over all the cells treated with a certain doxycycline concentration, and a
bar chart showing such averages for each peak in the histogram was created for each
doxycycline concentration (Fig. 4.4). Each bar in the chart represents therefore the
average number per cell of certain configurations of donors and acceptors in Fig. 4.2 (b).

Assuming first that the oligomers are exclusively in tetrameric form, the heights
of the individual bars in each chart were modelled using a set of mathematical
expressions that depend on the number of different permutations within each of the
tetrameric configurations shown in Fig. 4.2 (b) (e.g., two for the first configuration, two
for the second, four for the third, etc.) as well as the fraction of donor and acceptor
concentrations in the tetramers (see the caption to Fig. 4.4). As seen, the simulated bar
heights were in agreement with the experimentally determined heights, except for the
second bar (corresponding to the second peak in the Eapp histograms), for which the
experimental value exceeded the theoretical prediction by a significant amount. We also
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note that the ratio between donor and acceptor concentrations (see the values in Fig. 4.4
caption) increases with an increase in doxycycline concentration, as expected for an
increase in donor expression level. This speaks strongly in favor of the validity of the
rhombus tetramer model used to analyze the Eapp histograms, because extraction of the
correct donor to acceptor ratio confirms the validity of the mathematical expressions of
the amplitudes predicted by the rhombus tetramer. The same conclusion may be drawn by
simply noticing that the amplitudes of the peaks 1 and 2 increase with an increase in
donor expression level, while the amplitudes of the peaks 4, and 5 decrease, as expected
for a rhombus tetramer in which the proportion of the tetramer configurations rich in
donors increases with donor expression level at the expense of the configurations rich in
acceptors.

The excess in the cumulative amplitudes corresponding to the second peak
suggests that an additional population of complexes must be present, which is
characterized by only one peak in its Eapp histogram whose position is determined by the
same pair-wise FRET efficiency (Ep) as for the tetramers. The only possible explanation
for the observed excess in the area of the second peak of the Eapp histogram appears to be
the co-existence of dimers with tetramers at the membrane.

Since trimers should

contribute not only to the second but also to the fourth peak (65) in the experimentally
determined histogram, we conclude that trimers are absent from our system. Overall,
these observations suggest that the dimers and tetramers may dynamically interconvert at
the plasma membrane. We will return to this idea later on in this section.
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Figure 4.4: Bar charts of the average area under each Gaussian peak in Eapp histograms. ‘Experimental’
bars represent the areas under each Gaussian peak in the individual Eapp histograms, as in Fig. 4.2 (c),
averaged over several cells. ‘Theoretical’ bars represent simulations using amplitudes predicted for the
rhombus tetramer model shown in Fig. 4.2 (b). Each bar represents the average number of tetramers per
cell corresponding to a certain configuration of donors and acceptors shown in Fig. 4.2 (b). For a
tetramer model, the heights of the vertical bars are given by the following family of expressions
corresponding to each donor-acceptor configuration shown in Fig. 4.2 (b): 2𝑃𝐷 3 𝑃𝐴 1 𝑠 , 2𝑃𝐷 3 𝑃𝐴 1 𝑠 ,
4𝑃𝐷 2 𝑃𝐴 2 𝑠 , (2𝑃𝐷 1 𝑃𝐴 3 + 𝑃𝐷 2 𝑃𝐴 2 + 𝑃𝐷 2 𝑃𝐴 2 )𝑠 , and 2𝑃𝐷 1 𝑃𝐴 3 𝑠 , where s is a scaling factor, while 𝑃𝐷 =
[𝐷]/[𝐴]
1+[𝐷]/[𝐴]

and 𝑃𝐴 =

1
1+[𝐷]/[𝐴]

are the fractions of donors and acceptors, respectively, in complexes, with

[D] being the concentration of donors and [A] the concentration of acceptors. Each panel in the figure
corresponds to different donor expression levels, as induced by the following doxycycline
concentrations: Panel (a): 0.5 ng mL-1; Panel (b): 1.0 ng mL-1; Panel (c): 10.0 ng mL-1; Panel (d): 100.0
ng mL-1 (see ref (63) for details). The theoretical simulations for the bar heights were performed
simultaneously for peaks 1, 3, 4, and 5 by adjusting the D to A concentration ratio and the scaling factor
s. The best-fit values for [D]/[A] and s were, respectively: 0.60 and 2587 (N = 36 cells) for panel (a);
1.44 and 2548 (N = 85 cells) for panel (b); 2.87 and 4231 (N = 90 cells) for panel (c); 3.57 and 4342 (N
= 113 cells) for panel (d). This figure was reproduced from (74).

Having established the identity of the oligomeric structures present at the plasma
membrane, we next used the observed excess in the height of the second bar in the charts
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(relative to the prediction by the tetramer model) to determine the ratio between the
number of protomers associated into dimers with mixed composition (i.e. with both
donor- and acceptor-tagged receptors) vs. those in tetramers with mixed composition.
This was computed as the ratio between the excess height (i.e., experimental minus
predicted value) of the second bar times two (because a dimer contains two protomers)
and the sum of the heights of the five simulated bars in the individual charts multiplied by
four (because each tetramer contains four protomers). The results corresponding to the
four panels in Fig. 4. 3 are, in order from A to D: 0.11, 0.10, 0.09, and 0.08.

Beyond a desire to use the same cell lines that had been used previously to define
that M3R formed some element of quaternary structure (63), the combination of wild type
and the mutationally modified M3R in these cells allowed distinct and independent
estimates of the levels of expression of the receptors in these studies. Specific radioligand
binding using [3H]QNB allowed selective measurement of the acceptor species (FLAGM3R-Citrine) as this ligand does not bind with high affinity to Myc-Tyr149Cys,
Ala239GlyM3R-Cerulean (63), and this was complemented by determination of the
expression level of donor-tagged receptor, which was based on micro-spectroscopic
measurements. Based on determinations of the donor fluorescence intensity corrected for
loss through FRET, as described in section 4.2.1.8, in this work we estimated the donor to
be present to between 1 x 105 and 2.5 x 105 molecules per cell for doxycycline
concentrations ranging from 0.5 to 100 ng mL-1 (see section 4.2.1.8). The ratios of donor
to acceptor concentrations determined from fitting the bar chart for peak areas (Fig. 4.4),
together with the determined concentrations of donors, allowed us to estimate the
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concentrations of acceptors, which varied between 2 x 105 and 7 x 104 molecules per cell
as the doxycycline concentration was changed between 0.5 and 100 ng mL-1. Importantly,
these values are very similar to the number of acceptor-tagged copies per cell (~2 x 105)
determined from binding of the highly-specific [3H]QNB ligand to the acceptor (FLAGM3R-Citrine) in the absence of doxycycline. The total expression level of receptor was
about 3 x 105 receptors per cell, almost independent of doxycycline concentration. This is
consistent with the almost constant ratio of dimer to tetramer concentration (see previous
paragraph).

4.2.3.3 Quaternary structure of M3R at the plasma membrane in the presence of
agonists
In separate experiments, we took batches of cells induced by 10 ng mL-1 of doxycycline
to coexpress both forms of the receptor and separated them into three aliquots: One
sample was treated with CNO (100 µM for 5-20 minutes), which acts as a highly
selective agonist for Myc-Tyr149Cys, Ala239GlyM3R-Cerulean (63, 77), another sample
was treated with carbachol (100 µM), a stable mimetic of the natural M3R receptor ligand
acetylcholine, while an untreated one was used as a control. We imaged the cells as
described before and then analyzed the Eapp histograms using the rhombus tetramer
model shown in Fig. 4.2 (b). The Ep values obtained for various cells treated with ligand
fell in the same range of values as that corresponding to the untreated cells; this
suggested that both the global geometry of the complexes and the distances between their
protomers remain largely unaffected upon binding of an agonist ligand. Next, we
generated bar charts by adding together the average areas under the Gaussian peaks (Fig.
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4.5) and determined the ratios of protomer concentrations in dimers and tetramers from
the excess in height of peak #2 in the bar chart (see previous paragraph for details of this
procedure), which were 0.16, 0.09, and 0.09 for carbachol-treated, CNO-treated and
untreated cells, respectively.

Figure 4.5: Bar charts showing the cumulative areas under each Gaussian peak in Eapp histograms as in Fig.
4.2 (c) for multiple cells in presence and absence of ligand (‘Experimental’) and simulations using
amplitudes predicted for the parallelogram model shown in Fig. 4.2 (b) (‘Theoretical’) in the main text.
Panel (a): control cells induced with 10 ng mL-1 of doxycycline. Panel (b): cells induced with 10 ng mL-1 of
doxycycline and treated with CNO ligand, which acts as a highly specific agonist only for the MycTyr149Cys, Ala239GlyM3R-Cerulean energy donor form of the receptor. Panel (c): cells induced with 10
ng mL-1 of doxycycline and treated with carbachol, an agonist that binds to the wild-type receptor (FLAGM3R-Citrine). The theoretical simulations for the bar heights were performed simultaneously for all five
bars by adjusting [D]/[A] and the scaling factor s. The best-fit values for [D]/[A] and s were, respectively:
2.36 and 2760 (N = 44 cells) for panel (a); 2.35 and 2866 (N = 42 cells) for panel (b); 2.57 and 3289 (for
25 cells) for panel (c). The ratios of protomer concentrations in dimers and tetramers (see main text for
details of how these were determined) which were 0.09 for panel (a), 0.09 for panel (b), and 0.16 for panel
(c). This figure was reproduced from (74).

Because of the variability of this ratio (from 0.09 to 0.15) observed in several
experiments even in the absence of ligand, at this time we choose to not assign any
significance to the slight differences between the partitions of protomers among dimers
and tetramers in the presence and absence of the selective agonist ligands. The precise
interpretation of these results is further complicated by the fact that although saturation
binding experiments indicate that the wild-type M3 receptor binds CNO with an affinity
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of ~15 M (see Table 4.1 in reference (78)), the receptor does not generate a response to
this concentration of CNO (see Fig. 4.1 in (77)). More detailed experiments would need
to be conducted in the future to more clearly determine whether ligand binding has
significant effect on the dimer/oligomer fraction.

4.2.3.4 Testing the stability of the oligomeric complexes
Since our FRET measurements suggested that M3Rs form rhombus-shaped tetramers as
well as dimers at the plasma membrane, we hypothesized that tetramers of M3R may be
meta-stable complexes, although it is widely accepted that oligomeric organization is
initiated during the processes of protein synthesis and maturation (58). We used coimmunoprecipitation studies to assess whether recently synthesized receptors would
rapidly form stable oligomeric complexes, or whether such complexes might represent
transient species that can interchange. To do so, we took advantage of the ability to treat
the cells with the de novo N-glycosylation inhibitor tunicamycin to allow the separate
identification of recently synthesized and longer lived copies of M3R. Initially, to ensure
that elimination of N-glycosylation did not prevent cell surface delivery of the M3R,
untreated and tunicamycin-treated cells that were induced to express Myc-Tyr149Cys,
Ala239GlyM3R-Cerulean were subjected to biotinylation to identify cell surface receptor
proteins. Biotinylated proteins were isolated and then resolved by SDS-PAGE. Detection
of biotinylated anti-Myc immunoreactivity in samples from both untreated (110 kDa) and
tunicamycin-treated (90 kDa) cells defined whether the receptor had been present at the
cell surface. The observed ratio of biotinylated N-glycosylated and non-glycosylated
M3R was similar to their proportions in total cell lysates (Fig. 4.6 (a)); this indicated that
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prevention of N-glycosylation does not interfere with cell surface delivery of this
receptor. Myc-Tyr149Cys, Ala239GlyM3R-Cerulean was then immunoprecipitated from
cells that were concurrently doxycycline-induced and tunicamycin-treated. Following
SDS-PAGE, immunoblotting such samples with anti-FLAG identified both nonglycosylated and N-glycosylated forms of FLAG-M3R-Citrine associated with MycTyr149Cys, Ala239GlyM3R-Cerulean (Fig. 4.6 (b)).

Figure 4.6: Interactions between M3R protomers synthesized at different times (a) Cell surface proteins
were labeled with biotin and, after their capture with streptavidin, these were resolved by SDS-PAGE
and anti-Myc reactivity monitored (left-hand panel). Total lysates of such cells were resolved and antiMyc reactivity measured (right-hand panel). (b) Flp-InTM T-RExTM 293 cells were treated with 100 ng
mL-1 doxycycline to induce expression of Myc-Tyr149Cys, Ala239GlyM3R-Cerulean for a 24 hour
period. Tunicamycin treatment was maintained during the entire induction period to prevent Nglycosylation of newly synthesized proteins. Anti-Myc immunoprecipitates were resolved by SDSPAGE and immunoblotted with anti-FLAG. The presence of N-glycosylated FLAG-M3R-Citrine as well
as the non-glycosylated form in these immunocomplexes is shown. This figure was reproduced from
(74).

Based on the earlier studies, the presence of the N-glycosylated form in anti-Myc
immunoprecipitates must reflect a complex that now contains a FLAG-tagged form of the
receptor

synthesized

prior

to

induction

of

expression

of

Myc-Tyr149Cys,

Ala239GlyM3R-Cerulean. Because both forms of the FLAG-tagged receptor are
immunoprecipitated with an anti-Myc antibody this demonstrates that induced MycTyr149Cys, Ala239GlyM3R-Cerulean protomers are present in complexes synthesized at
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different times. Thus, these results confirm that the oligomeric nature of the complexes is
non-permanent, and that the dimers and tetramers can interconvert.

4.2.4 Discussion
4.2.4.1 The M3R exists as a mixture of dimers and tetramers at the cell surface
By co-expressing differing ratios of Myc-Tyr149Cys, Ala239GlyM3R-Cerulean and
FLAG-M3R-Citrine in living cells and using spectrally resolved FRET we determined
apparent FRET efficiency (Eapp) histograms, reflecting oligomers of these forms of M3R
located in regions at or near the plasma membrane. The broad histograms obtained were
rich in information that could only be defined by organization of the M3R within a
rhombic tetramer and were incompatible with the oligomeric form of the M3R being
limited to a simple dimer, for which a single peak is expected (54, 65). By using this
method to analyze data from numerous cells expressing donor-tagged receptors at various
levels, the computed areas under each individually described Gaussian were averaged
over all cells, and bar charts displaying the average number of oligomers corresponding
to each of the five anticipated donor-acceptor configurations of a rhombus tetramer were
created for each of four donor expression levels. We modelled the expected contributions
of the component bars using a simple model that takes into account the ratio between
donor and acceptor concentrations, and this was subsequently compared to the
experimental data. This ratio was observed to increase with increasing doxycycline
concentrations, as expected for an increase in donor expression level. This provided
further support to our observation that the largest quaternary structure of M3R at the
plasma membrane was a rhombus tetramer.
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Despite this, the analyses of the experimental data clearly indicated a marked
excess in the amplitude of the second peak in the Eapp histogram compared to that
anticipated if the oligomeric M3R existed solely as a rhombic tetramer.

This

experimental excess could only be accounted for in models that allow dimers, but not
trimers or other oligomeric sizes, to also be present. In support of dynamic
interconversion between such oligomeric states over time, co-immunoprecipitation assays
suggested that receptors synthesized at different times can be detected in the same
oligomer and, therefore, that such complexes are transient in nature and able to
interchange protomers. Furthermore, by extension, the absence of M3R trimers in the
plasma membrane as indicated by the Eapp histogram data implies that protomers do not
associate into tetramers one at a time, but rather as dimeric pairs. These observations
lead to the conclusion that the molecular bonds within dimers are probably rather strong
and suggest that no species with an odd number of protomers are likely to exist under
physiological conditions; this excludes both monomers and trimers from the mix. Clearly,
non-covalent bonds between the protomers of a receptor dimer can be broken, as a range
of studies have produced and purified monomeric G-protein coupled receptors for both
biophysical and biochemical analysis (79, 80). Despite this, our results suggest for the
first time that dimers may be the smallest structural unit in which M3R exist at the plasma
membrane, and that the dimers associate reversibly to form tetramers. No direct evidence
for hexamers or further higher-order oligomers was obtained in these studies. This may
indicate that the tetramer is the highest-order structure of the M3R.
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Although our interpretation of the data as presented above appears to be selfconsistent, one could, in principle, argue that combinations of dimers and free donors (or
donor-only dimers) in our samples may have given the appearance of a combination of
dimers and rhombus-shaped tetramers. This possibility, while often mentioned in
discussions on this topic, is actually rather easily dismissed. Numerical simulations
previously performed by some of us did indeed indicate that the presence of noninteracting free donors in the same excitation volume with a mixed dimer composed of a
donor and an acceptor leads to a reduction in the amplitude of the dimer peak in the Eapp
histogram and an appearance of a broader distribution of FRET efficiencies towards
values lower than those of the dimer (73). However, no clearly individualized peak (apart
from that of the dimer) emerged from those simulations, and the rather amorphous
distribution of FRET efficiencies observed at values lower than that of the dimer ended
abruptly on the upper end of the Eapp scale. These features are at variance with the
histograms obtained in the present study which show multiple peaks whose amplitudes
decrease gradually towards the higher end of the Eapp distributions. We conclude that our
results are inconsistent with a combination of monomers (or just donor-only dimers) and
donor-acceptor dimers, and thus our proposal for mixtures of stable dimers and dynamic
tetramers continues to stand.

The concept that a dimer may be the minimal in situ configuration of a GPCR is
supported by recent work at single particle level which concluded that the serotonin 5HT2C receptor is present as a dimer at the plasma membrane but not as a monomer (81).
Notably, however, the same study was also unable to detect tetramers of this receptor.
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Furthermore, biochemical analysis of the organization of the orexin OX1 receptor has
recently concluded that this GPCR also exists predominantly as a dimer (82). Moreover,
although an earlier single molecule-tracking study on the muscarinic M1 receptor
apparently identified monomer-dimer formation and dissociation (62), these conclusions
relied entirely on the view that the ligand used to label the receptor was monitoring
monomer-dimer transitions rather than, as suggested herein, potential dimer-tetramer
transitions. If all class A GPCRs might be expected to show the same basic homooligomerization behavior, the available data (i.e. presence vs. absence of tetramers) can
be rationalized if receptor expression level in the serotonin 5-HT2C receptor study (81)
was substantially lower than in the present study and hence the proportion of dimers to
tetramers may have been driven towards a predominance of dimers. This hypothesis
could be tested if the overall expression level of the receptors was known in different
studies. In the present study, the total concentration of donor- and acceptor-tagged
receptors was ~3 x 105 per cell (see the Results section).

4.2.4.2 The ligand does not alter significantly the relative abundance of dimers and
tetramers
In addition to determining the quaternary structure of the M3R, we have also determined
that selective agonist binding to either of the M3R receptor forms did not have a
significant effect on its structure and distribution among different oligomer sizes. While
this agrees with the findings of other similar studies (83) (and see (84) for review) we
cannot, at this stage, completely eliminate the possibility that ligands may affect the
partition between dimers and tetramers under extreme concentration situations. To test
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this possibility will necessitate the use of rapid excitation switching to determine total
concentrations of receptors in the cells and a way to vary the total expression level of
M3R over a broad range of concentrations. In addition, because agonist ligand binding to
M3R is known to cause rapid conformational changes associated with receptor activation
(77), this may mean that the transmembrane domains that undergo conformational
changes as a result of activation and those that are involved in protein-protein interfaces
binding are distinct from one another. It has also been observed that the binding of an
inverse agonist ligand to purified and reconstituted β2-adrenoceptors could modulate
tetrameric organization (83). Future studies should, therefore, attempt to probe such rapid
alterations in quaternary structure.

4.2.4.3 A general framework for describing GPCRs oligomerization
In summing up our observations above, we propose a general oligomeric structure model
that is consistent with the present results while also emphasizing some of the salient
features of GPCR oligomeric structure as noted from the abundant literature. Our model
(Fig. 4.7) assumes that there are two different binding sites on each receptor, each of
which may be associated with a separate transmembrane domain or group of
transmembrane domains. If the interaction between the dissimilar binding sites is much
stronger than that between the similar binding sites, the monomers will associate first into
stable dimers (Fig. 4.7 (a)); then, the dimers may associate weakly (by comparison to
protomers within dimers) to form tetramers with ‘closed’ structures, i.e., structures that
cannot grow further (Fig. 4.7 (b)). In addition, these tetramers are predicted to take a
rhombic shape (Fig. 4.7 (b)). As discussed above, the M3R appears to indeed present
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these features, i.e., it forms rhombus shaped tetramers, but not hexamers. If, by contrast,
each binding site interacts strongly with the site of its own type but weakly with a
dissimilar site, the dimers (Fig. 4.7 (c)) can form ‘open’ tetramers (Fig. 4.7 (d)), i.e.,
tetramers that can grow into higher order oligomers by successive addition of dimers, as
suggested initially by Lopez-Gimenez et al. (85).

Figure 4.7: A general two-interaction site model of GPCRs. If the strength of the interaction for
dissimilar binding sites is very high and exceeds that of similar sites, stable dimers form (a) which may
associate reversibly into tetramers (b). If similar sites interact strongly and more than the dissimilar sites,
stable dimers (d) may associate reversibly into open tetramers (c), which may be conducive to higher
order structures under certain circumstances. Binding sites are shown as small triangles and squares, and
same shapes represent same type of site. The star-shapes in all the structures represent the fluorescent
tags, which could be donors and acceptors, or combinations thereof. This figure was reproduced from
(74).

An argument can also be made for the existence of a third possibility, which is in
fact a particular case of the first two - that of indistinguishable binding sites. In this case,
dimers and tetramers may coexist with monomers and trimers. Also in this case, whether
the receptors may form oligomers with open or closed configurations may depend on
secondary factors, such as additional nonspecific interactions, concentration, and
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temperature. In fact, these factors may also alter the degree of association between the
two types of dimers illustrated in Fig. 4.7, but they would not be decisive with regard to
whether the higher order oligomer has a closed or open structure.

Our proposal reconciles published experiments that report different oligomeric
sizes or combinations thereof for different receptors and perhaps different expression
levels. Further investigations are necessary in order to fully elucidate which receptor
exactly falls into which category and also to identify the specific binding sites.
Availability of atomic level crystal structures for greater numbers of receptors would
provide a tremendous boost to wide-ranging efforts to determine the location of the
binding interfaces on individual receptors. The structure of M3R has been determined
very recently (86), while efforts are underway in various labs to determine the crystal
structure of other GPCRs.

Only two clear examples identifying interfaces able to form dimers (49) and
tetramers (50)

as well as their orientation within the dimer/oligomer are currently

available. The atomic level structure of the µ-opioid receptor illustrates the potential for
dimeric-tetrameric exchange and that the extent of this might be defined by expression
levels and local variations in receptor concentration e.g. in distinct regions of the plasma
membrane such as cholesterol-rich domains or rafts. The structure (50) shows a dimeric
4-helix bundle interface provided by many of the residues of transmembrane domains V
and VI. Such an extensive interface is likely to be highly stable and would provide a basis
for the minimum organisation of the receptor being a dimer. However, although clearly
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observed in the crystal structures the second interface, provided by amino acids from
transmembrane domains I and II and elements of helix 8, is much less extensive, and
therefore intrinsically likely to be far less stable. This might well provide a molecular
basis for our observations of the co-existence of dimers and tetramers of M3R within the
plasma membrane and the potential for the proportion of each to be determined by
receptor expression level. Even though in the current experiments the donor expression
level was controlled by induction of expression of the energy donor species, we have not
been able to control total expression level over a wide range to allow detailed analysis of
this question, although it is noteworthy that the estimated proportion of dimers decreased
as we increases expression of the energy donor variant. Given that the M3R receptor is
expressed in high amounts in various smooth muscles and in certain regions of the brain
but at lower levels in tissues such as salivary gland and pancreatic beta cells (87) it may
be that the steady-state distribution between dimers and tetramers will vary in different
cells and tissues.
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Chapter 5 Conclusion and future direction of work

5.1

Conclusion

As described in chapter 3, we tested the spectral FRET method for determination of
quaternary structure of proteins using obligate trimers and tetramers. The results showed
that the measured average FRET efficiencies of membrane trimers and cytoplasmic
tetramers were same as predicted by the kinetic theory of FRET. We further used the
method to determine the quaternary structure of M3Rs in presence and absence of ligands.
Our findings revealed that M3Rs exist as stable dimers at the plasma membrane while a
fraction of it forms transient rhombus tetramers without forming any other oligomers. We
didn’t see any effect of ligand on the proportion of dimers to tetramers. Based on our
findings, we proposed a general framework for GPCR oligomerization that reconcile the
published experiments reporting different oligomeric size or combinations for different
receptors that can be due to different expression levels of the receptors.

5.2

Future direction of research

5.2.1 Monte Carlo simulations to study protein oligomerization
The FRET spectrometric method developed in our lab and described in the previous
chapters is a very powerful tool to study protein-protein interaction for very low
expression levels of the proteins of interest, ideally single complexes per pixel. However,
the limitations of this method were not investigated fully. For instance, it is important to
understand that how the expression level of membrane receptors affects the FRET
efficiency histogram. In study started very recently, we have used a Monte Carlo
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simulation-based approach that uses the FRET theory described previously (1, 2) to
generate Eapp histograms for different numbers of complexes per pixel. The simulated
histogram is then compared with the experimental Eapp histogram to obtain information
on the protein oligomerization and concentration. We have applied the method to study
oligomerization of M3R in the intracellular vesicles based on the known results that M3Rs
mostly form rhombus tetramer complexes on the plasma membrane (3).

In the first step of the simulation, a two-dimensional grid (or lattice) was
generated in which the complexes were distributed randomly. The average number of
complex per cell in the lattice (or pixel in the Eapp map) was set as a variable. The Eapp
values at each pixel was calculated individually, and an Eapp histogram was generated by
binning pixels of same Eapp value (with bin interval = 0.01 in the scale of 1) and plotting
them against Eapp. Based on the simulation results, we observed that the shape and size of
the Eapp histogram changed with the number of complex per pixel (Ncom).
(i)

If Ncom ≤ 1, the Eapp histograms were broad with distinct narrow peaks as

predicted by the rhombus tetramer model as shown in Fig. 5.1 (a). The pair-wise FRET
efficiency, characterizing the energy transfer in a single donor and acceptor pair (Ep) that
determines simultaneously the positions of the five Gaussian peaks of rhombus tetramer
model was taken as 0.4. The peak positions of simulated histogram were at 0.27, 0.40,
0.49, 0.57, and 0.67 that were also the peak positions predicted by the rhombus tetramer
model for Ep = 0.4.
(ii)

For 1 < Ncom ≤ 5, the simulated histograms were usually broad showing

continuous distributions of FRET efficiencies and some extra peaks apart from the peaks
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predicted by the model. Fig 4.1 (b) shows Eapp histograms Ncom = 3 where several peaks
appear along with the five peaks predicted by the model with Ep = 0.4.
(iii)

For, Ncom >10, the Eapp histogram collapses to a single and narrow peak,

termed as “histogram collapse” as shown in Fig 4.1 (c) (for Ncom = 20). This was due to
the mixture of more than a single type of complexes at every pixel giving an average Eapp
value. If the number of complex per pixel is high (>10 as observed from the simulation),
the average Eapp value at each pixel could be similar to the global average value of Eapp
resulting in a single peak. The peak positions in this case, were generally different from
that predicted by the model.

After generating the Eapp histograms at every iteration, the dominant peak position
(Eapp value) of the Eapp histogram was collected. Thus, a meta-histogram was generated
using the collected peak positions that represented number of peaks for each Eapp value
(in bin interval of 0.025 in the scale of 1). Since, the meta-histogram was obtained from
the peak positions in the Eapp histograms, hence the number and positions of the peaks in
the meta-histogram also depended on the number of complex per pixels. Similar to the
results obtained for Eapp histogram, the simulated meta-histogram resulted in same peak
positions as predicted by the model for Ncom ≤ 1, however, for 1 < Ncom ≤ 5, there were
certain extra peaks that were not predicted by the model. For Ncom >10, the metahistogram smeared to a continuous distribution of FRET efficiencies ranging from zero to
the highest FRET efficiency predicted by the model.
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Figure 5.1: Simulated Eapp histogram of a rhombus tetramer. The pair wise FRET efficiency of a donoracceptor pair, Ep = 0.4, total number of pixels = 10,000 and number of complex per pixels (a) Ncom = 0.1,
(b) Ncom = 3, and (c) Ncom = 20.

Based on the simulated results, we concluded that it is important to have
controlled expression of proteins in the systems of study for correct interpretation of the
results using the FRET spectrometric method. The current simulation method could not
predict the amplitudes of the peaks since the dependence of FRET efficiencies on the
fluorophore orientations were not known. Also, the method should be generalized to be
applicable for unknown receptors that can exist as differently sized oligomers.
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5.2.2 Quaternary structure of M3R in intracellular vesicles
As described in section 4.2.2, Flp-In

TM

T-REx

TM

293 cells expressing inducible Myc-M3-

Cerulean, and FLAG-M3-Citrine individually were imaged to obtain the elementary
emission spectrum for donor and acceptor respectively. These elementary spectra were
used to un-mix the emission spectrum at every pixel of the imaged section of the cell coexpressing inducible Myc-M3-Cerulean and constitutive FLAG-M3-Citrine to obtain the
donor fluorescence intensity in presence of acceptor (kDA) and acceptor fluorescence
intensity in the presence of donors (kAD). Fig. 5.1 (a) shows kDA and kAD images of a
representative Flp-In

TM

T-REx

TM

293 cell co-expressing Myc-M3-Cerulean and FLAG-

M3-Citrine. The images revealed that the intracellular M3 receptors were localized in
what appeared to be individual dot-like structures shown by an arrow in Fig. 5.1 (a),
potentially representing endocytic transport vesicles. The average FRET efficiencies of
individual dots (i.e., transport vesicle) were calculated from average values of kDA and kAD
using equation (3.41), one dot at a time, with 𝑄 𝐷 = 0.62 (4) and 𝑄 𝐴 = 0.76 (5). Eapp
histograms (Fig. 5.1(c)) were generated by binning the Eapp values for all individual dots
collected from cells subjected to different doxycycline concentrations (0.1, 1.0, 10.0 and
100.0 ng mL-1) according to their value (bin size, 0.025) and plotting the number of dots
in each bin against Eapp.
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TM

TM

Figure 5.2: Spectral FRET analysis of Flp-In
T-REx
293 cells expressing Myc-M3R-Cerulean
(inducible) and FLAG-M3R-Citrine (constitutive). (a) Photomicrograph of a representative cell showing
donor fluorescence intensity in presence of acceptors (kDA) and acceptor fluorescence intensity in presence
of donors (kAD). The arrows in each image point to one of the many dot-like structures (potentially transport
vesicles) seen within the cytoplasm. (b) Possible configurations of donor and acceptors within a rhombus
tetramers model predicting five distinct peaks in an apparent FRET efficiency histogram (Eapp) expressed in
terms of pair-wise FRET efficiency Ep. (c) Cumulative histogram of apparent FRET efficiencies (Eapp)
calculated from the Eapp of individual dots. The experimental data (circles) were fitted with two subpopulations of rhombus tetramer model (thick solid lines), each characterized by a single Ep. Thin dotted
lines, simulation using Ep = 0.294 and thin solid lines, simulations using Ep = 0.343.

The Eapp histogram for intracellular complexes was fitted using various models of
oligomers with different sizes and geometries (1, 6). The pair-wise FRET efficiency, Ep
was used as a fitting parameter which determines the positions of Gaussian peaks in the
experimental data. Fig. 4.1 (c) shows the result of simulation using two subpopulations of
rhombus tetramer model illustrated in Fig. 4.1 (b). For comparison the experimental Eapp
histogram was also fitted using (i) a general parallelogram tetramer model (ii) mixer of
dimers and free donors model, (iii) dimer only model and, (iv) a hexamer model; but
based on the lowest fitting residual (see equation 4.3) we propose a combination of two
sub-populations of rhombus tetramers as the most likely quaternary structure for the M3R
within intracellular vesicles.
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Figure 5.3: Simulation of Eapp histogram of dots in intracellular vesicles using a rhombus tetramer model
using Ep = 0.5 and Ncom = 5 for total of 1200 dots (transport vesicles).

However, our results could not provide convincing evidence for the presence of
two different states of M3Rs inside the vesicles, which contrasts with the presence of a
single state at the plasma membrane. Therefore, we decided to use Monte Carlo
simulation method (described in section 5.1) to further

investigate whether the

appearance of extra peaks in the Eapp histogram other than the predicted peak positions by
a single state is the artifact of presence of more than single complexes inside the vesicles.
Fig 5.3 shows the simulation of the experimental Eapp histogram of dots or vesicles using
a rhombus tetramer model as shown in Fig 5.2 (b). The number of complex per dot used
to simulate the experimental histogram was 5, and Ep = 0.5. The simulated results showed
that the appearance of the peaks in the Eapp histogram other than the predicted peaks by a
rhombus tetramer model was due to the coexistence of more than one complex in the
vesicles. However, we were unable to simulate the amplitudes of the peaks in the
experimental Eapp histogram due to the lack of certain information in the method such as
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the variation of FRET efficiency due to fluorophore’s orientations and the presence of
dimers along with the tetramers in certain vesicles.

5.2.3 Quaternary structure of human secretin receptors
Human Secretin receptors (h-SecRs) are members of class B GPCRs and are known to
form homo- and hetero-oligomers (7-10), though there are inadequate evidences of
existence of secretin receptors as higher order oligomers than dimers. Using FRET
spectrometry, we have recently begun to investigate the oligomerization of wild type
human secretin receptor (wt-hSecR) and a mutant form of the receptor (mut-hSecR). The
mut-hSecR was made to prevent oligomerization by modifying the interacting sites of the
wt-hSecR (SecR G243A, I247A) (11). The plasmids DNA used for this study were made
in Miller lab, Mayo clinic and is described elsewhere (12). The protocol for sample
preparation and imaging is described in section 3.3. In short, wt-hSecR and mut-hSecR
tagged with GFP2 (donor) and YFP (acceptor) were transfected transiently to CHO cells
that were cultured overnight. For both wt-, and mut-hSecR, three types of samples were
prepared: (i) cells expressing wt/mut-hSecR-GFP2 to obtain donor spectrum, (ii) cells
expressing wt/mut-hSecR-YFP to obtain acceptor spectrum, and (iii) cells expressing
both wt-hSecR-GFP2 and wt-hSecR-YFP or mut-hSecR-GFP2 and mut-hSecR-YFP to
study interaction between receptors. A total of 2 µg plasmids DNA diluted in OptiMEM
medium was added to the cells to transfect with single plasmids DNA and 1 µg of
plasmids DNA from each plasmid was added to the cells to transfect with double
plasmids. A mock or untransfected sample was also prepared to use as a reference for
auto-fluorescence.
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The cells were imaged using optical micro-spectroscope (OptiMiS) and Eapp
histogram was obtained for individual cell as described in sections 3.4 - 3.6. Of all the
cells co-expressing wt-hSecR-GFP2 and wt-hSecR-YFP or mut-hSecR-GFP2 and muthSecR-YFP, roughly 60% exhibited either a single narrow peak or multiple dominant
peaks in the Eapp histogram while about 40% cells showed either a broad peak or no
distinct peak in their Eapp histograms. The peak positions of the ~ 60% cells showing
either single or multiple dominant peaks were collected, binned (bin interval = 0.02), and
number of cells vs. apparent FRET efficiencies were plotted to generate the metahistogram. Histograms of ~ 40% cells showing single broad peak were not included in
the meta-hisotgram.

Based on the various models used to simulate the meta-histogram of hSecRs, we
found that both wt-, and mut-hSecRs mostly existed as monomers and dimers. Also, the
probability of presence of higher order oligomers could not be neglected. The Eapp peak
positions predicted by dimer and free donor model were calculated using equation,

𝑛

𝐸𝑎𝑝𝑝 = 𝑘 𝐸𝑑 ,

(5.1)

where k being the number of donor per pixels and n takes integral values ranging from 1
to k and 𝐸𝑑 , the FRET efficiency of a dimer (13). The number of energy donors per pixel
which was set as a fitting parameter in a dimer and free donor model was found to be 12
indicating that there could be maximum of 12x2=24 receptors per pixel (including both
D- and A-tagged receptors) for both wt- and mut-hSecR. We also estimated the average
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number of receptors per pixel using known concentration of GFP2 protein solution (see
Appendix B), which was found to be 58 and 67 for wt- and mut-hSecR, respectively. The
disagreement between the number of receptors per pixel obtained from the two methods
could be due to the presence of dimers formed by acceptor only fluorophores or presence
of higher order oligomers along with dimers and monomers, information of which could
not be extracted from the meta-histogram. In order to confirm this hypothesis, further
experiments with controlled low expression level of receptors are needed to perform. For
very low expression level of receptors (close to single complex per pixel), the Eapp
histogram is expected to show distinct peaks (see simulation results described in section
5.1). The presence of mostly single complex per pixel should show a single peak in the
meta-hisotgram of the dimer-free donor model as described in equation (5.1). Thus, the
presence of tetramers or higher order oligomers will show extra peaks in the metahistogram other than the peak predicted for dimer. Hence, a parallel comparison of the
number and positions of peaks in the meta-histograms for both low and high expression
level of receptors can reveal the existence of higher order oligomers.

References:
1.

Raicu V, et al. (2009). Determination of supramolecular structure and spatial
distribution of protein complexes in living cells. Nature Photon 3(2):107-113.

2.

Raicu V (2007). Efficiency of resonance energy transfer in homo-oligomeric
complexes of proteins. J Biol Phys 33(2):109-127.

3.

Patowary S, et al. (2013). The muscarinic M3 acetylcholine receptor exists as two
differently sized complexes at the plasma membrane. Biochem J 452(2):303-312.

4.

Rizzo MA, Springer GH, Granada B & Piston DW (2004). An improved cyan
fluorescent protein variant useful for FRET. Nat Biotechnol 22(4):445-449.

170
5.

Griesbeck O, Baird GS, Campbell RE, Zacharias DA & Tsien RY (2001).
Reducing the environmental sensitivity of yellow fluorescent protein. Mechanism
and applications. J Biol Chem 276(31):29188-29194.

6.

Raicu V (2010). FRET-based determination of protein complex structure at
nanometer length scale in living cells. Nanoscopy and Multidimensional Optical
Fluorescence Microscopy, ed Diaspro A (CRC Press, Boca Raton).

7.

Harikumar KG, Ball AM, Sexton PM & Miller LJ (2010). Importance of lipidexposed residues in transmembrane segment four for family B calcitonin receptor
homo-dimerization. Regul Pept 164(2-3):113-119.

8.

Harikumar KG, Happs RM & Miller LJ (2008). Dimerization in the absence of
higher-order oligomerization of the G protein-coupled secretin receptor. Biochim
Biophys Acta 1778(11):2555-2563.

9.

Harikumar KG, Morfis MM, Sexton PM & Miller LJ (2008). Pattern of intrafamily hetero-oligomerization involving the G-protein-coupled secretin receptor.
J Mol Neurosci 36(1-3):279-285.

10.

Gao F, et al. (2009). Functional importance of a structurally distinct homodimeric
complex of the family B G protein-coupled secretin receptor. Mol Pharmacol
76(2):264-274.

11.

Harikumar KG, Pinon DI & Miller LJ (2007). Transmembrane segment IV
contributes a functionally important interface for oligomerization of the Class II G
protein-coupled secretin receptor. J Biol Chem 282(42):30363-30372.

12.

Siddiqui S, Cong WN, Daimon CM, Martin B & Maudsley S (2013). BRET
Biosensor Analysis of Receptor Tyrosine Kinase Functionality. Front Endocrinol
(Lausanne) 4:46.

13.

Raicu V, Singh DR (2013). FRET Spectrometry: A New Tool for the
Determination of Protein Quaternary Structure in Living Cells. Biophys J
105(9):1937-1945.

171

Appendix A
A.1.

Determination of FRET efficiency from intensity based measurements

In a mixture of donors (D) and acceptors (A), three different types of dimers can form:
DD, DA and AA. Donors and acceptors can also remain as monomer. Therefore the
emission intensity of donor in presence of acceptors when the donor is excited with an
excitation wavelength of 𝜆𝑒𝑥 can be expressed as (1):

𝐹 𝐷𝐴 (𝜆𝑒𝑥 ) = Γ 𝑒𝑥,𝐷 {[𝐷]𝑄 𝐷 + [𝐷𝐷]𝑄 𝐷 + [𝐷𝐴]𝑄 𝐷𝐴 }

(A.1)

Using equation (3.10) and knowing that excitation rate constant of donor in absence of
FRET is independent of FRET i.e., Γ 𝑒𝑥,𝐷 = Γ 𝑒𝑥,𝐷𝐴 , above equation can be written as:

𝐹 𝐷𝐴 (𝜆𝑒𝑥 ) = Γ 𝑒𝑥,𝐷 [𝐷]𝑇 𝑄 𝐷 − Γ 𝑒𝑥,𝐷 [𝐷𝐴]𝑄 𝐷 𝐸

(A.2)

Similarly, acceptor intensity can be expressed as:

𝐹 𝐴𝐷 (𝜆𝑒𝑥 ) = Γ 𝑒𝑥,𝐴 {[𝐴]𝑄 𝐴 + [𝐴𝐴]𝑄 𝐴 } + Γ 𝑒𝑥,𝐴𝐷 [𝐴𝐷]𝑄 𝐴

(A.3)

Since probability of acceptor excitation in presence of donor increases because of another
pathway to transfer donor excitation energy via dipole-dipole coupling, therefore the rate
of excitation of acceptor in presence of FRET can be defined as:
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Γ 𝑒𝑥,𝐴𝐷 = Γ 𝑒𝑥,𝐴 + Γ 𝑒𝑥,𝐷 𝐸

(A.4)

Thus using equations (3.10) and (I.4), the acceptor intensity can be written as:

𝐹 𝐴𝐷 (𝜆𝑒𝑥 ) = Γ 𝑒𝑥,𝐴 [𝐴] 𝑇 𝑄 𝐴 + Γ 𝑒𝑥,𝐷 [𝐷𝐴]𝑄 𝐴 𝐸

(A.5)

where [𝐷], [𝐴], [𝐷𝐴], [𝐷𝐷], and [𝐴𝐴] are concentrations of free donors, acceptors,
donors forming dimers with acceptors, donor only, and acceptor only dimers respectively
and [𝐷] 𝑇 and [𝐴] 𝑇 are the total concentrations of donor and acceptors respectively. For a
mixture of oligomers of size n with 𝜇𝑜𝑙𝑖𝑔𝑜 as total concentration of oligomers and k as the
number of donors in oligomer; the total concentrations of donors and acceptors can be
expressed as:

𝑛

𝑛
[𝐷] 𝑇 = [𝐷] + 𝜇𝑜𝑙𝑖𝑔𝑜 𝑛𝑃𝐷 = [𝐷] + 𝜇𝑜𝑙𝑖𝑔𝑜 ∑ 𝑘 ( ) 𝑃𝐷𝑘 𝑃𝐴𝑛−𝑘
𝑘

(A.6)

𝑘=1

𝑛−1

𝑛
[𝐴]𝑇 = [𝐴] + 𝜇𝑜𝑙𝑖𝑔𝑜 𝑛𝑃𝐴 = [𝐴] + 𝜇𝑜𝑙𝑖𝑔𝑜 ∑(𝑛 − 𝑘) ( ) 𝑃𝐷𝑘 𝑃𝐴𝑛−𝑘
𝑘

(A.7)

𝑘=0

where 𝑃𝐷 = [𝐷]

[𝐷]𝐷 +[𝐷]𝐴
𝐷 +[𝐷]𝐴 +[𝐴]𝐷 +[𝐴]𝐴

and 𝑃𝐴 = [𝐷]

[𝐴]𝐷 +[𝐴]𝐴
𝐷 +[𝐷]𝐴 +[𝐴]𝐷 +[𝐴]𝐴

are the probabilities of

donor and acceptor concentrations respectively in the oligomers while [𝐷], [𝐷]𝐴 , and
[𝐷]𝐷 are the concentrations of free donors, donors forming complexes with acceptor, and
donors only complexes respectively; [𝐴], [𝐴]𝐷 , and [𝐴]𝐴 are concentration of free
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acceptors, acceptors forming complexes with donors, and acceptors only complexes.
Considering similar approach as in equations (A.2) and (A.5) the emission intensities of
donor and acceptor for the complex can thus be expressed as:

𝑛

𝑘

𝐷𝐴
𝐹𝑛𝐷𝐴 (𝜆𝑒𝑥 ) = Γ 𝑒𝑥,𝐷 {[𝐷]𝑄 𝐷 + 𝜇𝑜𝑙𝑖𝑔𝑜 ∑ ∑ 𝑃𝐷𝑘 𝑃𝐴𝑛−𝑘 ∑ 𝑄𝑖,𝑘,𝑛,𝑞
}
𝑘=1 𝑞

𝑖=1

𝑛−1

𝑛−𝑘

(A.8)

𝑒𝑥,𝐴𝐷
𝐹𝑛𝐴𝐷 (𝜆𝑒𝑥 ) = 𝑄 𝐴 {Γ 𝑒𝑥,𝐴 [𝐴] + 𝜇𝑜𝑙𝑖𝑔𝑜 ∑ ∑ 𝑃𝐷𝑘 𝑃𝐴𝑛−𝑘 ∑ Γ𝑗,𝑘,𝑞
}
𝑘=0 𝑞

(A.9)

𝑗=1

Using equation (3.10) with (A.6) and (A.7) above equations can be written as:

𝑛−1

𝐹𝑛𝐷𝐴 (𝜆𝑒𝑥 )

=Γ

𝑒𝑥,𝐷

𝑘

𝑛
𝑄 {[𝐷] 𝑇 − 𝜇𝑜𝑙𝑖𝑔𝑜 ∑ ∑ ( ) 𝑃𝐷𝑘 𝑃𝐴𝑛−𝑘 ∑ 𝐸𝑖,𝑘,𝑛,𝑞 }
𝑘
𝐷

𝑘=1 𝑞

𝑖=1

𝑛−1

𝐹𝑛𝐴𝐷 (𝜆𝑒𝑥 )

𝐴

= 𝑄 {Γ

𝑒𝑥,𝐴 [𝐴]

𝑇

+Γ

𝑒𝑥,𝐷

(A.10)

𝑘

𝑛
𝜇𝑜𝑙𝑖𝑔𝑜 ∑ ∑ ( ) 𝑃𝐷𝑘 𝑃𝐴𝑛−𝑘 ∑ 𝐸𝑖,𝑘,𝑛,𝑞 }
𝑘
𝑘=1 𝑞

(A.11)

𝑖=1

Table A.1: Measured and predicted Eapp of VCVV for various sets of experiments

Day

1

2

3

4

5

6

7

8

9

Measured
Eapp

0.78

0.69

0.79

0.81

0.78

0.87

0.83

0.81

0.80

0.74

0.78

0.77

0.79

0.78

0.80

0.78

0.77

0.76

Predicted
Eapp
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Table A.2: Measured and predicted Eapp for cytoplasmic tetramers for different expression level

ACVA

VCAA

ACAV

VCVVmeasured

VCVVpredicted

3.5 - 4.0

0.49 ± 0.02

0.55 ± 0.05

0.35 ± 0.02

0.76 ± 0.05

0.73 ± 0.04

4.0 - 4.2

0.48 ± 0.04

0.58 ± 0.03

0.41 ± 0.04

0.80 ± 0.04

0.75 ± 0.03

4.2 - 4.4

0.52 ± 0.04

0.61 ± 0.02

0.45 ± 0.04

0.81 ± 0.04

0.79 ± 0.03

4.4 - 4.6

0.53 ± 0.04

0.64 ± 0.01

0.47 ± 0.03

0.84 ± 0.03

0.79 ± 0.02

4.6 - 4.8

0.55 ± 0.03

0.66 ± 0.01

0.52 ± 0.03

0.87 ± 0.02

0.81 ± 0.02

4.8 – 5.5

0.60 ± 0.02

0.69 ± 0.00

0.55 ± 0.00

0.91 ± 0.00

0.83 ± 0.01

log FD

A.2.

Investigation of excess in FRET efficiencies of VCVV with expression level

The difference in measured and predicted Eapp (ΔEapp ) of VCVV for range of
expression level as shown in Table A.2 is listed in Table A.3. The error for ΔEapp is
calculated using following equation:

𝐸𝑟𝑟𝑜𝑟 = ∆𝐸1 + ∆𝐸2

(A.12)

where ∆𝐸1 and ∆𝐸2 are errors for measured Eapp and predicted Eapp of VCVV
respectively.
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Table A.3: ΔEapp of VCVV and their errors for different expression level

log FD

ΔEapp

Error

3.5 - 4.0

0.03

0.09

4.0 - 4.2

0.05

0.07

4.2 - 4.4

0.03

0.07

4.4 - 4.6

0.05

0.05

4.6 - 4.8

0.06

0.04

4.8 – 5.5

0.07

0.01
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Appendix B
B.1

Estimation of receptors concentration:

To calculate the number of receptors per pixel of hSecRs, we used the known
concentrations of GFP2 protein solution that was obtained as a generous gift from
Lucigen Corporation, WI, USA. The GFP2 stock solution at concentration of 137 µM
were diluted in deionized water to prepare seven different concentrations: 100, 50, 75, 25,
10, 5 and 2.5 µM. A 30µL of each solution was taken in a Petri dish with 0.13 mm glass
bottom coverslip for imaging. The fluorescence intensities of GFP2 solution at a
particular concentration was calculated by integrating the measured emission spectrum
for that concentration. Fig. (B.1) shows fluorescence intensity vs. concentration graph of
the GFP2 protein solution where closed circles and solid line are the data points and their
linear fitting respectively. As described in section 4.2.2.8, fluorescence of the donor in
absence of acceptor (FD) for hSecR can be calculated using the kDA and kAD values
determined from spectral unmixing. We calculated the average FD value per pixel for
each cell used in the meta-histogram both for wt- and mut-hSecRs. Under the same
experimental conditions for GFP2 solution that was used for wt-, and mut-hSecR,
equation (4.1) becomes:
𝐹𝑥
𝐶𝑥 = 𝐶𝑠 𝑠 ,
𝐹

(B.1)

where ‘x’ and ‘s’stands for hSecRs and GFP2 solution respectively. Thus, using any point
on the straight ling in Fig. B.1 for known concentration (𝐶𝑠 ) and fluorescence intensity
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(𝐹 𝑠 ) along with the calculated values of average FD value per pixel and size of a pixel (2),
the average number of receptors expressed per pixels can be calculated.

Figure B.1: Intensity vs. concentration graph of GFP2 protein solution. Closed circles are the
experimental data point and solid line is the linear fitting of the experimental data point.
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